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The primary function of skeletal muscle is to produce the forces that are 
needed to generate movement of the body. Muscle strength and muscle 
power are largely dependent on muscle mass. Consequently, skeletal muscle 
mass represents a major determinant of functional performance. 
Furthermore, as skeletal muscle tissue comprises ~70% of body cell mass, it 
plays a major role in glucose, fat, and protein metabolism. Even with healthy 
aging, there is a gradual, progressive decline in muscle mass with an 
advancing age. The latter leads to the loss of muscle strength and, as such, a 
decline in functional performance. The loss of muscle mass and function 
with aging has been termed sarcopenia. Sarcopenia is recognized as an 
important factor in determining the ability of elderly people to live 
independently, and is associated with a reduction in the quality of life (69). 
Given the global changes in population demographics and the increased life 
expectancy, sarcopenia is becoming a major health care and socio-economic 
problem. The detrimental consequences of sarcopenia necessitate the 
development of interventional strategies to improve muscle mass and 
function in the elderly. Throughout the lifespan, skeletal muscle tissue 
appears to retain at least part of its remarkable capacity to adapt to changes 
in physiological demands. Resistance type exercise training represents the 
most effective interventional strategy to improve skeletal muscle mass and 
strength, even in the very old. However, the exact pathways by which 
physical activity induces the skeletal muscle adaptive response, as well as 
the specific mechanisms underlying the process of sarcopenia itself remain 
to be elucidated. 
In this thesis, age-related changes in muscle mass and strength are studied on 
a whole-body, limb, and myocellular level. Specific attention is given to the 
potential role of myonuclei and satellite cells (or skeletal muscle stem cells) 
in the etiology of sarcopenia and in the skeletal muscle adaptive response to 
intervention programs designed to counteract the loss of muscle mass and 
function in the elderly. 
Aging and sarcopenia 
Population demographics show that in Western societies, the number of 
people aged 65 years and over will rise by 70-100% over the next 40 years; 
from 61 million up to 103 million in Europe (28) and from 46 million to 108 
million in the United States (104). In The Netherlands, similar trends are 
observed, with an expected rise in the number of people aged 65 years and 
over from 2.4 to 4.2 million between 2007 and 2040 (16). As such, the 
proportion of elderly in the population will increase from ~15% to more than 
25% within the next 40 years. 
With aging, there is a gradual but progressive loss of skeletal muscle mass 
and function, which is referred to as sarcopenia. The term sarcopenia was 
first introduced by Rosenberg (89) in an attempt to draw more attention 
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towards the clinical importance of the progressive decline in muscle tissue as 
a cause of reduced functional performance in the elderly. The word stems 
from the Greek language and literally means poverty (penia) of flesh (sarco). 
Sarcopenia is not associated with any specific disease state and is, therefore, 
distinct from cachexia and/or muscle wasting as observed in diseases like 
cancer, human immunodeficiency virus (HIV), or chronic obstructive 
pulmonary disease (COPD) (94). With normal human growth and 
development, skeletal muscle mass increases until the third decade and then 
remains relatively stable until the age of 40-50 years. Thereafter, a gradual 
but progressive decline is observed, with the loss of skeletal muscle mass 
predominantly located in the extremities. Baumgartner et al. (5) defined 
sarcopenia as an appendicular skeletal muscle mass value (sum of lean tissue 
mass in the arms and the legs) of at least 2 standard deviations below the 
gender-specific mean for healthy, young adults. Using this criterion, the 
prevalence of sarcopenia in a population-based sample of people above the 
age of 60 years was shown to be ~25%, and up to ~50% in individuals aged 
80 years and over. Similar findings were reported by Ianuzzi et al. (50) and 
Janssen et al. (52). For regional muscle volume and/or cross-sectional area 
of specific muscles or muscle groups, cross-sectional studies have shown 
decreases of ~4-11% per decade between the ages 20-85 years, with a more 
predominant decline in the lower extremities (24, 53, 73, 74, 97). 
Longitudinal data support these findings by showing similar, or even larger 
declines after 5-12 years of follow-up in the elderly (35, 39). 
Consequences of sarcopenia 
Muscle mass has been shown to be a major determinant of muscle strength 
(36, 63). The strong correlation between muscle mass (total thigh muscle 
cross-sectional area) and muscle strength (one-repetition maximum leg press 
strength) is depicted in Figure 1.1. In line with the age-related loss of 
skeletal muscle mass, muscle strength starts to decline after the 3rd decade, 
with a more rapid decline after the 5th decade (70, 74). Lower extremity 
muscle mass and strength are closely linked to functional performance and 
mobility in the elderly. Fiatarone et al. (31) observed an inverse correlation 
between quadriceps muscle strength and 6 m walking time, the number of 
steps needed to walk 6 m, and chair rise time. Likewise, Visser et al. (106) 
reported that a reduced thigh muscle area is associated with decreased lower 
extremity functional performance. Data from the New Mexico Elder Health 
Survey showed that the age-related decline in muscle mass and strength can 
result in serious functional impairment. The presence of sarcopenia was 
associated with a 2-4 times higher risk of balance abnormalities, the need to 
use a cane while walking, the prevalence of 3 or more disabilities in daily 
functioning, and/or having fallen once or more over the past year (5). In 
addition, the loss of muscle mass and strength with aging is also 
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accompanied by a decline in endurance capacity and increased fatigability 
(33). Eventually, advanced muscle weakness results in the inability to 
perform activities of daily living, an increased fall risk, the loss of 
independence, a greater need for institutionalization, and a higher mortality 
(8, 24, 29, 52, 86). As such, sarcopenia imposes a major burden on health 
care costs in Western societies. In 2000, the health care costs directly 
attributable to sarcopenia were estimated to be 1.5% of total health care 
expenditures (i.e. 18.5 billion dollar) in the United States (54). 
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Figure 1.1 Correlation between total thigh muscle cross-sectional area (CSA) measured by 
CT scan and one-repetition maximum (1RM) leg press strength (n = 60, r = 0.70, Verdijk 
2008, unpublished observations). 
 
Furthermore, it should be realized that skeletal muscle tissue represents a 
major metabolic organ, playing an important role in glucose, fat and protein 
metabolism. Consequently, sarcopenia is generally associated with an 
increased risk of developing chronic metabolic diseases, like type 2 diabetes, 
obesity, osteoporosis, and cardiovascular disease (29, 80). Taken together, 
the detrimental consequences of sarcopenia underline the importance of 
designing strategies that can effectively delay and/or reverse the loss of 
muscle mass with aging. Before describing such potential interventions to 
prevent or limit the loss of muscle mass with aging, the muscular features 
that characterize sarcopenia will be addressed and some of the mechanisms 
underlying the changes in muscle tissue with aging will be identified. 
Age-related changes in muscle characteristics 
From approximately the fourth decade, whole-body lean tissue mass 
progressively declines with increasing age. This loss of skeletal muscle mass 
is not uniformly distributed over the different body regions. First of all, the 
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decline seems to be larger in the extremities when compared with the trunk 
(6, 39). Furthermore, leg muscles have been reported to be affected to a 
greater extent than arm muscles (39, 53), which might explain the apparent 
loss of mobility with aging. In addition, different muscle groups are affected 
differently throughout the aging process, which is probably due to their 
functional and/or structural diversity (3, 63). Besides the apparent decrease 
in whole-body and regional lean mass and muscle cross-sectional area, 
qualitative changes at the level of the entire muscle include an increase in 
connective tissue content and fat infiltration (43, 72). 
On the level of the muscle fiber, Lexell et al. (73) clearly show that both 
type I and type II muscle fibers are lost with aging. Some studies have 
shown an increased proportion of type I muscle fibers at a more advanced 
age, implying the predominant loss of type II muscle fibers (25, 71). In 
contrast, others report no changes in muscle fiber type composition, both in 
cross-sectional (48) and in longitudinal studies (3, 35). Furthermore, fiber 
type grouping (73) and decreased capillarization (35) have been observed in 
elderly muscle tissue. By far the most consistent is the observation of 
specific type II muscle fiber atrophy with aging. In contrast to the type I 
muscle fibers, type II muscle fiber size is 25-50% lower in the elderly when 
compared with the young (25, 44, 64, 71-73, 98). It should be noted that the 
majority of studies included biopsy samples taken from the vastus lateralis 
muscle. Changes in muscle fiber size with aging probably depend on the 
location of the muscle and on the functional demands placed on it. Although 
type II muscle fiber atrophy has also been observed in the masseter (62) and 
the biceps brachii muscles (64), generalization of these findings to other 
muscle groups of the human body should be performed with great caution. 
As mentioned above, the decrease in muscle mass, resulting from the loss 
and atrophy of the muscle fibers, is a major determinant of the age-related 
loss of muscle strength. In addition, qualitative changes in skeletal muscle 
tissue seem to contribute to the loss of functional capacity. This age-related 
change in muscle quality leads to a decline in specific force, i.e. muscle 
strength corrected for muscle mass. Specific force has been shown to be 
reduced at the level of the entire muscle (63, 83) and at muscle fiber level at 
a more advanced age (38). The qualitative changes underlying a decline in 
muscle force include specific type II muscle fiber atrophy, increased 
connective tissue content, greater fat infiltration, greater hydration level of 
lean tissue, reduced myofibrillar protein concentration, and impaired 
neuromuscular drive (4, 9, 22, 27, 43, 61, 72). The relative importance of 
these qualitative changes for the functional consequences of sarcopenia 
remains to be determined. 
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Etiology of sarcopenia 
It is generally acknowledged that sarcopenia forms a complex, multifactorial 
process. Although the exact cellular and/or molecular mechanisms 
underlying sarcopenia are still a matter of debate, a number of possible 
explanations have been suggested in the literature. The following is a 
summary of the etiological factors that are generally thought to be 
responsible for the loss of muscle mass with aging (24, 26, 29, 40, 58, 80, 
93, 105, 107). 
From the most basic point of view, any loss of muscle mass stems from a 
structural imbalance between muscle protein synthesis and muscle protein 
breakdown. Though initial studies have suggested that there might be an 
age-related reduction in basal muscle protein synthesis, most recent data 
indicate that basal muscle protein turnover rates do not differ between young 
and elderly adults when corrected for total muscle mass (80, 107, 108). 
Furthermore, a subclinical inflammatory state (with increased levels of 
TNFα, NF-ĸB and IL-6 in the elderly) has been suggested to lead to 
increased muscle protein catabolism (21, 24, 58, 93). However, as opposed 
to specific disease states (e.g. rheumatoid arthritis, HIV, cancer, COPD), 
whole-body protein breakdown rates do not seem to differ between healthy 
young and elderly subjects (84). As basal muscle protein synthesis and/or 
whole-body breakdown rates do not seem to differ between the young and 
elderly, most research groups now hypothesize that the loss of muscle mass 
with aging is, at least partly, attributed to a blunted muscle protein synthetic 
response to the main anabolic stimuli, i.e. protein intake and/or physical 
activity (107). In accordance, recent studies show a reduced sensitivity and 
responsiveness to the anabolic properties of protein or amino acid ingestion 
in the elderly (21, 60). Furthermore, the increase in muscle protein synthesis 
rate observed following a single bout of resistance type exercise has been 
shown to be attenuated in the elderly when compared with the young (65, 
68). The mechanisms responsible for this apparent anabolic resistance to 
food intake and/or physical activity remain to be elucidated. 
Decreased systemic and/or local concentrations of testosterone, estrogen, 
growth hormone (GH) and/or insulin like growth factor (IGF)-1 have also 
been implicated as potential contributing factors to the etiology of 
sarcopenia (59, 93, 107). Since IGF-1 is also locally synthesized in skeletal 
muscle tissue, it remains to be determined whether its reduced hormone 
concentration might lead to muscle atrophy, or vice versa. Next to the 
endocrine aspects, neurologic alterations might contribute to the loss of 
muscle mass and function with aging. Age-related changes in motor unit 
activation and/or co-activation might negatively affect force generating 
capacity. In addition, the loss of motor neurons from the spinal cord is 
considered an important factor in the loss of muscle fibers at a more 
advanced age. Furthermore, surviving motor neurons can re-innervate the 
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denervated muscle fibers, resulting in the histological observation of fiber 
type grouping (24, 105). The loss of motor neurons might partly be 
attributed to apoptosis, resulting from oxidative damage. Likewise, DNA 
deletion mutations induced by reactive oxygen species probably result in the 
loss of myonuclei and/or mitochondria, resulting in mitochondrial 
dysfunction. The latter has been suggested to contribute to muscle fiber 
atrophy and to the reduced muscle oxidative capacity observed in elderly 
muscle (58, 80, 107). 
In addition to the above mentioned aspects, there are 2 important etiological 
factors that are related to lifestyle changes: a less than optimal nutrition and 
physical inactivity at a more advanced age. With aging, food intake has been 
shown to decline progressively, due to decreased energy expenditure, 
reduced taste sensation, and/or social isolation. The resulting decline in 
protein intake seems to be the most important nutritional factor that can 
contribute to the loss of muscle mass with aging (26, 29, 58, 107). The 
current recommended dietary allowance (RDA) for protein intake in the 
elderly is set at 0.8 g/kg/d (85, 103). However, the adequacy of the RDA for 
maintaining and/or improving skeletal muscle mass in the elderly has been a 
matter of scientific debate for many years. Campbell et al. (12) recently 
suggested that the current RDA meets the minimum dietary needs of 
virtually all elderly. However, in a 14 week dietary control study, the same 
authors showed that intake of the RDA is marginally inadequate to increase 
skeletal muscle mass following resistance type exercise training (14), and 
results in a reduction in quadriceps cross-sectional area in sedentary elderly 
men and women (15). In contrast, when habitual dietary protein intake is 
modestly above the current RDA, resistance type exercise training induces 
an increase in muscle mass and strength. Further increasing protein intake 
does not seem to augment these beneficial effects (11, 13, 51). Although 
specific guidelines for dietary protein intake in the elderly remain to be 
established, it seems evident that habitual protein under-nutrition may 
contribute to the loss of muscle mass observed with aging. 
Furthermore, an increase in age is generally associated with the adoption of a 
more sedentary lifestyle, which reduces the anabolic stimuli related to 
mechanical loading (24, 80, 107). Moreover, there appears to be an ongoing 
downward spiral in which physical inactivity leads to reduced muscle mass, 
resulting in a further decline in habitual physical activity levels, and so on. 
As such, sedentary elderly have been reported to show a faster decline in 
muscle mass compared with their physically active peers (24). However, 
even in elderly with a life-long history of exercise training, muscle mass 
declines with an advancing age. In particular, elderly weightlifters show 
remarkably little change in muscle fiber size and lean mass when compared 
with (sedentary) young, healthy adults (64). Yet, these active elderly still 
have shown a decline in muscle mass when compared with young, resistance 
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type exercise-trained athletes. Thus, the general consensus is that sarcopenia 
is not merely a consequence of disuse, but also represents the result of aging 
per se. 
In summary, many mechanisms have been proposed to underlie the age-
related loss of muscle mass. The relative importance of each of these factors, 
as well as their interaction, remains to be established. Furthermore, the exact 
molecular and cellular (signaling) pathways that explain the proposed 
relation between the above mentioned etiological factors and the progressive 
decline in muscle mass and strength are still poorly understood. Establishing 
the physiological and molecular mechanisms responsible for the loss of 
muscle mass would provide valuable information to define more effective 
exercise, nutritional, and/or pharmacological intervention strategies to 
prevent and/or treat sarcopenia. 
Interventions for sarcopenia 
Most intervention studies that aim to increase skeletal muscle mass and 
improve muscle function in the elderly have focused on some of the 
proposed etiological factors of sarcopenia; i.e. endocrine changes, physical 
activity, and/or nutrition (8, 24, 29, 49, 58, 107). With respect to hormonal 
interventions, testosterone administration has been shown to be most 
effective, resulting in greater muscle mass and muscle strength (58, 99). 
However, several attempts are currently being made to stimulate anabolic 
and/or inhibit catabolic pathways by modulating systemic availability and/or 
local expression of specific hormones, such as GH and IGF-1 (40, 75). The 
long-term efficacy and safety of hormone administration, or pharmacological 
interventions in general, remain to be determined (8, 59). 
Nutritional interventions have mainly focused on increasing the dietary 
protein intake and/or the ingestion of specific protein or (essential) amino 
acid mixtures thought to augment muscle anabolism. The potential of food 
ingestion to stimulate muscle protein accretion has been well established (88, 
109). Moreover, post-exercise amino acid/protein administration has been 
shown to substantially augment net muscle protein accretion following 
exercise (7, 65, 66, 102). However, long-term intervention studies have 
generally failed to observe any surplus benefits of protein supplementation 
in the elderly, either as a separate interventional strategy or as an adjunct to 
prolonged exercise training (32, 41, 51). Yet, data on long-term interventions 
are relatively scarce, and the efficacy of timed protein supplementation 
regimens designed to augment the skeletal muscle adaptive response to 
exercise training forms a promising field for further work in this area. 
Prolonged resistance type exercise training has proven the most effective 
interventional strategy to counteract sarcopenia (49). Frontera et al. (37) 
were amongst the first to show that elderly are still capable of increasing 
skeletal muscle mass and strength in response to resistance type exercise 
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training. Numerous studies have since confirmed the substantial clinical 
benefits of resistance type exercise training in various elderly 
subpopulations, even in nonagenarians (17, 31, 32, 46, 67, 92). The benefits 
of resistance type exercise training generally include an increase in whole-
body lean tissue mass, greater cross-sectional area of the trained muscle 
group, muscle fiber hypertrophy, and substantial gains in muscle strength. 
Furthermore, some studies also assessed the functional outcome in terms of 
activities of daily living and report improved walking speed and stair 
climbing power (31, 32). Notably, improvements in other health parameters, 
like insulin sensitivity, blood pressure and body weight, have also been 
reported (49, 111). Endurance type exercise training has been shown to 
improve oxidative capacity in elderly adults (29, 34), but does not increase 
absolute muscle mass. Therefore, resistance type exercise training is 
currently considered required in the effective prevention and/or treatment of 
sarcopenia and should, as such, be implemented in physical activity 
programs aiming to improve health and functional performance in the 
elderly population. 
The above findings clearly indicate that skeletal muscle tissue in the elderly 
is still capable of adapting to functional overload by inducing muscle 
hypertrophy, increasing muscle strength, and improving muscle function. 
However, it seems that the response in the elderly is limited and/or delayed 
when compared with younger adults (67, 110). The latter may be related to 
the attenuated exercise-induced muscle protein synthetic response in elderly 
versus young adults (68). This could be partially explained by an age-related 
impairment in anabolic hormone action, myogenic gene expression, and/or 
anabolic signaling (30, 42, 68, 98, 112). More work is needed to extend our 
knowledge on these and other potential mechanisms to assess why elderly 
respond differently to anabolic stimuli when compared with healthy, young 
adults. 
Satellite cells, myonuclei and sarcopenia 
Recently, there has been a renewed interest in the potential regulatory role of 
skeletal muscle satellite cells in the skeletal muscle adaptive response to 
resistance type exercise training and/or other interventions that induce 
skeletal muscle hypertrophy (77, 81). Satellite cells are essential for 
myofiber maintenance, growth, and regeneration (45). As such, changes in 
satellite cells have been implicated in the loss of muscle mass with aging. 
The current knowledge on the proposed role of satellite cells in the etiology 
of sarcopenia is described in more detail below. 
Skeletal muscle tissue is composed of thousands of muscle fibers. 
Throughout myogenesis, each muscle fiber is generated by fusion of 
numerous myoblasts. As such, skeletal muscle fibers contain multiple nuclei 
(or myonuclei). According to the myonuclear domain theory (2, 19), each 
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myonucleus controls gene expression over a finite volume of cytoplasm, 
known as the myonuclear domain. Therefore, changes in the size of a muscle 
fiber will theoretically be associated with a change in the size of the 
myonuclear domain and/or a change in the number of myonuclei within the 
muscle fiber. In accordance, muscle fiber atrophy has been associated with 
both a decline in myonuclear domain size (1, 82), and a decline in 
myonuclear content (1, 10). Likewise, muscle hypertrophy is associated with 
an increase in myonuclear domain size (56), and an increase in myonuclear 
number (57). In addition to the latter, there is a constant need for new 
myonuclei throughout the lifespan, to accomplish growth and to replace 
myonuclei that are lost following injury or apoptosis. However, myonuclei 
are post-mitotic and, as such, unable to account for the incorporation of new 
myonuclei. Therefore, the ability of skeletal muscle tissue to adapt to various 
physiological demands largely depends on a small population of skeletal 
muscle stem cells, termed satellite cells (45). 
Satellite cells were first described by Mauro in 1961 (76). They owe their 
name to their localization under the basement membrane, but outside the 
plasma membrane of the muscle fiber. In adult skeletal muscle, satellite cells 
normally reside in a quiescent state in their niche below the basement 
membrane. Upon activation, satellite cells start to proliferate. Subsequently, 
they either differentiate to form new myonuclei, or return to quiescence 
thereby replenishing the resident satellite cell pool through self-renewal (23, 
45, 113). Interestingly, satellite cells seem to represent the only source for 
the generation of newly formed myonuclei in vivo (2, 78, 79). Thus, satellite 
cells are essential for maintenance, repair, and growth of skeletal muscle 
tissue. Figure 1.2 shows a scheme of the theoretical adaptation of 
myonuclear and satellite cell content associated with muscle fiber atrophy 
and hypertrophy. 
Given their importance in the regulation of skeletal muscle mass, satellite 
cells might play a prominent role in the mechanisms underlying muscle 
wasting conditions. Moreover, their ability to provide additional myonuclei 
underlines their importance in skeletal muscle maintenance and hypertrophy. 
As such, the interest in satellite cells in relation to sarcopenia has increased 
rapidly over the past 20 years. One of the first questions to be answered was 
how the satellite cell pool changes throughout life. During postnatal growth 
and development, up to 15% of the myonuclei are satellite cells (101). In 
adults, skeletal muscle satellite cells comprise only 1-5% of all myonuclei 
(25, 57, 87). 
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Figure 1.2 Myonuclei and satellite cells in the skeletal muscle adaptive response. A: cross-
section of a muscle fiber containing several myonuclei. Muscle hypertrophy is associated with 
an increase in myonuclear domain size (due to increased protein synthesis induced by the 
existing myonuclei) and/or an increase in the number of myonuclei. In contrast, atrophy is 
associated with a reduced myonuclear number and/or domain size. B: longitudinal section of a 
muscle fiber containing several myonuclei and a satellite cell. Skeletal muscle satellite cells 
normally lie quiescent between the basal lamina and the plasma membrane of the associated 
myofiber. Upon injury or mechanical loading, satellite cells are activated and start to 
proliferate. Following differentiation, new myonuclei will be incorporated into the myofiber 
to achieve hypertrophy. In addition, part of the proliferated satellite cells will return to 
quiescence to replenish the satellite cell pool. Alternatively, differentiated cells can fuse 
together to generate new myofibers in case of significant myofiber damage (not shown). 
Reprinted from Ageing Res Rev, Snijders T, Verdijk LB, van Loon LJC, The impact of 
sarcopenia and exercise training on skeletal muscle satellite cells, in press, © (2009), with 
permission from Elsevier. 
 
In animal studies, the number of satellite cells was shown to decline with an 
increasing age. The latter has been proposed to result in the loss of 
myonuclei, triggering muscle fiber atrophy (10). Likewise, Shefer et al. (96) 
suggested that the loss of satellite cells would cause loss of myogenic 
potential, leading to a reduction in regenerative capacity and impaired 
myofiber maintenance. These studies suggest that a decline in satellite cell 
content contributes to the age-related loss of muscle mass. However, studies 
performed on human muscle tissue have been less consistent. Some authors 
report a decline in satellite cell content in the elderly versus the young, with 
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no apparent decline in myonuclear content (55, 87). In contrast, others failed 
to report significant differences in both satellite cell and myonuclear content 
between young and elderly men and women (25, 47, 91). So far, the apparent 
discrepancy in the literature remains unresolved. 
Rosenblatt et al. (90) showed that satellite cell activity and incorporation of 
myonuclei derived from satellite cells are required for loading-induced 
hypertrophy in adult rat muscle. In humans, the number of satellite cells was 
shown to be increased 24 h after a single exercise session (25), implying that 
activation and proliferation of satellite cells occurs within a short time period 
after mechanical loading. However, studies evaluating the long-term 
adaptive response to exercise intervention in humans have not provided 
conclusive data. In healthy young men, muscle fiber size and satellite cell 
content have been reported to increase in response to resistance type exercise 
training, with no changes in the number of myonuclei per muscle fiber (56). 
In contrast, other studies report that muscle fiber hypertrophy is 
accompanied by an increase in both myonuclear and satellite cell content, 
suggesting successful incorporation of satellite cell progeny (57, 100). 
Similar inconsistencies have been reported in the elderly. Following 
endurance type exercise training in elderly males, a moderate increase in 
muscle fiber size was accompanied by an increase in satellite cell content, 
but no change in myonuclear content (18). Furthermore, an increase in 
satellite cell content was only reported in the exercised leg after unilateral 
strength training (92), underlining the importance of mechanical loading for 
inducing satellite cell proliferation in the elderly. In contrast, significant 
muscle fiber hypertrophy following resistance type exercise training has also 
been observed without apparent accompanying changes in myonuclear 
and/or satellite cell content (47). The factors underlying the apparent 
discrepant findings are presently unclear. 
Aside from age-related changes in the skeletal muscle satellite cell pool size, 
there might be an age-related impairment in the ability of satellite cells to 
become active, proliferate and/or differentiate in response to anabolic 
stimuli. Such an impairment in satellite cell functioning has been suggested 
to contribute to the age-related loss of muscle mass and/or to a reduction in 
the regenerative potential of skeletal muscle tissue. Early studies have shown 
a potential delay in the in vitro cell cycle entry (i.e. activation) of satellite 
cells from aged animals (95). However, subsequent satellite cell proliferation 
appeared to progress normally. Furthermore, Conboy et al. (20) have shown 
that satellite cell activation can be normalized by exposing aged muscle to a 
young systemic environment. These findings suggest that the intrinsic 
regenerative potential of satellite cells is not altered with age. Age-related 
changes in the interplay between satellite cells and their surrounding milieu 
are more likely to play a key role in the blunted activation of satellite cells 
with aging. 
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In summary, both a decline in the number of satellite cells and reduced 
sensitivity to the stimuli leading to the activation, proliferation and 
differentiation of satellite cells might be of key importance in understanding 
the molecular mechanisms responsible for the age-related loss of muscle 
mass. Although aged skeletal muscle tissue seems to retain at least part of its 
ability for adaptation, considerable discrepancy exists in the literature. Age-
related changes in satellite cell content and in the response of satellite cells 
to exercise or other anabolic interventions in the elderly remain far from 
being elucidated. Since much of the available information stems from 
specific animal models and cell culture experiments, part of the 
inconsistency reported in the literature may be attributable to differences in 
the species or models studied. Additionally, differences in subjects’ age, 
gender, and training background, are likely to modulate the process of 
muscle mass loss with aging, resulting in considerable inter-individual 
variability. The different function and/or mode of action of the specific 
muscle groups under investigation might also explain at least some of the 
inconsistency. Muscle fiber atrophy with aging has been shown to be largely 
confined to the type II muscle fibers. In addition, the skeletal muscle 
adaptive response to altered use or, more specifically, to exercise 
intervention, has generally been shown to be muscle fiber type-specific. As 
such, it is very likely that the effects of aging and/or exercise intervention on 
satellite cells are also muscle fiber type-specific. Such fiber type-specificity 
might be the key issue linking the above mentioned variables (i.e. 
differences in species, age, training background, etc) to the reported 
inconsistency regarding age-related differences in satellite cell content. 
However, muscle fiber type-specific data on satellite cell content are 
completely lacking for human muscle. 
To provide a better insight into the potential role of satellite cells in age-
related skeletal muscle atrophy and exercise induced muscle hypertrophy, it 
seems imperative to evaluate muscle fiber characteristics in a fiber type-
specific manner. Specific human in vivo studies are needed to explore the 
fiber type-specific changes in satellite cell content that might occur with 
aging, and in response to exercise and/or nutritional intervention in the 
elderly. Integrating such analyses with fiber type-specific data on muscle 
fiber composition, size, and myonuclear content could reveal important 
mechanistic concepts of sarcopenia and provide new leads for the 
development of effective exercise, nutritional, and/or pharmacological 
interventions to prevent and/or reverse the progressive loss of muscle mass 
and function with aging. Therefore, in the present thesis we aim to 
investigate age-related changes in skeletal muscle mass, strength, and muscle 
fiber type-specific composition, size, and satellite cell content, and the 
adaptive response of these variables to resistance type exercise training in 
the elderly. 
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Thesis outline 
This thesis describes a series of studies in which the age-related changes in 
muscle mass and strength are studied on a whole-body, limb, and 
myocellular level. In Chapter 2, we determine the validity of one-repetition 
maximum (1RM) strength testing to determine leg muscle strength. 
Therefore, 1RM testing for leg extension strength is compared to gold 
standard dynamometry testing. In chapter 3, we confirm our hypothesis that 
type II muscle fiber atrophy in the elderly is associated with a fiber type-
specific decline in satellite cell content. In chapter 4, we present correlations 
between whole-body muscle mass and strength, and specific muscle fiber 
characteristics in the elderly. Chapters 5 and 6 discuss the results of a long-
term exercise intervention program. In chapter 5, we assess whether the age-
related muscle fiber type-specific changes can be reversed following 3 
months of resistance type exercise training in healthy, elderly men. In 
chapter 6, we test our hypothesis that the gain in muscle mass and strength 
following prolonged resistance type exercise training can be further 
augmented by timed protein supplementation prior to and immediately after 
each exercise bout. In chapter 7, we finally discuss the outcome of the 
studies described in chapters 2-6 and provide general conclusions. In 
addition, the implications of this thesis are discussed and future research 
aims are identified to extend on the knowledge currently available regarding 
the proposed role of satellite cells in the etiology of sarcopenia, and in the 
mechanisms associated with skeletal muscle hypertrophy in response to 
different interventional strategies to prevent and/or treat the progressive loss 
of skeletal muscle mass and function with aging. 
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ABSTRACT 
Skeletal muscle strength is often determined to evaluate the adaptive 
response to an exercise intervention program. Although dynamometry is 
considered the gold standard for the assessment of muscle strength in vivo, 
one-repetition maximum (1-RM) testing performed on training specific 
equipment is more commonly applied. We assessed the validity of specific 
knee extension 1-RM testing by comparison with dynamometry in a 
heterogeneous population (n=55). All participants performed 1-RM tests on 
regular leg extension and leg press machines. Additionally, isometric (at 7 
different knee angles) and isokinetic (at 4 different velocities) knee 
extension peak torques were determined. Pearson’s r was calculated for the 
relations between 1-RM data and peak torques for the entire population and 
for subgroups defined by age and gender. 1-RM strength correlated strongly 
with the dynamometer results. 1-RM leg extension correlated stronger with 
peak torques than did 1-RM leg press (0.78≤r≤0.88 vs 0.72≤r≤0.77, 
respectively; P<0.001). Similar correlations were observed in all subgroups. 
We conclude that 1-RM testing represents a valid means to assess leg muscle 
strength in vivo in young and elderly men and women. Considering the 
importance of training specificity in strength assessment, we argue that 1-
RM testing can be applied to assess changes in leg muscle strength following 
exercise intervention. 
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Introduction 
Skeletal muscle strength is an important determinant of the functional 
capacity of an individual. Whereas in young adults muscle strength has been 
related to athletic performance, in the elderly greater strength is generally 
associated with better health and a higher level of independent living, both of 
which contribute to a higher quality of life. In the elderly, strong correlations 
have been reported between leg muscle strength and functional performance 
in activities of daily living, such as stair climbing (22), the ability to rise 
from a chair (3, 5), and balance recovery tasks (40). The age-associated 
decline in skeletal muscle mass and strength can have detrimental effects, 
including increased incidences of falls and bone fractures, and the general 
loss of independence (11, 36, 37, 44). The importance of muscle strength for 
daily function necessitates the development of reliable and valid procedures 
to quantify muscle strength. The latter are needed to compare muscle 
strength on an individual and population level, to evaluate muscle strength 
loss following disease or disability, and to evaluate the benefits of 
intervention programs. 
In general, two forms of strength assessment are frequently used: one-
repetition maximum (1-RM) testing and dynamometry. 1-RM testing 
requires an isoinertial contraction; i.e., a constant weight is lifted at a 
voluntary speed. Dynamometry requires either an isometric or isokinetic 
contraction. When appropriate standardization is applied, e.g., 
familiarization with the exercise, positioning and stabilization of the 
participant, and instruction and encouragement of the participant, 
dynamometry has been shown to provide highly reliable test results (1). 
Because of the high reliability and objectivity, isometric and isokinetic peak 
torque measurements performed on a dynamometer (e.g. Cybex) are 
considered the gold standard for the in vivo assessment of skeletal muscle 
strength in humans (1, 24, 29). Consequently, dynamometry is generally 
applied to validate other strength assessment procedures (13, 21, 41). 
However, a major disadvantage of dynamometry is that the contraction 
patterns used generally do not resemble the patterns that are performed in 
exercise intervention programs (1). Evaluating the effects of training in a 
training specific context is considered to provide a more sensitive measure 
and thus represents a more accurate evaluation of strength gain (1, 2). 
Therefore, in most exercise intervention studies, strength is determined by 1-
RM testing, using the equipment used in the training regimen (17, 25, 31, 
43). 
Similar criteria apply to dynamometry and 1-RM testing when the aim is to 
establish reliable test results. Prediction equations for 1-RM testing facilitate 
the assessment of valid 1-RM measurements within 4 consecutive attempts, 
thereby preventing fatigue as a potential confounder (1). Thus, when applied 
in a standardized manner, 1-RM testing has been proposed to represent a 
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reliable method for the assessment of muscle strength in both the young and 
elderly (34, 35). In addition, several studies have compared 1-RM testing 
with dynamometry. Whereas training induced changes measured with these 
2 procedures seem to be unrelated, the correlations between 1-RM testing 
and dynamometry are generally high (2, 4, 32), implying the validity of 1-
RM testing for strength assessment. However, most research has investigated 
arm strength and only small groups of young participants have been studied 
(2, 4, 32). Hence, although leg strength is probably the most important factor 
affecting mobility in elderly (5, 15, 22) and numerous studies have included 
leg extension and leg press exercises for training of the upper legs (17, 25, 
33), these specific 1-RM testing procedures have yet to be validated with 
dynamometry. The latter might be even more important in different 
subpopulations. Qualitative changes in muscle mass and muscle function 
with aging (8, 12) and gender based differences in muscle characteristics 
(28) may differentially affect muscle strength as measured with different 
assessment procedures. Therefore, the validity of 1-RM testing should be 
assessed in different age and gender subgroups. 
In the present study, we assessed whether 1-RM testing represents a good 
means of evaluating leg muscle strength when compared with the use of 
dynamometry as the accepted gold standard. Therefore, we compared the 
results of 1-RM testing (leg extension and leg press) with isometric and 
isokinetic knee extension peak torque measurements in a large 
heterogeneous population, as well as in more homogeneous subgroups based 
on age and/or gender. 
Methods 
Participants 
A total of 55 adults volunteered to participate in this study (Table 2.1). All 
participants were healthy volunteers; participants with any pathology or 
disorder known to compromise their ability to perform maximal strength 
exercises were excluded. To validate 1-RM testing for large heterogeneous 
populations and to correlate levels of muscle strength with age, both men 
and women over a large age range were selected. For validation in more 
homogeneous populations, subgroups were defined based on either gender or 
age (young: age<60 y and old: age≥60 y). Age cut-off points were based on 
the finding that an age-related decline in muscle mass and function generally 
becomes more significant after the age of 60 (12, 39). All trials were 
performed on 2 days separated by no less than 3 days, and performed at the 
same time of day. Participants were instructed to refrain from intense 
physical activity in the 2 days prior to the test days. After explaining all 
procedures in detail, informed consent was obtained from all participants. 
The study was approved by the local Medical Ethics Committee. 
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Table 2.1 Participants’ characteristics 
 Total Female Male Elderly Young 
 n=55 n=26 n=29 n=22 n=33 
Age (y)  47±3 45±4 49±4 69±1* 33±2 
Height (m)  1.72±0.01 1.65±0.01 † 1.79±0.02 1.68±0.02 * 1.75±0.02 
Body mass (kg)  73.8±1.4 68.5±1.9 † 78.6±1.5 77.0±2.1 71.7±1.7 
BMI (kg/m2)  25.0±0.5 25.1±0.8 24.8±0.7 27.3±0.8 * 23.4±0.5 
Leg volume (L)  8.6±0.2 8.1±0.2 † 9.1±0.2 8.1±0.2 * 9.0±0.2 
PT isom (N·m) 155±6 131±6 † 177±8 135±7 * 168±8 
PT 2.09 (N·m)  105±4 88±3 † 119±4 92±4 * 114±5 
PT 3.14 (N·m)  86±3 72±3 † 98±4 74±3 * 95±4 
PT 4.19 (N·m)  72±3 59±2 † 83±4 63±3 * 78±4 
PT 5.24 (N·m)  63±3 50±2 † 73±3 54±3 * 69±3 
1-RM LE (kg)  81±3 67±3 † 93±4 70±4 * 88±4 
1-RM LP (kg)  167±6 137±5 † 193±8 148±9 * 179±8 
Values are means ± standard error. PT: peak torque. isom: isometric. 2.09, 3.14, 4.19, 5.24: 
isokinetic velocities in rad/s. 1-RM: one-repetition maximum. LE: leg extension. LP: leg 
press. †: significantly different compared with males. *: significantly different compared with 
the young. No age x gender interactions were observed. 
Test procedures 
At the first visit, the 1-RM for the leg press and the leg extension were 
estimated using the multiple-repetitions testing procedure and regular fitness 
machines (Technogym, Rotterdam). After a 5-min warm-up session on a 
cycle ergometer and demonstration of the lifting technique, familiarization 
trials were performed to ensure proper execution of the exercise protocol. 
The maximum amount of repetitions (reps) measured for a certain load was 
used to estimate the 1-RM: 1-RM = load / (1.0278 – 0.0278*reps) (30). This 
estimate was used at the second visit to determine the initial load for the 
actual 1-RM test. Body mass (digital balance scale; accuracy 0.01 kg) and 
height (wall mounted stadiometer; accuracy 0.1 cm) were measured with 
participants standing barefoot and dressed lightly. Leg volume was assessed 
according to the method described by Jones and Pearson as an estimate of 
leg muscle mass (9, 23). Since muscle mass is one of the major factors 
affecting muscle strength, we also aimed to determine whether leg volume 
represents a valid (indirect) marker for muscle strength. 
At the second visit, 1-RM leg press and 1-RM leg extension were measured 
following the protocol described by Kraemer and Fry (26). In short, the load 
was set at 90% of the estimated 1-RM (30) and was increased by 2.5–5 % 
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after each successful lift, until failure. Resting periods of 3 min were allowed 
between successive attempts. Although Mayhew et al., (30) developed their 
prediction equation in young adults performing a bench press exercise, 1-
RM for leg extension and leg press in the present study was typically 
reached within 3-4 attempts in all subgroups. Moreover, no significant 
differences were observed between predicted and measured 1-RM in any of 
the subgroups. After 30 min of rest, dynamometer testing took place on a 
Cybex-II dynamometer. Participants were in a seated position, with the hip 
joint at 80º of flexion (0º corresponding to the upper leg in line with the 
trunk). The lateral femoral epicondyl was aligned with the axis of rotation of 
the Cybex and the upper leg and pelvis were stabilized with Velcro straps to 
restrict compensatory movement. The lever arm was attached just proximal 
to the ankle joint. Familiarization trials at low intensity were performed 
before each measurement. All trials were separated by 2 min of rest to 
reduce fatigue. Since instantaneous muscle strength depends on muscle 
length, isometric contractions were randomly performed at 7 different knee 
joint angles (20, 35, 50, 65, 80, 95 and 110º, with 0º representing a fully 
extended knee joint). Participants were instructed to provide maximal 
voluntary contractions for 2-3 s. To study the effect of different contractile 
velocities, isokinetic knee extension torque was randomly measured at 4 
different speeds (2.09, 3.14, 4.19 and 5.24 rad/s). The hip joint angle and 
fixation to the chair were the same as in the isometric condition. A cyclic 
protocol was used, in that 3 consecutive extension / flexion movements were 
performed for each speed. All dynamometer data were sampled at 1,000 Hz 
and were digitized with a 12-bit analog-to-digital converter. All 
anthropometric and dynamometer measurements were performed on the 
right leg and all testing procedures were performed by the same investigator. 
Although test-retest reliability was not explicitly determined in the present 
study, all necessary measures were taken to ensure reliable test results for 
both 1-RM and dynamometry testing by adhering to a standardization 
routine (1). 
Data analysis 
After correction for gravitational forces (18), isometric peak torque was 
determined as the absolute maximum of all the torque data for knee 
extension. The knee joint angle at which isometric peak torque was obtained 
averaged 79±2°, with no differences between age and/or gender subgroups. 
The latter is in agreement with optimum knee joint angles reported 
previously (7, 27, 39).  Isokinetic data were first filtered with a 4th order low-
pass Butterworth filter with a cut-off frequency of 5 Hz. Then, isokinetic 
knee extension peak torque was determined as the maximum of the 3 
consecutive attempts for each speed. Thus, a total of 7 strength indices were 
determined for all participants: 1-RM leg extension, 1-RM leg press, 
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isometric peak torque and isokinetic peak torque at 2.09, 3.14, 4.19 and 5.24 
rad/s. 
Statistics 
To determine between-group differences in anthropometric variables and 
muscle strength (all 7 strength indices), a 2-way ANOVA was performed 
with age and gender as factors. To compare the outcome of the 1-RM testing 
with the dynamometer testing, bivariate Pearson correlation coefficients (r) 
were calculated for the primary outcome measures; 1-RM leg extension and 
1-RM leg press were correlated with isometric peak torque and with all 
isokinetic peak torques. This was done for the group as a whole, as well as 
for the young and elderly, and for males and females separately. As a 
measure of reliability for the comparisons between the different methods of 
strength assessment, 95% confidence intervals (95%-CI) were computed for 
the correlation coefficients (20). Also, standard errors of the estimates (SEE) 
were calculated as an indication of the magnitude of error involved in the 
comparisons. Differences between the correlation coefficients calculated for 
leg extension and leg press were tested statistically (20). Bonferroni 
corrections were used for multiple testing. 
The relation between age and all 7 strength indices was investigated by 
calculating Pearson correlation coefficients for the entire group and for the 
male and female subgroups separately. In addition, the correlation between 
leg volume (as an estimate of muscle mass/volume) and all 7 strength 
indices was determined. All statistical procedures were performed with 
SPSS 13.0. Statistical significance was set at P<0.05. 
Results 
A total of 55 participants aged 19-84 y were examined in this study (Table 
2.1). For leg muscle strength, significant age and gender effects were 
observed for the group as a whole, with no age x gender interactions. Males 
were significantly stronger than females on all 7 strength indices (P<0.001). 
Young adults were significantly stronger than the elderly, with leg extension 
and leg press strength and all isokinetic and isometric peak torques being 
higher in the young vs the elderly (P<0.01). These age and gender effects 
were evident in both the male and female and in the young and elderly 
subgroups, respectively (P<0.05). 
The correlations between 1-RM and isometric/isokinetic peak torques were 
stronger for leg extension than for leg press (Figure 2.1 and Table 2.2), with 
r-values ranging from 0.78 to 0.88 (SEE: 0.06-0.09) and from 0.72 to 0.77 
(SEE: 0.08-0.09), respectively (P<0.001). The strongest correlation was 
found between 1-RM leg extension and isometric peak torque (r=0.88; SEE: 
0.06, 95%-CI: 0.81-0.93). The correlations between 1-RM and isometric 
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peak torque and between 1-RM and isokinetic peak torque at 3.14 rad/s were 
markedly larger for leg extension than leg press (P<0.05). 
 
Table 2.2 Correlations between different strength indices 
    PTisom PT 2.09 PT 3.14 PT 4.19 PT 5.24 
Total 
 
1-RM LE 
 
0.88 ‡ 
(0.81-0.93) # 
0.85 ‡ 
(0.75-0.91) 
0.84 ‡ 
(0.74-0.91) # 
0.78 ‡ 
(0.65-0.87) 
0.80 ‡ 
(0.68-0.88) 
 1-RM LP 
 
0.77 ‡ 
(0.63-0.86) 
0.77 ‡ 
(0.63-0.86) 
0.74 ‡ 
(0.59-0.84) 
0.74 ‡ 
(0.59-0.84) 
0.72 ‡ 
(0.57-0.83) 
Female 
 
1-RM LE 
 
0.83 ‡ 
(0.66-0.92) 
0.64 † 
(0.33-0.82) 
0.73 ‡ 
(0.47-0.87) 
0.47 * 
(0.19-0.72) 
0.69 ‡ 
(0.41-0.85) 
  
1-RM LP 
 
0.75 ‡ 
(0.51-0.88) 
0.72 ‡ 
(0.47-0.87) 
0.73 ‡ 
(0.48-0.87) 
0.61 † 
(0.29-0.81) 
0.71 ‡ 
(0.45-0.86) 
Male 
 
1-RM LE 
 
0.83 ‡ 
(0.67-0.92) # 
0.82 ‡ 
(0.64-0.91) # 
0.79 ‡ 
(0.59-0.90) # 
0.73 ‡ 
(0.49-0.86) 
0.69 ‡ 
(0.43-0.84) 
  
1-RM LP 
 
0.64 ‡ 
(0.36-0.81) 
0.59 † 
(0.29-0.79) 
0.56 † 
(0.25-0.77) 
0.56 † 
(0.25-0.77) 
0.50 † 
(0.17-0.73) 
Elderly 
 
1-RM LE 
 
0.93 ‡ 
(0.83-0.97) # 
0.75 ‡ 
(0.49-0.89) 
0.77 ‡ 
(0.52-0.90) 
0.76 ‡ 
(0.49-0.89) 
0.81 ‡ 
(0.59-0.92) # 
  
1-RM LP 
 
0.76 ‡ 
(0.49-0.89) 
0.60 † 
(0.24-0.82) 
0.64 † 
(0.30-0.84) 
0.58 † 
(0.21-0.81) 
0.63 † 
(0.28-0.83) 
Young 
 
1-RM LE 
 
0.84 ‡ 
(0.69-0.92) # 
0.84 ‡ 
(0.70-0.92) 
0.82 ‡ 
(0.67-0.91) 
0.73 ‡ 
(0.52-0.86) 
0.72 ‡ 
(0.51-0.85) 
  
1-RM LP 
 
0.73 ‡ 
(0.52-0.86) 
0.79 ‡ 
(0.62-0.89) 
0.72 ‡ 
(0.50-0.85) 
0.75 ‡ 
(0.55-0.87) 
0.70 ‡ 
(0.47-0.84) 
Data are Pearson’s r, with 95% confidence intervals in parentheses. Standard errors of the 
estimates were between 0.06 and 0.09 for the group as a whole and between 0.08 and 0.17 for 
the subgroups. PT: peak torque. isom: isometric. 2.09, 3.14, 4.19, 5.24: isokinetic velocities in   
rad/s. 1-RM: one-repetition maximum. LE: leg extension. LP: leg press. *: P<0.05; †: P<0.01; 
‡: P<0.001. #: significantly different from 1-RM LP (P<0.05). 
 
In general, stronger relations were observed between 1-RM leg extension 
and peak torque values than between 1-RM leg press and peak torque values 
in the different age and gender subgroups, except in the female subgroup. In 
all subgroups separately, the strongest correlation was found between 1-RM 
leg extension and isometric peak torque with r ranging from 0.83 (SEE: 
0.11, 95%-CI: 0.67-0.92) to 0.93 (SEE: 0.08, 95%-CI: 0.83-0.97; P<0.001). 
Statistically significant differences between leg extension and leg press 
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(P<0.05) were observed for the relation between 1-RM and isometric peak 
torque (male, elderly and young subgroups), and for the relation between 1-
RM and isokinetic peak torque at 2.09 and 3.14 rad/s (male subgroup) and at 
5.24 rad/s (elderly subgroup). For the study population as a whole and for 
the subgroups, the correlations between 1-RM (both leg extension and leg 
press) and isokinetic peak torques tended to decrease with an increase in 
angular velocity. Correlations between 1-RM and peak torque values were at 
all times moderate to strong with only 6 out of the 50 r-values being below 
0.60 and 35 of the r-values being 0.71 and higher (Table 2.2). 
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Figure 2.1 Scatterplots of the relations between one-repetition maximum (1-RM) and peak 
torque (PT) data. Subgroups are indicated by different symbols. a-b-c: 1-RM leg extension vs 
isometric, isokinetic 2.09 rad/s, and isokinetic 5.24 rad/s peak torques, respectively. d-e-f: 1-
RM leg press vs isometric, isokinetic 2.09 rad/s and isokinetic 5.24 rad/s peak torques, 
respectively. Lines represent the fitted regression. 
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Leg volume was significantly correlated with all strength indices, with r 
ranging from 0.64 to 0.72 (P<0.001). The strongest relations were found 
between leg volume and 1-RM measures (Figure 2.2, Table 2.3). 
Correlations were shown to be similar in the male, young and elderly 
subgroups, although the absolute r-values tended to be lower in the elderly 
subgroup (range 0.46 to 0.66). In the female subgroup, the correlation 
between leg volume and strength was relatively weak and r only reached 
significance for the correlation between leg volume and 1-RM leg extension, 
1-RM leg press, isometric peak torque and isokinetic peak torque at 2.09 
rad/s, with r-values of 0.56, 0.49, 0.40 and 0.41, respectively. 
Age correlated negatively with all strength indices, with r ranging from -0.30 
to -0.43 (Table 2.3). In the gender subgroups, the correlations tended to be 
even stronger, with r ranging from -0.32 to -0.61 and from -0.50 to -0.64 in 
the female and male subgroups, respectively (P<0.05). 
 
Table 2.3 Correlations between strength, age, and leg volume 
  1-RM LE 1-RM LP PT isom PT 2.09 PT 3.14 PT 4.19 PT 5.24 
Total Age -0.40 † -0.34 * -0.36 † -0.39 † -0.43 † -0.30 * -0.37 † 
 legV 0.72 ‡ 0.72 ‡ 0.67 ‡ 0.68 ‡ 0.65 ‡ 0.64 ‡ 0.67 ‡ 
F Age -0.48 * -0.57 † -0.45 * -0.56 † -0.61 † -0.32 -0.54 * 
 legV 0.56 † 0.49 * 0.40 * 0.41* 0.32 0.14 0.31 
M Age -0.64 ‡ -0.50 † -0.50 † -0.57 † -0.56 † -0.51 † -0.55 † 
 legV 0.66 ‡ 0.70 ‡ 0.65 ‡ 0.65 ‡ 0.65 ‡ 0.68 ‡ 0.69 ‡ 
O legV 0.60 † 0.66 † 0.56 † 0.54 * 0.46 * 0.46 * 0.56 † 
Y legV 0.72 ‡ 0.69 ‡ 0.65 ‡ 0.67 ‡ 0.65 ‡ 0.64 ‡ 0.64 ‡ 
1-RM: one-repetition maximum. LE: leg extension. LP: leg press. PT: peak torque. isom: 
isometric. 2.09, 3.14, 4.19, 5.24: isokinetic velocities in rad/s. F: female. M: male. O: elderly. 
Y: young. legV: leg volume *: P<0.05; †: P<0.01; ‡: P<0.001. 
Discussion 
The aim of the present study was to determine whether 1-RM testing is a 
valid means to assess muscle strength of the knee extensors. A strong 
correlation was observed between strength measured with 1-RM testing and 
knee extension peak torque as obtained using dynamometry. Furthermore, 
the strong correlation was shown to be independent of age and/or gender. 
1-RM testing and isometric/isokinetic dynamometry are the main methods of 
strength assessment in scientific research (1, 4, 24). Because of superior 
reliability and high internal validity, dynamometry is considered the gold 
standard for strength assessment. In addition, the function of individual 
muscles can be studied more appropriately when using dynamometry (19, 
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38). However, in exercise intervention programs, resistance training 
equipment is used instead of dynamometers. Therefore, 1-RM testing is 
generally performed on the same equipment used in the training to evaluate 
changes in muscle strength. 
 
Figure 2.2 Scatter plots of the relations between leg volume and different strength indices. 
Subgroups are indicated by different symbols. a-b-c-d: leg volume vs one-repetition 
maximum (1-RM) for the leg extension, 1-RM for the leg press, isometric peak torque (PT) 
and isokinetic 2.09 rad/s peak torque (PT 2.09), respectively. Lines represent the fitted 
regression. 
 
The 1-RM strength testing procedure represents a training specific 
assessment, e.g., considering activation and coordination related aspects. As 
such, 1-RM testing should provide the most sensitive measure of the training 
response (1). In accordance, greater increases have been reported in 1-RM 
strength when compared to isometric/isokinetic peak torques after a period 
of resistance training in both the young (2, 4) and elderly (14, 16, 42). 
Resistance training programs in the elderly have often included leg press and 
leg extension exercises, since quadriceps muscle strength is strongly 
associated with mobility (10, 15, 17, 25). Strength assessment procedures 
used in these training programs should not only be sensitive to temporal 
changes, but should also allow discrimination between participants of 
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different strength. Unfortunately, most validation studies comparing 1-RM 
testing with dynamometry have focused on arm strength in young 
participants (2, 4, 32). Therefore, in the present study, we evaluated the 
validity of 1-RM leg extension and 1-RM leg press for measuring maximal 
knee extension strength with knee extension dynamometry in a 
heterogeneous population, consisting of participants of various ages and both 
sexes. 
Skeletal muscle strength is affected by the speed and mode of contraction, as 
well as by muscle length during contraction. Each of these factors is likely to 
influence the relation between 1-RM testing and dynamometry. Nonetheless, 
in the present study we observed strong significant correlations between 
strength as assessed by 1-RM leg extension and dynamometry (Figure 2.1 a-
c; 0.78≤r≤0.88; SEE: 0.06-0.09). The latter clearly shows that there is 
excellent agreement between muscle strength as assessed by 1-RM leg 
extension and knee extension peak torques. This strong correlation is likely 
attributed to the similarity in joint positioning, the single-joint movement 
(isolating the quadriceps) and the open-chain of resistance that characterize 
both approaches. The differences in contraction velocity and the single-leg 
versus the two-legged nature of the exercises clearly do not seem to have a 
major effect on the relation between 1-RM leg extension and dynamometry. 
Our findings are in line with those of other studies reporting strong 
correlations between upper extremity strength as assessed with 1-RM testing 
and isometric/isokinetic dynamometry in young males (2, 32). 
Although strong correlations were also observed between 1-RM leg press 
and knee extension peak torques, the observed correlations were generally 
lower than those between 1-RM leg extension and peak torques (Table 2.2). 
Although not always statistically significant, this difference was evident for 
all peak torques separately and is likely explained by the different 
characteristics of the leg press exercise. Leg press consists of a closed-chain 
exercise including hip, knee and ankle joint movement, representing whole 
limb extension strength rather than isolating the knee extensors, as is the 
case with leg extension and dynamometry. Several other studies have 
suggested that weaker correlations between different testing methods are the 
result of dissimilarities in the execution of the movement (24, 32). 
For both leg extension and leg press, correlations tended to be stronger with 
isometric and low velocity isokinetic peak torques than with high velocity 
isokinetic peak torques. The stronger correlations are probably due to greater 
similarities in contraction velocity between the different methods, which has 
been reported previously (24). This finding might be explained by the fact 
that a change in maximum force with a change in contraction velocity has a 
differential effect in participants: this effect depends on, for example, the 
different training background of the participants, the activation status of the 
muscle (7), and fiber type differences (i.e. percentage type II fibers) between 
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participants (8). Because of the high load in 1-RM testing, the contraction 
velocity is relatively low. Since the strongest correlations were found 
between 1-RM data and isometric peak torques, it could be argued that the 
contraction velocity during 1-RM testing is closest to the isometric 
condition. In addition, larger differences in the contraction velocity between 
the 1-RM testing and the high velocity isokinetic testing could have caused 
the larger variability between these testing modalities, thereby explaining the 
decrease in the respective correlations. In the present study, all correlations 
between 1-RM and dynamometer data were > 0.71. The latter implies that 1-
RM testing is a valid means to evaluate maximal muscle strength. 
In the present study, subgroups were defined to investigate the possible 
modulating effect of age and gender on the relation between strength as 
assessed by 1-RM and dynamometry. Although the population size of the 
individual groups was relatively small (n=22), leading to somewhat larger 
SEE (see Table 2.2), we observed good correlations between the 1-RM 
(especially leg extension) and dynamometer data within each of the 
subgroups, with the only exception being the relation between 1-RM leg 
extension and peak torque at 4.19 rad/s in the female subgroup. Hence, we 
conclude that 1-RM testing can be applied in both the young and elderly, 
independent of gender, as a valid measure of knee extensor strength. In 
addition, the subtle differences we observed between both 1-RM exercises 
and their correlation with dynamometry suggest that leg extension more 
accurately isolates knee extension strength and leg press represents not 
merely quadriceps strength but is related to both hip and knee extension 
strength. 
In general, the measurement of strength in a large heterogeneous population 
inherently increases the likelihood of finding significant correlations 
between the different assessment methods. To limit the range over which 
strength was measured, we defined specific subgroups, to improve the 
usefulness of correlation analyses. It should be noted that correlation 
analyses as applied in the present study is accompanied by further 
limitations, such as the inability to detect non-linear relations between the 
measured variables. However, since other methods of assessing validity, 
such as limits of agreement (6), cannot be used to compare data with 
different units of measurement, correlation analysis was regarded the most 
appropriate way of assessing 1-RM validity in the present study (13, 41). 
Significant correlations were observed between leg volume and all 7 
different strength indices, supporting the contention that leg volume can be 
indicative of leg muscle strength. Although the use of computed tomography 
and/or magnetic resonance imaging likely provides a much better estimate of 
leg muscle mass, we argue that non-invasive anthropometric leg volume 
measures may be helpful in future studies in which large cohorts are 
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subjected to, for example, lifestyle intervention programs, to determine 
whether increases in muscle mass and/or strength have occurred. 
We conclude that 1-RM testing represents a valid means to evaluate leg 
muscle strength in vivo in both young and elderly men and women. Although 
dynamometry can reveal additional information about the underlying aspects 
of muscle strength, it is not essential. Considering the importance of training 
specificity in exercise intervention studies, we suggest that training specific 
1-RM strength assessment can be used to assess changes in muscle strength. 
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ABSTRACT 
Satellite cells (SC) are essential for skeletal muscle growth and repair. 
Because sarcopenia is associated with type II muscle fiber atrophy, we 
hypothesized that SC content is specifically reduced in the type II fibers in 
the elderly. A total of eight elderly (E: 76±1 y) and eight young (Y: 20±1 y) 
healthy males were selected. Muscle biopsies were collected from the vastus 
lateralis in both legs. ATPase staining and a pax7-abtibody were used to 
determine fiber type-specific SC content (i.e. pax7-positive SC) on serial 
muscle cross-sections. In contrast to the type I fibers, the proportion and 
mean cross-sectional area of the type II fibers were substantially reduced in 
E vs Y. The number of SC per type I fiber was similar in E and Y. However, 
the number of SC per type II fiber was substantially lower in E vs Y 
(0.044±0.003 vs 0.080±0.007; P<0.01). In addition, in the type II fibers, the 
number of SC relative to the total number of nuclei and the number of SC 
per fiber area were also significantly lower in E. This study is the first to 
show type II fiber atrophy in the elderly to be associated with a fiber type-
specific decline in SC content. The latter is evident when SC content is 
expressed per fiber or per fiber area. The decline in SC content might be an 
important factor in the etiology of type II muscle fiber atrophy, which 
accompanies the loss of skeletal muscle with aging. 
Thesis _Verdijk_v02.pdf   48 11-8-2009   14:54:59
FIBER TYPE-SPECIFIC SATELLITE CELL CONTENT 
 49 
Introduction 
The gradual loss of skeletal muscle mass with aging, or sarcopenia, 
represents a major factor determining the decline in functional capacity, 
mobility and general health in the elderly. Muscle mass represents a main 
determinant of muscle strength and has been strongly associated with 
performance in activities of daily living and the level of independence in the 
elderly (16, 36, 49). Much work has been devoted to describing the 
alterations in skeletal muscle that occur with aging. The most consistent 
findings have been the decline in the total number of muscle fibers and the 
specific atrophy of the type II fibers, both contributing to the loss of skeletal 
muscle mass (18, 28, 30). In accordance, type II muscle fiber atrophy and 
necrosis have been shown to result in a reduced (area) proportion of type II 
muscle fibers in skeletal muscle tissue in the elderly (15, 28, 29). 
Although the exact mechanisms that cause sarcopenia remain to be 
elucidated, the hypothesis that satellite cells could play an important role in 
this age-related loss of skeletal muscle mass has recently gained much 
interest. Satellite cells (SC) or “muscle stem cells” are the sole source for the 
generation of new myonuclei in vivo in skeletal muscle tissue (2, 34, 35). As 
such, SC seem to be essential for the repair and hypertrophy of skeletal 
muscle tissue. Normally, SC lie quiescent between the basal lamina and the 
plasma membrane of muscle fibers (32). On activation and subsequent 
proliferation, the majority of these SC differentiate to form new myonuclei 
that either fuse with existing fibers or generate new fibers, while a small 
proportion returns to quiescence (24, 50). 
Because SC are responsible for the maintenance of skeletal muscle mass, a 
decrease in the number of SC or in their ability to become activated and 
proliferate in response to anabolic stimuli is likely to result in impaired 
skeletal muscle structure and function (44). Although the latter has been 
speculated to occur in sarcopenia, studies investigating the effects of aging 
on skeletal muscle SC content in humans have been inconclusive. Whereas 
some studies reported both a reduced number of SC per muscle fiber and a 
smaller proportion of SC relative to the number of myonuclei in the elderly 
(22, 38), other studies have failed to observe such differences (15, 20, 40). 
Although it has been reported that no differences exist in the number of SC 
between type I and II muscle fibers in young adults (23), it could be 
speculated that the specific type II muscle fiber atrophy with aging is 
associated with a fiber type-specific reduction in SC content. Such a fiber 
type-specific reduction in SC content could represent an important factor in 
the etiology of sarcopenia and might explain the apparent discrepancy in the 
literature regarding the effects of aging on muscle fiber SC content. 
In the present study, we assessed skeletal muscle fiber type-specific 
characteristics and fiber type-specific satellite cell content in young and 
elderly men. Therefore, skeletal muscle biopsy samples were taken from the 
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vastus lateralis in both the left and right legs of eight young (20±1 y) and 
eight elderly (76±1 y), lean males. Immunohistological staining of muscle 
cross-sections was performed to assess muscle fiber type-specific SC content 
and muscle fiber characteristics. 
Methods 
Subjects 
Eight elderly (76±1 y) and eight young (20±1 y), body weight-matched, 
male volunteers with no history of participating in any regular exercise 
program were recruited to participate in the present study. Subjects’ 
characteristics are shown in Table 3.1. All subjects were informed on the 
nature and possible risks of the experimental procedures before their written 
informed consent was obtained. This study was approved by the Medical 
Ethics Committee of the Academic Hospital Maastricht. 
Pretesting 
The medical histories of subjects were evaluated, and an oral glucose 
tolerance test was performed at least 2 weeks before the start of the trials (1, 
31). Subjects with orthopedic and/or cardiovascular abnormalities or type 2 
diabetes were excluded from participation. After selection for this study, 
maximal strength was assessed in two one-repetition maximum (1-RM) 
strength tests on a leg press and leg extension machine, respectively. First, a 
familiarization trial was performed. Proper lifting technique was 
demonstrated and practiced for each of the two lower limb exercises. 
Thereafter, maximum strength was estimated using the multiple repetitions 
testing procedure (33). In an additional session, at least ten days prior to 
muscle biopsy collection, each subject’s 1-RM was determined. After 
warming up, the load was set at 90-95% of the estimated maximum strength, 
and increased after each successful lift until failure. A 3-min resting period 
between subsequent attempts was allowed. A repetition was valid if the 
subject was able to complete the entire lift in a controlled manner without 
assistance. 
The weight and height of subjects were measured, and leg volume was 
determined as described previously (21). In short, leg circumference and 
height were measured at seven different sites, dividing the leg into six 
segments. The volume of each segment was calculated by treating each 
segment as a truncated cone, using the anthropometric measurements for 
determining the height and the surface areas of each cone. All subjects were 
instructed to refrain from strenuous physical activity for 3 days prior to 
muscle biopsy collection and to maintain their normal habitual dietary 
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intake. On the day before biopsy collection a standardized meal was 
provided, and from 9:00 pm, subjects remained fasted. 
 
Table 3.1 Subjects’ characteristics 
 Young (n=8) Elderly (n=8) 
Age (y) 20±1 76±1 * 
Weight (kg) 73.7±3.2 75.5±2.1 
Height (m) 1.81±0.03 1.71±0.01 * 
BMI (kg/m2) 22.5±1.1 25.7±0.7 * 
Leg volume (L) 9.4±0.4 8.2±0.3 * 
HbA1c (%) 5.0±0.2 5.7±0.1 * 
Basal glucose (mmol/L) 5.3±0.1 5.4±0.2 
Basal insulin (mU/L) 12.8±1.1 10.2±1.5 
HOMA-IR 3.0±0.3 2.5±0.4 
1-RM leg extension (kg) 108±4 78±4 * 
1-RM leg press (kg) 204±7 151±7 * 
Values are means±SEM. BMI: body mass index; HOMA-IR: homeostasis model assessment 
of insulin resistance (31); 1-RM: one-repetition maximum. *Significantly different compared 
with the young (P<0.05). 
Muscle biopsies 
After an overnight fast, subjects arrived at the laboratory by car or public 
transportation at 8:00 am. After 30 min of supine rest, a basal venous blood 
sample was collected. After local anesthesia, percutaneous needle biopsies 
(50-80 mg) were taken from the vastus lateralis muscle ~15 cm above the 
patella in both the left and right leg of each subject (3). Any visible 
nonmuscle tissue was removed from the biopsy samples, which were then 
frozen in liquid nitrogen-cooled isopentane, embedded in Tissue-Tek 
(Sakura Finetek, Zoeterwoude, The Netherlands), and stored at -80ºC until 
further analyses. 
Immunohistochemistry 
From all biopsies, 5-µm-thick cryosections were cut at -20ºC and samples 
from the left and right leg of each subject were mounted together on 
uncoated glass slides. Care was taken to properly align the samples for cross-
sectional fiber analyses. Slides from elderly and young subjects were stained 
simultaneously to ensure identical staining efficiency. 
An ATPase staining was performed after acid pre-incubation to determine 
muscle fiber type as described previously (5, 8, 9). Instead of dehydration of 
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the slides at the end of the ATPase staining procedure (5), sections were 
stained with anti-laminin (polyclonal rabbit anti-laminin, Sigma, 
Zwijndrecht, The Netherlands) and thereafter with the appropriate secondary 
antibody goat anti-rabbit IgG AlexaFluor488 (Molecular Probes, Invitrogen, 
Breda, The Netherlands). Nuclei were stained with 4’,6-Diamidino-2-
phenylindole (DAPI; Molecular Probes), similar to the procedures described 
below. At a pH of 4.45, we were able to differentiate between black (type I), 
white (type IIa) and intermediate (type IIb/IIx) fibers (Figure 3.1). The 
assessment of muscle fiber typing at this pH was validated by staining serial 
muscle cross-sections of three young and three elderly subjects with myosin 
heavy chain (MHC)-I and MHC-IIa antibodies (A4.840 and N2.261 
respectively; Developmental Studies Hybridoma Bank [DSHB], Iowa City, 
IA, USA). Because too few type IIb/IIx fibers were present for reliable SC 
counts in some of the biopsies, SC content and fiber characteristics were 
assessed in type I and type II muscle fibers only. 
 
 
Figure 3.1 Muscle fiber type analyses performed on muscle tissue collected from elderly (A) 
and young (B) males by ATPase staining of muscle cross-sections; type I fibers are black, and 
type II fibers are white (IIa) or show intermediate staining (IIb/IIx). Type II fibers are 
significantly smaller in the elderly vs the young. 
 
Immunostaining for the detection of myocellular SC content was performed 
on serial cross-sections with both pax7 (mouse anti-pax7, DSHB), which 
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marks both quiescent and activated SC (43, 50), and CD56 (mouse anti-
CD56, BD Biosciences, San Jose, CA, USA), which has been extensively 
used for SC determination in human muscle tissue (10, 15, 22, 23). Because 
of superior staining efficiency when using pax7, this marker was used for the 
quantification of SC in the present study. After fixation for 5 min with 
acetone, slides were air-dried and incubated for 60 min at room temperature 
with primary antibodies directed against laminin (dilution 1:50) and pax7 
(dilution 1:20), diluted in 0.05% Tween-PBS. Slides were then washed for 3 
x 5 min in PBS, before incubation for 60 min at room temperature with the 
appropriate secondary antibodies, purchased from Molecular Probes. Goat 
anti-rabbit IgG-AlexaFluor555 (dilution 1:200) and goat anti-mouse IgG1-
AlexaFluor488 (dilution 1:500) were diluted together with DAPI (0.238 µM) 
in 0.05% Tween-PBS to, respectively, stain laminin in red, pax7 in green 
and myonuclei in blue (Figure 3.2). After incubation, slides were again 
washed for 3 x 5 min in PBS and then covered with cover glasses using 
Mowiol (Calbiochem, VWR, Amsterdam, The Netherlands). 
Although pax7 is essential for the specification of SC, it has been reported 
that pax7 expression declines when SC ontogeny proceeds into terminal 
differentiation (43, 50). As such, the use of pax7 staining as a marker for SC 
content could theoretically lead to an underestimation of total SC count. 
Therefore, we validated the use of pax7 by simultaneously staining cross-
sections of 3 young and 3 elderly subjects with pax7, CD56 and DAPI. In 
agreement with earlier findings (37), >96% of CD56-positive SC were also 
pax7-positive, with no differences between age groups. In the present study, 
the term ‘satellite cells’ (SC) refers to the number of satellite cells that 
stained positive for pax7. 
Data analyses 
All images were digitally captured, using both light microscopy (ATPase) 
and fluorescence microscopy (laminin, pax7 and DAPI) with a Nikon E800 
combined light/fluorescence microscope (Nikon Instruments Europe B.V., 
Badhoevedorp, The Netherlands) coupled to a Basler A113 C progressive 
scan color CCD camera with a Bayer color filter. Epifluorescence signal was 
recorded using a Texas Red excitation filter (540-580 nm) for laminin, a 
FITC excitation filter (465-495 nm) for pax7, and a DAPI UV excitation 
filter (340-380 nm) for the nuclei. Image processing and quantitative 
analyses were done using Lucia 4.81 software package (Nikon). All image 
recordings and analyses were performed by an investigator blinded to the 
subject coding. 
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Figure 3.2 Muscle fiber type analyses for satellite cell content. A: laminin+DAPI+pax7 
staining; B: only pax7 staining; and C: DAPI+pax7 staining. Arrows indicate the satellite cell. 
D: ATPase staining from serial muscle cross-section of image A-C; the marked area 
represents the same area as shown in frame A-C. 
 
From the ATPase-stained slides, images were captured at 120x 
magnification. Laminin was used to determine cell borders, and for all fibers 
within each image, type I (black) and type II (white and intermediate) fibers 
were identified (Figure 3.1). Within each image, the number of fibers, the 
mean fiber cross-sectional area (CSA), the number of myonuclei per fiber 
and the mean fiber area per nucleus (fiber CSA/no. of myonuclei), were 
measured for the type I and type II fibers separately. As a measure of fiber 
circularity, form factors were calculated using the formula (4π*CSA) / 
(perimeter)2. Fiber circularity was not different between the muscle cross-
sections from the elderly vs the young for any fiber type. 
From the pax7-stained slides, images were captured at 240x magnification to 
allow clear determination of SC localization. Laminin was used to visualize 
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the cell borders. Fiber typing was determined by matching the serial 
ATPase-stained cross-sections. Satellite cells were determined in each fiber 
between the basal lamina and the plasma membrane and stained positive for 
both DNA (DAPI) and pax7 (see Figure 3.2 for example). The data were 
used to calculate the number of SC per muscle fiber, the proportion of SC 
(no. of SC/[no. of SC + no. of myonuclei]) and the number of SC per fiber 
area in mm2 for the type I and type II muscle fibers separately. 
Because there were no differences in muscle fiber type composition and 
CSA of the type I and II fibers between muscle samples taken from the left 
vs the right leg, muscle fiber data were pooled from both biopsies in each 
subject, resulting in a mean number of 401±32 and 507±69 individual 
muscle fibers being analyzed in the young and elderly subjects, respectively. 
For SC count, 287±26 and 291±29 fibers were analyzed in the muscle 
samples collected in the young and elderly subjects, respectively. 
Statistics 
All values are expressed as means±SEM. Muscle characteristics in muscle 
biopsies collected from the left and right legs were analyzed using paired t-
tests. General differences between elderly and young subjects were 
evaluated by independent t-tests. In addition, fiber type-specific variables 
were analyzed using mixed model analyses with ‘age group’ (young and 
elderly) as between subjects factor and ‘fiber type’ (type I and II) as within 
subjects factor. In the case of significant interaction, between group 
differences were analyzed for the different fiber types separately, and within 
group differences were analyzed for the young and elderly separately. An α-
level of 0.05 was used to determine statistical significance. All analyses were 
performed using SPSS version 11.5 (Chicago, IL, USA). 
Results  
Subjects 
Subjects’ characteristics are provided in Table 3.1. Basal blood glucose and 
insulin levels, and whole-body insulin sensitivity as assessed by the 
homeostasis model assessment of insulin resistance (HOMA-IR) index (31) 
did not differ between groups. Blood HbA1c concentrations were within a 
normal range for both groups, but were significantly greater in the elderly. 
Muscle strength as assessed by 1-RM for both leg press and leg extension 
was significantly lower in the elderly (151±7 and 78±4 kg, respectively) vs 
the young (204±7 and 108±4 kg, respectively; P<0.001). The latter was 
accompanied by a lower leg volume in the elderly compared with the young. 
In accordance, leg volume was significantly correlated with muscle strength 
(r = 0.53; P<0.05). 
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Fiber characteristics 
Fiber type composition was significantly different between groups (Table 
3.2). Type II muscle fiber content was significantly lower in the elderly 
(47±3 %) vs the young (57±3 %; P<0.05). In addition, the percentage of total 
muscle area occupied by type II fibers was also significantly smaller in the 
elderly (42±4 %) vs the young (59±3 %; P<0.01). Type II, but not type I 
muscle fiber CSA differed significantly between groups, with mean type II 
muscle fiber CSA being smaller in the elderly vs the young (4451±396 vs 
6126±393 µm², respectively, P<0.05; Table 3.2, Figure 3.1). There was a 
significant interaction between age group and fiber type CSA (P<0.05). In 
the young, fiber CSA did not differ between fiber types. In contrast, in the 
elderly muscle fiber CSA was significantly smaller in the type II vs the type 
I fibers (P<0.05; Table 3.2). 
 
Table 3.2 Muscle fiber characteristics 
 Young Elderly 
 CSA (µm2) fiber% CSA% CSA (µm2) fiber% CSA% 
Type I 5589±281 43±3 41±3 5471±227 53±3 * 58±4 * 
Type II 6126±393 57±3 59±3 4451±396 *† 47±3 * 42±4 * 
Values are means±SEM. CSA: fiber cross-sectional area; CSA%: percentage muscle area 
occupied per fiber type. For CSA, significant interaction between group and fiber type was 
observed. *Significantly different compared with the young (P<0.05). †Significantly different 
compared with the type I muscle fibers (within groups; P<0.05). 
Myonuclei 
In both the young and elderly, the number of myonuclei per fiber was 
significantly higher in the type I muscle fibers compared with the type II 
muscle fibers (Table 3.3). In accordance, the fiber area per myonucleus was 
smaller for the type I vs the type II muscle fibers. The number of myonuclei 
per muscle fiber differed significantly between groups for both the type I and 
II muscle fibers (Table 3.3). More myonuclei were present per type I and II 
muscle fiber in the elderly compared with the young (type I: 3.5±0.2 vs 
3.0±0.2 and type II: 2.6±0.1 vs 2.3±0.1, respectively, P<0.01). For the fiber 
area per myonucleus, there was significant interaction between age group 
and fiber type. Separate analysis showed significant differences between 
groups, with the elderly showing a significantly smaller fiber area per 
myonucleus in both the type I and II muscle fibers when compared with the 
young; the latter difference being more pronounced in the type II muscle 
fibers (Table 3.3; P<0.05). 
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Satellite cells 
In type I muscle fibers, no differences were observed in SC content, neither 
as the number of SC per fiber nor as the number of SC per mm2 between the 
young and the elderly (Table 3.3). In addition, SC proportion in type I fibers 
did not differ between the young and the elderly. In contrast, in the type II 
muscle fibers, SC content was significantly lower in the elderly vs the 
young. The number of SC per type II muscle fiber was significantly reduced 
in the elderly when compared with the young (0.044±0.003 vs 0.080±0.007, 
respectively; P<0.01) (Figure 3.3). The latter was also evident when 
correcting for CSA, as the number of SC per mm² of type II muscle fiber 
was also significantly reduced in the elderly compared with the young 
(9.7±1.0 vs 12.6±0.9, respectively; P<0.05). In accordance, SC proportion 
was significantly different between groups, with SC representing 1.5±0.2 % 
of nuclei in the elderly type II muscle fibers compared with 2.9±0.4 % in 
type II muscle fibers of the young (P<0.01). For all SC variables, there was a 
significant interaction between age group and fiber type. In the young, no 
significant differences were observed for any of the SC characteristics 
between the type I and II muscle fibers. In the elderly, the number of SC per 
muscle fiber, the number of SC per mm2 of muscle fiber and the proportion 
of SC were substantially lower in the type II vs the type I muscle fibers 
(Table 3.3 and Figure 3.3). 
 
Table 3.3 Myonuclei and satellite cell characteristics 
 Fiber type Young Elderly 
Type I 3.0±0.2 3.5±0.2 * Nuclei/fiber 
Type II 2.3±0.1 † 2.6±0.1 *† 
Type I 1849±71 1562±56 * Fiber area/nucleus (µm2) 
Type II 2549±129 † 1760±104 *† 
Type I 0.071±0.006 0.082±0.005 SC/fiber 
Type II 0.080±0.007 0.044±0.003 *† 
Type I 2.4±0.1 2.4±0.2 SC % 
Type II 2.9±0.4 1.5±0.2 *† 
Type I 12.7±1.1 13.8±1.0 SC/mm2 
Type II 12.6±0.9 9.7±1.0 *† 
Values are means±SEM. SC: satellite cells; SC %: SC proportion (no. of SC/[no. of SC + no. 
of myonuclei]). *Significantly different compared with the young (P<0.05). †Significantly 
different compared with the type I muscle fibers (within groups; P<0.05). 
Thesis _Verdijk_v02.pdf   57 11-8-2009   14:55:00
CHAPTER 3 
 58 
n
r 
o
f 
S
C
 p
e
r 
m
u
s
c
le
 f
ib
e
r
0,00
0,02
0,04
0,06
0,08
0,10 young
elderly
* #
type I fibers type II fibers
 
Figure 3.3 Satellite cell (SC) content in type I and II muscle fibers in the young vs the 
elderly. *Significantly different compared with the young (P<0.01); #Significantly different 
compared with the type I muscle fibers (P<0.01). 
Discussion 
In the present study, we confirm that both the proportion and CSA of the 
type II skeletal muscle fibers are substantially reduced in skeletal muscle 
tissue in the elderly. As far as we know, this is the first report that shows that 
type II muscle fiber atrophy in the elderly is associated with a specific 
reduction in the number of SC in these fibers. The latter is evident when 
expressed as number of SC per muscle fiber, as proportion of SC relative to 
the total number of nuclei, or as number of SC per muscle fiber area. This 
muscle fiber type-specific decline in SC content might represent an 
important factor in the etiology of sarcopenia. 
Numerous studies have demonstrated that the age-related loss of skeletal 
muscle mass is characterized by a reduction in the total number of muscle 
fibers and specific atrophy of the type II muscle fibers (18, 29, 30, 45). The 
decline in maximal strength with age has been attributed to this gradual loss 
of skeletal muscle tissue, but other intrinsic changes, e.g. fiber type shifts 
and reduced concentrations of contractile material could also contribute to 
this phenomenon (6, 12). Our data seem to confirm earlier reports (26, 27, 
48) showing a reduced leg volume and muscle strength in the elderly vs the 
young (Table 3.1). Furthermore, at the muscle level, we observed a 
significantly higher percentage of type I muscle fibers and the specific 
atrophy of the type II muscle fibers in the elderly (Table 3.2). These findings 
are consistent with previous reports (15, 28, 45) and are likely responsible 
for the reduced muscle strength in the elderly (Table 3.1). 
Even though the changes in muscle fiber type composition and morphology 
with aging have been described rather consistently in the literature, there is 
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still considerable debate on the underlying mechanisms responsible for these 
changes. It has been suggested that SC content in muscle plays an important 
role in the age-related changes in skeletal muscle structure and function (44). 
However, although this topic has received much attention over the past ten 
years (10, 15, 19, 20, 22, 38, 40, 41, 47), the exact changes in the SC pool 
that occur with aging still remain unresolved. Two recent studies have 
reported a decline in SC content with aging in the tibialis anterior (22) and 
in the biceps and masseter muscle (38) in humans. In contrast, other studies 
failed to observe such differences in either SC proportion, or in the number 
of SC in muscle fibers taken from the vastus lateralis muscle in young vs 
elderly subjects (15, 20, 40). The apparent discrepancy between these 
findings might be attributed to differences in study design, e.g., selection of 
subjects’ age, the number of fibers analyzed and the specific muscle group 
studied. 
So far, studies investigating age-related differences in SC content in human 
skeletal muscle have been limited to mixed muscle fiber analyses. In contrast 
to the fiber type-specific differences in SC content that have been 
consistently shown in rodent muscle (17, 42, 44), Kadi et al. (23) recently 
reported no differences in SC content between type I and II muscle fibers in 
young adults. However, because sarcopenia is associated with the specific 
atrophy of type II muscle fibers, we hypothesized that fiber type differences 
in SC content might exist at an older age. Therefore, in the present study, we 
determined type I and II muscle fiber type-specific SC content in both young 
and elderly men. In accordance with Kadi et al. (23), we observed ~0.075 
SC per muscle fiber, with no differences between the type I and II muscle 
fibers in the young subjects (Table 3.3). Extending their findings and 
consistent with the specific atrophy of type II muscle fibers with aging, we 
observed a 44±6 % lower SC content in the type II vs type I muscle fibers in 
the elderly. Furthermore, SC content in the type II muscle fibers in the 
elderly was significantly lower when compared with type II muscle fiber SC 
content in the young (Table 3.3, Figure 3.3). Notably, even when correcting 
for fiber CSA, type II muscle fiber SC content was still significantly lower in 
the elderly vs the young (Table 3.3). These data support the idea that SC 
content is strongly associated with myofiber maintenance and imply that the 
age-related reduction in type II muscle fiber SC content might represent an 
important factor in the specific loss and atrophy of type II muscle fibers with 
aging. 
As stated in the methods section, we used pax7 staining to assess muscle 
fiber type-specific SC content in skeletal muscle cross-sections. It should be 
noted that a slight proportion of SC may be pax7-negative in vivo, i.e. those 
SC that are progressing into terminal differentiation (43, 50). Therefore, we 
cross-validated our data by double staining with anti-CD56 in a subset of 
muscle samples. The vast majority of SC was both CD56- and pax7-positive, 
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with no differences between the young and elderly (94.9% vs 96.5%, 
respectively). As such, the latter could not be responsible for the substantial 
differences in skeletal muscle fiber SC content between groups. 
Findings from several rodent (7, 39, 44) as well as human studies (10, 25, 
46) suggest that the abundance of SC within skeletal muscle fibers represents 
an important factor determining the capacity for myofiber maintenance. On 
the other hand, type II myofiber atrophy and a reduction in SC content might 
be caused by one and the same phenomenon, e.g. decreased neuronal input 
(13). In addition, Bonavaud et al. (4), recently reported that myotubes 
formed by the fusion of human SC from either fast or slow muscle fibers in 
vitro express both fast and slow MHC isoforms. This finding would argue 
against a direct causal link between type II fiber SC loss and atrophy, as the 
loss of SC could theoretically be compensated for by incorporating SC 
progeny from type I fibers. However, the latter has yet to be established, and 
one could argue that in an in vivo situation, where SC progeny generally 
fuses with already existing fibers, expression of fast MHC isoforms by SC 
originating from slow fibers might not occur. 
Our data support the idea that SC abundance is an important factor 
regulating myofiber size. In addition, the reduced SC content in type II fibers 
in the elderly might attenuate their response to anabolic stimuli, stressing the 
need for potent interventions for reversing the loss of skeletal muscle mass 
and function with aging. Nevertheless, a direct causal link between SC loss 
and myofiber atrophy remains to be established. Furthermore, qualitative 
changes (e.g. blunted SC activation) likely play another important role in the 
impaired regenerative capacity of skeletal muscle tissue with aging. As such, 
endocrine changes as well as changes in the local SC environment with 
aging might also contribute to the loss of SC due to the prevention of SC 
self-renewal (11, 14, 44). At this moment, we can only speculate on the 
potential causes and clinical relevance of qualitative and quantitative 
changes in skeletal muscle fiber SC content with aging, and more research is 
warranted. 
In conclusion, this study is the first to show that SC content is specifically 
reduced in the type II muscle fibers in elderly men. The latter is shown to be 
evident when SC content is expressed as number of SC per fiber as well as 
number of SC per fiber area. The fiber type-specific reduction in SC content 
might represent an important regulatory factor in the loss of skeletal muscle 
mass, structure and function with aging. 
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ABSTRACT 
Objective: To investigate the relationship between skeletal muscle fiber type 
characteristics, circulating hormone concentrations, and skeletal muscle 
mass and strength in the elderly. Design: Cross-sectional analyses. Setting: 
University research centre. Participants: Forty-one healthy, community-
dwelling, elderly males (>65 y). Measurements: Leg strength (1-RM) and 
whole-body and limb muscle mass (DXA-CT) were determined and muscle 
fiber type composition, cross-sectional area (CSA), myonuclear content, and 
satellite cell content were assessed in skeletal muscle biopsy samples. In 
addition, blood samples were collected to determine serum testosterone, sex 
hormone binding globulin, growth hormone, insulin like growth factor 
(IGF)-1, and IGF binding protein-3 concentrations. Results: Muscle mass 
(DXA-CT) correlated with muscle strength (0.41≤r≤0.72; P<0.01). Muscle 
fiber CSA, myonuclear content, and satellite cell content were significantly 
lower in type II vs type I muscle fibers. Myonuclear and satellite cell content 
were positively correlated with muscle fiber CSA. Furthermore, greater 
muscle fiber CSA (type I and II) was associated with greater thigh muscle 
area and muscle strength (0.30≤r≤0.45; P<0.05). Testosterone concentration 
was positively correlated with muscle mass and muscle fiber CSA. 
Conclusion: Skeletal muscle mass and strength in elderly men are associated 
with muscle fiber type-specific changes in CSA, myonuclear content and 
satellite cell content. These findings support the assumption that a decline in 
satellite cell content plays a key role in the age-related decline in muscle 
mass and strength. 
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Introduction 
Aging is associated with a gradual but progressive loss of skeletal muscle 
mass and function, termed sarcopenia. The prevalence of sarcopenia is ~25% 
beyond the age of 60 y, increasing up to ~50% in subjects aged 80 y and 
over (5, 23, 24). In accordance, a 4-11% decline in muscle volume and 
cross-sectional area (CSA) has been reported per decade from an age of 20 
to 85 y (12, 25, 33, 34, 41). Concomitant with the loss of muscle mass, 
muscle strength declines after the 3rd decade, with a more rapid decline after 
the 5th decade (30, 34). The latter leads to a decline in functional capacity 
and the subsequent loss of mobility and independence. Therefore, it is 
imperative to identify key factors relevant to the etiology of sarcopenia. 
The etiology of the age-related loss of muscle mass is generally studied in a 
cross-sectional manner within a large population of individuals with ages 
ranging from 20-80 y. However, there is little data available on the 
prevalence of such age-related changes in muscle mass and strength within 
an elderly population. Some studies have reported that both muscle mass and 
strength continue to decline after the age of 65 y (29, 43). The latter seems 
consistent with the greater prevalence of sarcopenia in elderly aged 80+ vs 
elderly aged 60+ (5, 23, 24) and agrees well with longitudinal changes 
reported previously (14, 17). However, there is a large variability in muscle 
mass and strength within the elderly population that is not necessarily related 
to age per se (6). Therefore, studying the potential determinants of muscle 
mass within the elderly population (i.e. independent of age) could provide 
better insight into the etiological factors of sarcopenia. 
Interestingly, leg skeletal muscle mass seems to be the main determinant for 
leg muscle strength, independent of age (15, 49). By comparing elderly vs 
young subjects, the age-related loss of leg muscle mass has been attributed to 
a decline in the number of muscle fibers and, more specifically, to type II 
muscle fiber atrophy (28, 31, 33). We recently extended on these findings by 
showing a type II muscle fiber specific decline in satellite cell content in 
elderly vs young muscle (45). It has been suggested that such an age-related 
decline in muscle fiber satellite cell content plays a key role in inducing 
muscle fiber atrophy in the elderly (20, 40). The latter would imply that 
satellite cell content, muscle fiber size, and muscle mass are closely linked, 
independent of age. Therefore, we hypothesize that within the elderly 
population, muscle fiber type characteristics are predictive of whole-body 
and/or limb skeletal muscle mass and strength. 
There have been ample suggestions that age-related changes in hormonal 
profile can strongly modulate skeletal muscle mass and strength in the 
elderly (27). In accordance, significant correlations have been reported 
between whole-body lean mass and serum testosterone and IGF-1 
concentrations in elderly males (6, 23, 50). It remains to be assessed whether 
such serum hormone concentrations are predictive of skeletal muscle mass, 
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muscle fiber characteristics, and/or muscle strength in a healthy, elderly 
population. 
In the present study, we investigate determinants of muscle mass and 
strength within the elderly population. We hypothesize that muscle fiber type 
characteristics and hormonal profile are predictive of muscle mass and 
strength within a population of healthy, elderly males, independent of age. 
Therefore, we assess skeletal muscle characteristics at the whole-body, limb, 
and muscle fiber level, and determine circulating hormone concentrations in 
healthy, elderly males. 
Methods 
Subjects 
A total of 41 healthy, elderly males (65-86 y) were included in the present 
study. All subjects participated in different studies that are part of a greater 
project investigating the clinical benefits of exercise and/or nutritional 
intervention in the elderly. Medical history of all subjects was evaluated and 
an oral glucose tolerance test (OGTT) and resting ECG were performed. 
Subjects with (silent) cardiac or peripheral vascular disease, orthopedic 
limitations and/or type 2 diabetes (1) were excluded. All subjects were living 
independently and had no history of participating in any structured exercise 
training program for at least 5 years. All subjects were informed on the 
nature and possible risks of the experimental procedures, before their written 
informed consent was obtained. The study was approved by the Medical 
Ethics Committee of the Academic Hospital, Maastricht. 
Study design 
After inclusion in this study, subjects underwent a series of measurements 
(outlined below) to determine muscle characteristics at the whole-body, 
limb, and myocellular level. In addition, fasting blood samples were taken to 
assess blood glucose homeostasis and hormonal profile. 
Dietary intake and physical activity standardization 
Standardized meals (51 kJ/kg body mass; 57 Energy% (En%) carbohydrate, 
13 En% protein, and 30 En% fat) were consumed by all subjects the evening 
prior to each test day (i.e. muscle biopsy and blood sampling, and DXA-CT 
scanning). Subjects refrained from strenuous physical activity for 3 days 
prior to testing. On all test days, subjects arrived at the laboratory by car or 
public transportation at 8 am and in an overnight fasted state. 
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Strength assessment 
Maximum strength was assessed by one-repetition maximum (1-RM) 
strength tests on leg press and leg extension machines (Technogym, 
Rotterdam, The Netherlands). During a familiarization trial, proper lifting 
technique was demonstrated and practiced. Maximum strength was 
estimated using the multiple repetitions testing procedure (36). In an 
additional session, at least one week prior to muscle biopsy collection, each 
subject’s 1-RM was determined as described previously (46). 
Thigh muscle CSA 
Anatomical cross-sectional area (CSA) of the thigh muscles was assessed by 
CT scanning (IDT 8000, Philips Medical Systems, The Netherlands), as 
described previously (44). Scans were performed at mid-thigh level, and 
images were loaded onto a pc using AGFA IMPAX imaging software, 
version 5.2 (AGFA Healthcare, Belgium). Muscle area of the right leg was 
selected between -29 and +150 Hounsfield units (37), after which the 
quadriceps muscle was selected by manual tracing. Total thigh and 
quadriceps muscle area were calculated using Lucia 4.81 software (Nikon 
Instruments Europe, Badhoevedorp, The Netherlands). All analyses were 
performed by 2 investigators blinded to subject coding; intra-class 
correlation coefficients for inter- and intra-investigator reliability were 0.997 
and 0.998, respectively. 
Body composition 
Directly after CT-scanning, body composition and bone mineral content 
were measured with dual-energy X-ray absorptiometry (DXA, Lunar 
Prodigy Advance, GE Healthcare, Madison, WI). The system’s software 
package (enCORE 2005, version 9.15.00) was used to determine whole-
body and regional lean and fat mass. DXA scans were performed in a fasted 
state, after subjects had voided. CV for repetitive scans (n = 4, 2 weeks 
apart) were 0.4%, 1.0%, and 1.1% for whole-body lean mass, fat mass, and 
leg lean mass, respectively. Appendicular skeletal muscle mass (ASM) was 
calculated as the sum of lean mass in the arms and legs (5). In addition, body 
mass was measured to the nearest 0.1 kg using an electronic balance scale 
and height was measured to the nearest 0.1 cm using a wall mounted 
stadiometer. To control for the potential confounding effect of body size, all 
body composition measures were adjusted for knee height (11). Knee height 
was chosen instead of normal height, because the latter is confounded by 
age-related disorders affecting the spine, e.g. osteoporosis (39). 
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Oral glucose tolerance test 
During screening, a standard oral glucose tolerance test (OGTT) was 
performed. A fasting blood sample was drawn after which 75 g glucose 
(dissolved in 250 mL water) was ingested. Thereafter, blood was sampled 
every 30 min until t=120 min. Plasma glucose and insulin concentrations 
were determined and whole-body insulin sensitivity was determined using 
the oral glucose insulin sensitivity (OGIS)-index (35). 
Blood samples 
Fasting blood samples were collected in both EDTA containing tubes and 
serum tubes. After centrifugation, aliquots of plasma and serum were frozen 
in liquid nitrogen and stored at -80°C. Plasma glucose concentrations were 
analyzed with a COBAS FARA analyzer (Uni Kit III, Roche, Basel, 
Switzerland). Insulin concentration was analyzed by RIA (Insulin RIA Kit, 
Linco Research Inc., St. Charles, MO). Blood HbA1c content (3 mL blood 
sample, EDTA) was analyzed by high-performance liquid chromatography 
(Bio-Rad Variant II, Munich, Germany). 
Total serum testosterone and sex hormone binding globulin (SHBG) 
concentrations were measured using reagents from Roche Diagnostics 
(Mannheim, Germany), and assays were run on a Modular Analytics E170 
analyzer (Hitachi Data Systems, Santa Clara, CA). The intra-assay CV’s are 
2.7-1.8% and 1.1-1.7% for low-high concentrations of testosterone and 
SHBG, respectively. Bio-available testosterone was determined as non-
SHBG bound testosterone as described and validated previously (47). IGF-1 
was analyzed on a Liaison system (DiaSorin, Brussels, Belgium) with 
reagentia from DiaSorin. Intra-assay CV’s are 2.4-4.4% for high and low 
concentrations, respectively. IGF binding protein (BP)-3 was analyzed using 
a commercially available test kit (Biosource Europe, Nivelles, Belgium) on a 
Tecan/GENios analyzer (Tecan Group Ltd., Männedorf, Switzerland), with 
intra-assay CV’s of 4-8%. For human growth hormone (hGH) analysis, 
reagents came from Beckman Coulter (Fullerton, CA) and assays were run 
on an Access analyzer (Beckman Coulter). Intra-assay CV’s for different 
concentrations were between 1.5-3.5%. 
Muscle biopsy sampling 
Muscle biopsy samples were collected from the right leg, in the morning 
following an overnight fast. After local anesthesia, percutaneous needle 
biopsies (50–80 mg) were taken from the vastus lateralis muscle, ~15 cm 
above the patella (7). Any visible non-muscle tissue was removed 
immediately, and biopsy samples were embedded in Tissue-Tek (Sakura 
Finetek, Zoeterwoude, The Netherlands), frozen in liquid nitrogen-cooled 
isopentane, and stored at -80°C. 
Thesis _Verdijk_v02.pdf   70 11-8-2009   14:55:01
MUSCLE FIBER CHARACTERISTICS IN ELDERLY MEN 
 71 
Immunohistochemistry 
From all biopsies, 5 µm thick cryosections were cut at -20°C. Samples from 
2 subjects were mounted together on uncoated glass slides. Care was taken 
to properly align the samples for cross-sectional fiber analyses. Serial cross-
sections were stained for muscle fiber typing and myocellular satellite cell 
(SC) content. Details of the analytical procedures have been described 
previously (44). In short, muscle fiber typing (type I vs II) was determined 
based on MHC-staining, and a CD56 antibody was used to determine SC 
content. Laminin was used to visualize the basement membrane and nuclei 
were stained with DAPI. After staining, all images were digitally captured, 
using fluorescence microscopy (Nikon Instruments Europe). Image 
processing and quantitative analyses were done using Lucia 4.81 software 
package. All image recordings and analyses were performed by an 
investigator blinded to subject coding. Within each image, the number of 
fibers, the mean fiber cross-sectional area (CSA), the number of myonuclei 
per fiber, and the myonuclear domain (i.e. fiber CSA/number of myonuclei) 
were measured for the type I and type II muscle fibers separately. For the SC 
slides, fiber typing was determined by matching the serial fiber typing slides. 
Satellite cells were determined at the periphery of each fiber and stained 
positive for both DNA (DAPI) and CD56. The number of SC per muscle 
fiber and the percentage of SC [number of SC/(number of SC + number of 
myonuclei)*100] were determined for the type I and II muscle fibers 
separately. A mean total of 338±24 muscle fibers, i.e. 178±14 type I and 
160±14 type II muscle fibers, were analyzed for each subject. 
Statistics 
All data are presented as means±SE. After confirming normality of the data 
(Kolmogorov-Smirnov test), muscle biopsy data were analyzed for 
differences between type I and II muscle fibers with paired samples t-tests. 
Bivariate Pearson’s correlation coefficients were calculated to determine the 
relation between age and all other variables (measured from DXA, CT, 
muscle biopsy and blood sample analyses). The relation between the various 
muscle characteristics and between muscle characteristics and hormonal 
profiles was also determined by calculating bivariate Pearson’s correlation 
coefficients. In addition, partial correlations (adjusting for the effect of age) 
were calculated, eliminating age as a contributing factor to the correlation. 
Likewise, the correlation between age and muscle strength was adjusted for 
the effect of quadriceps muscle area. Differences between the various 
correlation coefficients were tested for statistical significance (21). All 
analyses were performed using SPSS version 15.0 (Chicago, IL). An α-level 
of 0.05 was used to determine statistical significance. 
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Results 
Subjects’ characteristics are provided in Table 4.1. Mean age of the 
participants was 72±2 y (range 65-86 y). All subjects were living 
independently and had no history of participating in any regular exercise 
program over the past 5 years. No mobility problems were reported and drug 
treatment was restricted to mild anti-hypertensive medication. Basal blood 
glucose concentrations (5.7±0.1 mmol/L), blood HbA1c contents 
(5.9±0.1%), and oral glucose tolerance were within a normal range for 
healthy, elderly males. 
 
Table 4.1 Subjects’ characteristics 
Age (y) 72±2 
Body mass (kg) 80.3±1.8 
Height (m) 1.73±0.01 
BMI (kg/m2) 27.0±0.5 
Fasting glucose (mmol/L) 5.7±0.1 
HbA1c (%) 5.9±0.1 
OGIS 366±10 
Body fat (%) 25.4±1.0 
Lean mass (kg) 56.1±0.8 
Data represent means±SEM. OGIS: oral glucose insulin sensitivity index (35). 
Age-related changes 
For both the leg press and leg extension exercises, muscle strength was 
negatively correlated with age (r=-0.41 and r=-0.45, respectively; P<0.01). 
Within this elderly population, age did not correlate with whole-body lean 
mass. However, there was a significant negative correlation between age and 
regional measures of muscle mass (Table 4.2). The strongest correlation was 
observed between age and total thigh and quadriceps muscle CSA; r=-0.55, 
and r=-0.51, respectively (P<0.001). Notably, when adjusted for the effect of 
quadriceps muscle area, the correlation between age and muscle strength 
disappeared (r=-0.10 and r=-0.14 for leg press and leg extension, 
respectively; P>0.40). 
At the myocellular level, significant differences were observed between type 
I and II muscle fibers (Table 4.3). Type II muscle fiber cross-sectional area 
(CSA) was smaller when compared with type I muscle fibers. In addition, 
both myonuclear and satellite cell content were lower in the type II vs type I 
muscle fibers. Whereas the percentage type I and II muscle fiber was similar, 
the percentage type II muscle fiber area was smaller when compared with 
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the type I muscle fibers. In contrast to type I muscle fiber CSA, type II 
muscle fiber CSA correlated significantly with age (r=-0.26; P<0.05). 
 
Table 4.2 Lean body compartments and their correlations with age 
 mean r P-value 
WB lean mass (kg) 56.1±0.8 -0.24±0.16 0.071 
Leg lean mass (kg) 17.8±0.3 -0.31±0.15 0.026 
Arm lean mass (kg) 6.5±0.1 -0.32±0.15 0.025 
ASM (kg) 24.3±0.4 -0.34±0.15 0.016 
Quadriceps CSA (cm2) 73.0±1.8 -0.51±0.14 <0.001 
Thigh muscle CSA (cm2) 159.2±3.0 -0.55±0.13 <0.001 
Data represent means±SEM and Pearson’s correlation coefficients (r) ± SEE. WB: whole 
body. ASM: appendicular skeletal muscle mass (sum of lean mass in arms and legs). CSA: 
cross-sectional area. 
 
Table 4.3 Muscle fiber type characteristics 
 Type I Type II 
Fiber % 52±2 48±2 
CSA (µm2) 6460±260 5276±219 * 
CSA% 57±2 43±2 * 
Nuclei/fiber 3.3±0.1 2.7±0.1 * 
CSA/nucleus (µm2) 2036±75 1970±79 
SC/fiber 0.087±0.004 0.050±0.003 * 
SC% 2.7±0.1 1.8±0.1 * 
Data represent means±SEM; CSA: muscle fiber cross-sectional area; CSA%: % of total area 
occupied per fiber type; SC: satellite cell; SC%: percentage of SC = number of SC /(number 
of SC + number of myonuclei) x 100%. *: significantly different compared with type I muscle 
fibers. 
Whole-body, regional, and myocellular characteristics 
All measures of lean mass (i.e. whole-body lean mass, ASM, leg lean mass) 
and thigh and quadriceps muscle CSA showed positive correlations with 
each other and with leg extension and leg press strength (0.41≤r≤0.72; 
P<0.01). However, correlations between quadriceps CSA and leg extension 
strength (r=0.72) and between thigh muscle CSA and leg press strength 
(r=0.72) were most pronounced (P<0.001). Partial correlation coefficients 
were calculated to eliminate the potential contributing effects of age. 
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Correlation coefficients between muscle mass and strength did not change 
when adjusted for age. 
For both the type I and type II muscle fibers, positive correlations were 
observed between muscle fiber CSA, myonuclear content, and satellite cell 
content. Greater muscle fiber CSA was associated with more myonuclei per 
fiber (r=0.56 for type I and II fibers; P<0.001), a greater myonuclear domain 
(r=0.41 for type I fibers, and r=0.50 for type II fibers; P<0.01), and more 
satellite cells per muscle fiber (r=0.55 for type I fibers, and r=0.50 for type II 
fibers; P<0.05). The number of myonuclei per muscle fiber correlated 
positively with the number of satellite cells per muscle fiber (r=0.40 for both 
type I and II muscle fibers; P<0.01). 
Both type I and II muscle fiber CSA showed a positive correlation with leg 
extension strength (Figure 4.1), and with quadriceps CSA, but not with leg 
press strength. All r-values were between 0.30 and 0.45 and correlations 
tended to be stronger for type II vs type I muscle fibers (P<0.10). Adjusting 
for age did not modulate any of the correlations. 
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Figure 4.1 Scatter plot for the correlation of type I (filled circles) and type II (open circles) 
muscle fiber cross-sectional area (CSA) with one-repetition maximum (1-RM) leg extension 
strength. Lines represent the fitted regression. Pearson’s correlation coefficient tended to be 
stronger (P=0.06) for type II (dashed line, r=0.45; P<0.01) vs type I muscle fibers (solid line, 
r=0.33; P<0.05). 
Hormonal profiles and muscle characteristics 
Higher total testosterone concentrations correlated with higher serum SHBG 
and hGH concentrations. Bio-available testosterone concentrations 
correlated positively with hGH and IGF-1. In addition, positive correlations 
were observed between SHBG and hGH, and between IGF-1 and IGF-BP3 
concentrations (all r-values between 0.27 and 0.52; P<0.05). 
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Higher levels of bio-available testosterone were associated with greater 
ASM (r=0.26; P<0.05), and greater muscle mass measured by CT (r=0.27; 
P<0.05). In addition, type I and type II muscle fiber CSA were greater with 
higher concentrations of bio-available testosterone expressed as a percentage 
of total testosterone. However, the latter correlation was only significant for 
the type II muscle fibers (r=0.30; P<0.05) and did not reach statistical 
significance for the type I fibers (r=0.23; P<0.07). Furthermore, higher bio-
available testosterone levels were associated with a larger percentage of fiber 
area occupied by type II muscle fibers (r=0.31; P<0.05). Fat mass was 
negatively correlated with total testosterone, bio-available testosterone, and 
SHBG concentrations (r= -0.52, -0.25, and -0.35, respectively; P<0.05). 
Discussion 
The present study shows that muscle fiber type characteristics and bio-
available testosterone concentrations are predictive of whole-body and/or 
limb skeletal muscle mass and strength in healthy, elderly males. Our 
findings provide further support to the idea that a decline in satellite cell 
content plays a key role in the loss of muscle mass and strength in the 
elderly. 
Skeletal muscle mass correlated strongly with muscle strength in this 
healthy, elderly population, with the strongest correlation observed for 
muscle CSA measured by CT scans. These findings are consistent with 
previous studies (6, 14, 15) and confirm that the loss of muscle mass is a 
major determinant of muscle weakness and functional impairment in the 
elderly (13, 49). The relation between muscle mass and strength has 
generally been assessed at the whole-body level and/or for specific muscle 
groups. Furthermore, we (45) as well as others (4, 20, 40) have suggested a 
link between the age-related loss of muscle mass and the age-related decline 
in muscle fiber size, myonuclear content, and/or satellite cell content. 
Although differences in skeletal muscle characteristics between young and 
elderly subjects are well-established, it remains to be determined whether the 
proposed age-related changes in muscle fiber characteristics are predictive 
for the actual amount of muscle mass and strength at a more advanced age. 
Therefore, we compared skeletal muscle fiber type characteristics with 
whole-body and limb muscle mass and strength within a large group of 
healthy, elderly males. 
Type II muscle fiber CSA was shown to be reduced when compared with 
type I muscle fiber CSA (Table 4.2). In addition, both myonuclear and 
satellite cell content were reduced in the type II vs type I muscle fibers. 
These data are in line with previous studies from our laboratory (44, 45) and 
others (31, 33, 48). Interestingly, both type I and type II muscle fiber satellite 
cell and myonuclear content were positively correlated with muscle fiber 
CSA. The relation between myofiber size and myonuclear content has been 
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attributed to the myonuclear domain theory (3, 10), which suggests that the 
ratio between cytoplasmic volume and the number of myonuclei remains 
relatively constant. Thus, large muscle fibers contain more myonuclei than 
small muscle fibers (2, 26). Moreover, a decline in myonuclear content will 
eventually result in muscle fiber atrophy (2, 9). It has been proposed that a 
decline in satellite cell content with aging results in a decreased capacity for 
myofiber maintenance (40) and a decline in the number of myonuclei (9). 
The observation that a reduced satellite cell content is associated with 
smaller muscle fiber CSA supports the idea that skeletal muscle satellite 
cells play a key role in the maintenance of muscle fiber size. The latter is 
further strengthened by the observation that the lower type II muscle fiber 
satellite cell content was associated with a reduced type II muscle fiber size 
when compared with the type I muscle fibers (Table 4.2). 
Apart from its relation with myonuclear and satellite cell content, muscle 
fiber size (CSA) correlated well with muscle mass and strength measured at 
the whole-body and/or limb level. Previous studies, with subjects selected 
over a wide age range (18-80 y), report similar correlations between strength 
and type I and II (30) or merely type II muscle fiber size (22). We extend on 
these findings by showing that independently of age, reduced type I and II 
muscle fiber size is associated with a lower quadriceps CSA and reduced leg 
strength within an elderly, male population. Notably, the correlation between 
muscle fiber size and muscle strength tended to be stronger for the type II vs 
type I muscle fibers (Figure 4.1). The latter is likely attributed to the 
observation that type II muscle fibers are stronger than type I muscle fibers, 
even after adjusting for muscle fiber size (16). As such, specific type II 
muscle fiber atrophy as observed with aging seems to cause muscle 
weakness from a quantitative (loss of muscle fiber area), as well as a 
qualitative perspective (relative increase of type I muscle fiber area). Besides 
type II muscle fiber atrophy, other (qualitative) changes likely contribute to 
the variability in muscle mass and strength within the elderly population. 
Increased intramuscular lipid and/or connective tissue content (19, 32), 
decreased neural function (12), and decreased level of physical activity (6, 
12) have been associated with a reduced muscle mass and strength. 
However, these aspects were not specifically addressed in the present study. 
Nonetheless, the present findings show that muscle fiber size represents a 
key factor in determining skeletal muscle mass and strength in the elderly. 
Furthermore, satellite cell content is closely related to myonuclear content 
and predictive of muscle fiber size. We speculate that the muscle fiber type-
specific decline in satellite cell content observed with aging represents a key 
factor in the gradual loss of muscle mass and strength with aging. 
Animal studies have shown that muscle fiber hypertrophy in response to 
exercise training is preceded by an increase in muscle fiber satellite cell 
content (3). In accordance, we recently reported that type II muscle fiber 
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hypertrophy following prolonged resistance type exercise training is 
associated with an increase in type II muscle fiber satellite cell content in 
healthy, elderly males (44). Furthermore, it has recently been suggested that 
muscle fiber hypertrophy following exercise is dependent on the size of the 
satellite cell pool prior to intervention (38). These findings confirm the 
significance of satellite cells in facilitating skeletal muscle fiber hypertrophy. 
As such, satellite cell content seems to represent an important diagnostic 
target when evaluating exercise, nutritional and/or pharmaceutical 
intervention strategies to improve skeletal muscle mass and strength in the 
elderly. 
Age-related changes in sex hormones and the growth hormone/IGF-1 axis 
have been suggested to be associated with the loss of muscle mass with 
aging (6, 23, 50). However, to what extent relations exist between hormonal 
profile and muscle fiber type characteristics within the elderly population 
remains to be determined. We observed a positive correlation between bio-
available testosterone levels and muscle mass (CT, DXA) and muscle fiber 
size. Furthermore, serum testosterone concentrations were negatively 
correlated with fat mass. These findings seem to be in line with previous 
work showing an increase in satellite cell content, myonuclear content and 
muscle fiber size (42) and a decrease in fat mass (8) after prolonged 
testosterone supplementation in elderly men. Previous studies have also 
reported positive correlations between GH/IGF-1 and muscle mass (6, 50). 
In the present study though, none of the hormones of the GH/IGF-1 axis 
showed significant correlations with measures of muscle mass and/or muscle 
fiber size in elderly men. However, the present findings seem to be in line 
with previous reports showing that GH supplementation generally fails to 
increase muscle mass and strength in healthy, elderly males (18). It remains 
to be determined whether other strategies to increase systemic and/or local 
GH/IGF-1 can prevent and/or reverse the progressive loss of muscle mass 
and function in the elderly (18). 
Obviously, the present cross-sectional analysis does not allow us to define 
any direct causal relationships. Longitudinal studies are difficult to assess 
and methodological problems regarding follow-up duration, sample size, and 
high drop-out rates generally hamper the study outcome. We determined 
correlations between muscle mass, strength, and muscle fiber characteristics 
within a large group of healthy, elderly men. The latter allows us to assess 
whether age-related changes in muscle fiber characteristics are associated 
with the large variance in muscle mass and strength within the elderly 
population. This is the first study to show a correlation between satellite cell 
content, muscle fiber size, and skeletal muscle mass and strength in elderly 
men. Combined with the findings from recent intervention studies (38, 42, 
44) and in vivo animal experiments (3, 9, 40), these data imply that satellite 
cells play a key role in the age-related loss of muscle mass and function. 
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In conclusion, muscle fiber size, myonuclear and satellite cell content and 
bio-available testosterone concentrations are predictive of skeletal muscle 
mass and strength in healthy, elderly males. Our findings provide further 
support to the idea that a decline in type II muscle fiber satellite cell content 
plays a key role in the loss of muscle mass and strength in the elderly. 
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ABSTRACT 
We determined muscle fiber type-specific hypertrophy and changes in 
satellite cell (SC) content following a 12-wk resistance training program in 
13 healthy, elderly men (72±2y). Leg strength and body composition (DXA 
and CT) were assessed, and muscle biopsy samples were collected. Leg 
strength increased 25-30% after training (P<0.001). Leg lean mass and 
quadriceps cross-sectional area increased 6-9% (P<0.001). At baseline, 
mean fiber area and SC content were smaller in the type II vs type I muscle 
fibers (P<0.01). Following training, type II muscle fiber area increased from 
5438±319 to 6982±503 µm2 (P<0.01). Type II muscle fiber SC content 
increased from 0.048±0.003 to 0.084±0.008 SC/fiber (P<0.001). No changes 
were observed in the type I muscle fibers. In the elderly, skeletal muscle 
tissue is still capable of inducing satellite cell proliferation and 
differentiation, resulting in type II muscle fiber hypertrophy. 
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Introduction 
Sarcopenia is defined as the gradual decline in skeletal muscle mass and 
strength with aging. On a myocellular level, sarcopenia is characterized by a 
reduction in the number of both type I and II muscle fibers (26) and specific 
type II muscle fiber atrophy (9, 24, 26, 44). In skeletal muscle tissue, 
satellite cells (SC) are essential for myofiber repair, maintenance and growth 
(16, 30, 33, 34). As such, an age-related decline in SC number and/or 
function could play an important role in the etiology of sarcopenia. Previous 
studies have either shown a similar (9, 18, 39, 43) or lower (20, 38) SC 
content in the elderly when compared with young adults. Recently, we 
reported that type II muscle fiber atrophy in the elderly is associated with a 
specific decline in type II muscle fiber SC content (44). The latter likely 
explains the discrepant findings in previous studies that only assessed SC 
content in mixed muscle tissue. 
Resistance type exercise training has been shown to represent an effective 
interventional strategy to augment muscle mass, strength, and function in the 
elderly (4, 13, 15, 23, 29, 42). Previous studies in the elderly have shown 
that the muscle adaptive response to resistance training is characterized by 
type II muscle fiber hypertrophy (4, 23, 29, 42). For muscle fiber 
hypertrophy to occur beyond a certain threshold, the addition of new 
myonuclei is essential. The latter is facilitated by the proliferation of SC and 
the differentiation of their progeny into new myonuclei that fuse with 
existing muscle fibers (2, 33, 34). Though the exact signaling pathways 
leading to muscle hypertrophy following resistance type exercise remain to 
be elucidated, it seems evident that an increase in the number of SC is 
needed to allow the muscle adaptive response to occur. In accordance, some 
studies (27, 40) have reported an upregulation of the number of SC in mixed 
muscle tissue following exercise training in the elderly. However, others 
have failed to confirm these findings (18, 36). The apparent discrepancy in 
the literature is likely attributed to the lack of fiber type-specific data on this 
topic. We hypothesized that resistance type exercise training in the elderly 
increases SC content in a fiber type-specific manner, thereby allowing type 
II muscle fiber hypertrophy. 
The present study aims to assess the impact of a 3 month resistance type 
exercise training program on muscle strength, body composition and muscle 
fiber type-specific characteristics in healthy, elderly men. Skeletal muscle 
biopsies were collected before and after completion of the exercise 
intervention program to determine the impact of resistance type exercise 
training on muscle fiber type-specific hypertrophy, myonuclei and satellite 
cell content in the elderly. 
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Methods 
Subjects 
A total of 14 healthy elderly men (65-85 y) volunteered to participate in a 12 
wk resistance type exercise intervention program (3 sessions/wk). One 
subject dropped out during the study because of an acute back problem that 
occurred during gardening. Medical history of all subjects was evaluated and 
an oral glucose tolerance test (OGTT) and resting ECG were performed 
before selection. Exclusion criteria were defined that would preclude 
successful participation in the exercise program, and included (silent) 
cardiac or peripheral vascular disease, orthopedic limitations and/or type 2 
diabetes (1). The latter was used as an exclusion criterion as insulin 
resistance and/or type 2 diabetes can strongly impact the process of muscle 
mass loss with aging (35). All subjects were living independently and had 
not participated in any structured exercise training program over the past 5 
years. 
All subjects were informed on the nature and possible risks of the 
experimental procedures, before their written informed consent was 
obtained. All procedures were performed according to the Declaration of 
Helsinki and the study was approved by the Medical Ethics Committee of 
the Academic Hospital, Maastricht. This study is part of a greater project 
investigating the clinical benefits of exercise intervention in the elderly. 
Study design 
After screening, all eligible subjects were enrolled in a 12 wk resistance type 
exercise intervention program. Before, during and after the exercise 
intervention, anthropometric measurements (height, body mass, leg volume 
(19)), strength assessments, CT- and DXA-scans were performed and muscle 
biopsies, blood samples, and dietary intake records were collected. 
Dietary intake and physical activity standardization 
Standardized meals (~4.0 MJ: 57 Energy% carbohydrate, 30 En% fat, and 13 
En% protein) were provided to all subjects prior to each test day and subjects 
were instructed to refrain from strenuous physical activity for 3 days prior to 
testing. Dietary intake was recorded for 2 days prior to muscle biopsy and 
blood sample collection. These records were used to standardize food intake 
prior to muscle biopsy and blood sampling 4 days after cessation of the 
exercise intervention program. On all test days, subjects arrived at the 
laboratory by car or public transportation, following an overnight fast. The 
latter was confirmed by dietary intake records and further verified by the 
assessment of basal blood glucose and insulin concentrations and blood lipid 
profile. To assess potential changes in daily food intake that might had 
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occurred during the intervention period, subjects recorded 3-day weighted 
dietary records (Thursday-Saturday), prior to the onset of the intervention 
program and in week 11 of the exercise intervention. Food intake records 
were analyzed with Eetmeter software 2005, version 1.4.0 
(Voedingscentrum, The Hague, The Netherlands). 
Strength assessment 
Maximum strength was assessed by means of one-repetition maximum 
(1RM) strength tests on regular leg press and leg extension machines 
(Technogym, Rotterdam, The Netherlands). During a familiarization trial, 
proper lifting technique was demonstrated and practiced and maximum 
strength was estimated using the multiple repetitions testing procedure (31). 
In an additional session, at least one week before muscle biopsy collection, 
each subject’s 1RM was determined as described previously (44). 1RM tests 
were repeated following 4 and 8 wks of intervention and after cessation of 
the intervention program, 2 days after the last exercise session. 
Exercise intervention program 
Supervised resistance type exercise training was performed 3 times a week 
for a period of 12 wks. Training consisted of 5 min of warming-up on a 
cycle ergometer, followed by 4 sets on both the leg press and leg extension 
machines, and a 5 min cooling-down period on the cycle ergometer. During 
the first 4 wks of training, the workload was increased from 60% of 1RM 
(10-15 repetitions in each set) to 75% of 1RM (8-10 repetitions). Starting at 
week 5, 4 sets of 8 repetitions were performed at 75-80% of 1RM on each 
machine. Resting periods of 1.5 and 3 min were allowed between sets and 
exercises, respectively. Workload intensity was adjusted based on the 1RM 
tests (week 4 and 8). In addition, workload was increased if more than 8 
repetitions could be performed in 3 out of 4 sets. Exercise sessions were 
always performed in the morning, at the same time of day. Subjects used 
breakfast 1.5 h before each exercise session, and lunch 2 h after each 
session. On average, subjects attended 35±1 of the 36 scheduled exercise 
sessions. 
CT-scans 
Anatomical cross-sectional area (CSA) of the quadriceps muscle was 
measured with a CT scanner (IDT 8000, Philips Medical Systems, The 
Netherlands) prior to and after cessation of the exercise intervention program 
(3 days after strength assessment and prior to muscle biopsy collection). 
With subjects lying supine, legs extended and their feet secured, a 3 mm 
thick axial image (scanning characteristics: 120 kV, 300 mA, rotation time 
of 0.75 s, field of view of 500 mm) was taken midway between the anterior 
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superior iliac spine and the bottom of the patella. The exact scanning 
position was measured and marked, to be replicated after cessation of the 
intervention program. Using the described approach we determined the 
coefficient of variation for repeated scans to be 0.6%. Images were loaded 
onto a PC using AGFA IMPAX imaging software, version 5.2 (AGFA 
Healthcare, Belgium). Muscle area of the right leg was selected between -29 
and +150 Hounsfield units (32), after which the quadriceps muscle was 
selected by manual tracing. Quadriceps CSA was calculated using Lucia 
4.81 software (Nikon Instruments Europe, Badhoevedorp, The Netherlands). 
All analyses were performed by 2 investigators blinded to subject coding; 
intraclass correlation coefficients for inter- and intra-investigator reliability 
were 0.997 and 0.998, respectively. 
DXA-scans 
Directly after CT-scanning, body composition and bone mineral content 
were measured with dual-energy X-ray absorptiometry (DXA, Lunar 
Prodigy Advance, GE Healthcare, Madison, WI). Whole-body and regional 
lean mass, fat mass and bone mineral content were determined using the 
system’s software package enCORE 2005 (version 9.15.00). 
Blood samples 
To determine glucose homeostasis and exclude insulin resistant and/or 
diabetic subjects, fasting blood samples were collected prior to the 
intervention, and 4 days after the strength assessment performed after 
completion of the exercise program. Blood samples were collected in EDTA 
containing tubes and centrifuged at 1000g and 4°C for 10 min. Aliquots of 
plasma were frozen in liquid nitrogen and stored at -80°C. Plasma samples 
were analyzed for glucose (COBAS FARA, Uni Kit III, Roche, Basel, 
Switzerland) and insulin concentrations (Insulin RIA Kit, LINCO Research 
INC., St. Charles, MO). Blood HbA1c content (3 mL blood sample, EDTA) 
was analyzed by high-performance liquid chromatography (Bio-Rad Variant 
II, Munich, Germany). Plasma glucose and insulin concentrations from the 
OGTT were used to estimate whole-body insulin sensitivity using the oral 
glucose insulin sensitivity (OGIS)-index (28). 
Muscle biopsies 
3 days prior to the onset of exercise training and 4 days after the post-
intervention strength assessment, muscle biopsy samples were taken from 
the right leg of each subject, in the morning after an overnight fast. After 
local anesthesia, percutaneous needle biopsies (50–80 mg) were taken from 
the vastus lateralis muscle, ~15 cm above the patella (3). The post training 
biopsy was performed ~1 cm proximal to the pre training biopsy, at the same 
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depth. Any visible non-muscle tissue was removed from the biopsy samples, 
which were then embedded in Tissue-Tek (Sakura Finetek, Zoeterwoude, 
The Netherlands), immediately frozen in liquid nitrogen-cooled isopentane, 
and stored at -80°C until further analyses. 
Immunohistochemistry 
From all biopsies, 5 µm thick cryosections were cut at -20°C. Pre- and post-
intervention samples from one subject were mounted together on uncoated 
glass slides. Care was taken to properly align the samples for cross-sectional 
fiber analyses. Serial cross-sections were stained for muscle fiber typing 
(FT) and myocellular satellite cell (SC) content as described previously (22, 
44). First antibodies used are directed against MHC-I (A4.951, 
Developmental Studies Hybridoma Bank [DSHB], Iowa City, IA; dilution 
1:20), laminin (polyclonal rabbit anti-laminin; Sigma, Zwijndrecht, The 
Netherlands; dilution 1:50) and CD56 (BD biosciences, San Jose, CA; 
dilution 1:40). The latter antibody has been extensively used for SC 
determination in human muscle tissue (5, 9, 20, 21, 27, 36). Appropriate 
secondary antibodies were applied: goat anti-mouse IgG1 AlexaFluor488, 
goat anti-rabbit IgG AlexaFluor555 (Molecular Probes, Invitrogen, Breda, 
The Netherlands; dilution 1:500 and 1:200, respectively) and Avidin-D 
(Vector Laboratories Inc., Burlingame, CA; dilution 1:333), respectively. 
Nuclei were stained with 4-,6-diamidino-2-phenylindole (DAPI; Molecular 
Probes; 0.238 µM). Staining procedures were as follows. After fixation (5 
min acetone), slides were air-dried and incubated for 60 min at room 
temperature with primary antibodies directed against laminin and either 
MHC-I or CD56, diluted in 0.05% Tween-PBS. Slides were then washed 
(3*5 min PBS). Slides for FT were then incubated for 30 min at room 
temperature with the appropriate secondary antibodies, diluted together with 
DAPI in 0.05% Tween-PBS. For optimizing the staining result, slides for SC 
were first incubated for 30 min with biotinylated horse anti-mouse IgG 
(Vector; dilution 1:150), diluted in PBS. After another washing step with 
PBS, SC slides were then incubated for 10 min with the secondary 
antibodies, diluted together with DAPI in 0.05% Tween-PBS. After a final 
washing step, all slides were mounted with cover glasses using Mowiol 
(Calbiochem, Amsterdam, The Netherlands). Staining procedures resulted in 
laminin stained in red, nuclei in blue, and either MHC-I or CD56 in green 
(Figure 5.1). 
All images were digitally captured, using fluorescence microscopy with a 
Nikon E800 fluorescence microscope (Nikon Instruments Europe) coupled 
to a Basler A113 C progressive scan color CCD camera with a Bayer color 
filter. Epifluorescence signal was recorded using a Texas Red excitation 
filter (540–580 nm) for laminin, a DAPI UV excitation filter (340–380 nm) 
for the nuclei, and a FITC excitation filter (465–495 nm) for either MHC-I 
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or CD56. Image processing and quantitative analyses were done using Lucia 
4.81 software package, as described previously (44). All image recordings 
and analyses were performed by an investigator blinded to subject coding. 
From the FT slides, images were captured at a 120x magnification. Laminin 
was used to determine the basement membrane, and all fibers within each 
image were identified as type I or type II fiber (Figure 5.1). Within each 
image, the number of fibers, the mean fiber cross-sectional area (CSA), the 
number of myonuclei per fiber, and the mean fiber area per myonucleus 
(fiber CSA/no. myonuclei) were measured for the type I and type II muscle 
fibers separately. To obtain the true number of myonuclei (i.e. not SC 
nuclei), the number of nuclei was corrected for the number of SC counted on 
the SC slides. Fiber circularity was calculated as (4π·CSA)/(perimeter)2; all 
fibers with circularity below 0.60 were excluded from analysis (23). No 
differences in fiber circularity were observed over time or between fiber 
types, validating the comparison of pre and post training data on muscle 
fiber CSA. 
 
 
Figure 5.1 Muscle fiber type-specific analysis for satellite cell content. A: MHC-
I+laminin+DAPI staining from serial cross-section of image B-D; the marked area represents 
the same area as shown in frame B-D; B: CD56+laminin+DAPI staining; C: CD56 staining; 
D: CD56+DAPI staining. Arrows indicate the satellite cells. Numbers indicate muscle fiber 
type I and II.  
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From the SC slides, images were captured at a 240x magnification to allow 
clear determination of SC localization. Laminin was used to visualize cell 
borders. Fiber typing was determined by matching the serial FT slides. SC 
were determined at the periphery of each fiber and stained positive for both 
DNA (DAPI) and CD56 (Figure 5.1). The number of SC per muscle fiber, 
the percentage of SC [no. SC/(no. SC + no. myonuclei)*100], and the 
number of SC per fiber area (in mm2) were calculated for the type I and type 
II muscle fibers separately. A mean total of 328±31 and 254±37 muscle 
fibers were analyzed in each subjects’ pre- and post-intervention biopsy 
sample, respectively. 
Statistics 
All data are expressed as means±SEM. Differences between pre- and post-
intervention values were analyzed with Student’s paired t-tests. In addition, 
2-way repeated measures ANOVA with time (pre vs post) and fiber type 
(type I vs type II) as within subjects factors was used to determine training 
induced changes in muscle fiber type-specific variables. In case of 
significant interaction, Student’s paired t-tests were performed for time 
effects within type I or type II muscle fiber characteristics, and/or effects of 
muscle fiber type within the pre- or post-intervention values. All analyses 
were performed using SPSS version 13.0 (Chicago, IL). An α-level of 0.05 
was used to determine statistical significance. 
Results 
Subjects 
Subjects’ characteristics at baseline and after intervention are provided in 
Table 5.1. Subjects’ age averaged 72±2 y. Total body mass, height and BMI 
did not change over the intervention period. Fasting blood glucose and 
insulin concentrations and HbA1c contents were within normal range for 
healthy individuals and did not change over time. 
Muscle strength 
Strength (1RM) increased significantly from pre- to post-intervention for 
both the leg extension and leg press exercises, from 88±4 to 111±5 kg and 
170±8 to 210±10 kg, respectively (P<0.001). Repeated measures analysis 
revealed that the increase in 1RM strength was statistically significant for 
each 4-wk interval during the intervention period for both exercises (data not 
shown). 
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Table 5.1 Subjects’ characteristics 
 Before After 
Body mass (kg) 80.2±3.4 80.1±3.4 
Height (m) 1.71±0.01 1.71±0.01 
BMI (kg/m2) 27.4±1.1 27.4±1.1 
Leg volume (L) 8.2±0.5 8.3±0.5 * 
Glucose (mmol/L) 5.6±0.2 5.5±0.1 
HbA1c (%) 5.8±0.1 5.7±0.1 
OGIS (mL/min/m2) 368±22 382±19 
1RM LE (kg) 88±4 111±5 * 
1RM LP (kg) 170±8 210±10 * 
Data are means±SEM; BMI: body mass index; OGIS: oral glucose insulin sensitivity-index 
(28); 1RM: one-repetition maximum; LE: leg extension; LP: leg press; *: significantly 
different compared with before the intervention (P<0.05). 
Body composition and muscle mass 
Whole-body lean mass tended to increase throughout the intervention period 
(from 57.4±1.6 to 58.0±1.7 kg; P=0.062). Total fat mass decreased 
significantly (P<0.01), resulting in a significant decline in whole-body fat 
percentage (P<0.01; Table 5.2). Leg lean mass increased from 18.3±0.5 to 
19.3±0.5 kg (P<0.001). In accordance, fat percentage in the legs had also 
decreased following the exercise intervention (P<0.05; Table 5.2). No 
changes were observed in whole-body and regional bone mineral content 
(data not shown). 
CT-scans of the upper leg, performed prior to and after the exercise program, 
revealed a substantial 8.8±1.4% increase in quadriceps anatomical CSA 
following the intervention program, from 75.9±3.7 to 82.4±3.9 cm2 
(P<0.001). 
Dietary records 
Analysis of the 3-day dietary records before and after 11 wks of intervention 
did not show any changes in total daily energy intake (9.2±0.6 vs 9.1±0.4 
MJ/d, respectively).  Likewise, macronutrient composition of the diet did not 
change during the intervention period, and averaged 50±2, 33±2 and 17±1 
Energy% before intervention and 52±2, 32±2 and 16±1 Energy% after 11 
wks of intervention, for carbohydrate, fat and protein, respectively. Daily 
protein intake averaged 1.1±0.1 g per kg body mass per day, both before and 
after 11 wks of intervention. 
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Table 5.2 Body composition and muscle mass 
 Before After 
Lean mass (kg) 57.4±1.6 58.0±1.7 
Fat mass (kg) 19.6±2.4 19.0±2.4 * 
Body fat (%) 23.6±2.2 22.9±2.2 * 
Leg lean mass (kg) 18.3±0.5 19.3±0.5 * 
Leg fat (%) 18.9±2.3 18.3±2.3 * 
CSA (cm2) 75.9±3.7 82.4±3.9 * 
Data are means±SEM; CSA: cross-sectional area of the right quadriceps muscle; *: 
significantly different compared with before the intervention (P<0.05). 
Muscle fiber type composition and fiber area 
At baseline, the proportion of type I and type II muscle fibers was 47±4 and 
53±4 %, and the proportion of muscle area occupied by type I and II fibers 
was 52±4 and 48±4 %, respectively. Muscle fiber type percentage, expressed 
either as fiber number or area occupied by type I and type II muscle fibers, 
did not show any changes following 3 months of exercise intervention 
(Table 5.3). 
For muscle fiber CSA, a significant ‘time x fiber type’ interaction was 
observed. At baseline, type II muscle fiber CSA was smaller than type I 
muscle fiber CSA (Table 5.3, P<0.01). However, the difference in fiber type 
CSA was no longer apparent after the intervention period, with a mean type I 
and II muscle fiber CSA of 6881±493 and 6982±503 µm2, respectively 
(Table 5.3). In contrast to the type I fibers, type II muscle fiber CSA 
significantly increased following exercise intervention from 5438±319 to 
6982±503 µm2 (P<0.01). 
 
Table 5.3 Muscle fiber type composition 
 Before intervention After intervention 
 fiber% CSA (µm2) CSA% fiber% CSA (µm2) CSA% 
Type I 47±4 6635±354 52±4 47±3 6881±493 46±3 
Type II 53±4 5438±319 † 48±4 53±3 6982±503 * 54±3 
Data area means±SEM; CSA: fiber cross-sectional area; CSA%: percentage area occupied by 
muscle fiber type; *: significantly different compared with before the intervention (P<0.01); †: 
significantly different compared with the type I muscle fibers (P<0.01). 
Myonuclear and satellite cell content 
At baseline, the number of myonuclei per muscle fiber was higher in the 
type I vs type II muscle fibers (3.6±0.2 vs 2.8±0.2, respectively; P<0.01). A 
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significant ‘time x fiber type’ interaction revealed that after the exercise 
intervention, differences in myonuclear content were no longer apparent 
between the type I and II muscle fibers (3.4±0.3 vs 3.3±0.8, respectively). In 
contrast to the type I fibers, the number of myonuclei per type II muscle 
fiber tended to increase from 2.8±0.2 to 3.3±0.3 during the intervention 
program (P=0.091). Mean fiber area per myonucleus was similar for the type 
I and II muscle fibers at baseline, and did not change over time (Table 5.4). 
 
Table 5.4 Myonuclear and satellite cell content 
  Before After 
Type I 3.6±0.2 3.4±0.3 No. nuclei  per fiber 
Type II 2.8±0.2 † 3.3±0.3 
Type I 1918±133 2096±118 Fiber area per nucleus (µm2) 
Type II 2029±159 2149±148 
Type I 0.089±0.006 0.096±0.011 No. SC per fiber 
Type II 0.048±0.003 † 0.084±0.008 * 
Type I 2.6±0.3 2.7±0.3 SC % 
Type II 1.8±0.1 † 2.6±0.3 * 
Type I 13.9±1.2 12.9±1.2 No. SC per mm2 
Type II 9.2±0.8 † 11.9±0.9 * 
Data are means±SEM; SC: satellite cells; SC %: number of SC as a percentage of the total 
number of nuclei (i.e. no. of myonuclei + no. of SC); Type I-II: type I and II muscle fibers *: 
significantly different compared with before the intervention (P<0.01); †: significantly 
different compared with the type I muscle fibers (P<0.01). 
 
For all SC variables, significant ‘time x fiber type’ interactions were 
observed. The number of SC per muscle fiber at baseline was lower for the 
type II fibers compared with the type I fibers (0.048±0.003 vs 0.089±0.006, 
respectively; P<0.001). For the percentage of SC and the number of SC per 
mm2, analysis also revealed a significantly lower SC content in the type II vs 
type I fibers at baseline (Table 5.4). In contrast to the type I muscle fibers, 
significant increases were observed in the type II muscle fiber SC content 
after 3 months of exercise intervention (Figure 5.2, Table 5.4). The number 
of SC per type II muscle fiber increased substantially from 0.048±0.003 to 
0.084±0.008 (P<0.001), the percentage of SC increased from 1.8±0.1 to 
2.6±0.3 (P<0.01), and the number of SC per mm2 of type II fiber area 
increased from 9.2±0.8 to 11.9±0.9 (P<0.01). In accordance, after the 
intervention program, no differences in SC content were observed between 
the type I and II muscle fibers for any of the SC variables (Figure 5.2, Table 
5.4). 
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Figure 5.2 Mean number of satellite cells (SC) in the type I and type II muscle fibers before 
and after the exercise intervention program. #: significantly different compared with the type I 
muscle fibers (P<0.01); *: significantly different compared with before the intervention 
(P<0.01). 
Discussion 
The present study shows that 3 months of resistance type exercise training 
augments muscle mass, reduces fat mass, and increases muscle strength in 
healthy, elderly men. The observed skeletal muscle hypertrophy is shown to 
be specific for the type II muscle fibers and accompanied by a specific 
increase in type II muscle fiber SC content. 
Aging is associated with the loss of muscle mass, strength and functional 
capacity (12, 14, 25). It has been well established that resistance type 
exercise training represents a feasible and effective interventional strategy to 
counteract sarcopenia in various elderly populations (4, 11-13, 15, 17, 23, 
27, 29, 40, 42). The resistance exercise program implemented in the present 
study was shown to be feasible, and resulted in a high compliance and 
adherence rate, with 35±1 out of 36 sessions being performed by the 
subjects. In accordance, we observed 25-30% improvements in 1RM 
strength for the LE and LP exercises. This increase in muscle strength is 
similar to previously published studies (23, 29, 40). Skeletal muscle strength 
has been positively correlated with muscle mass and muscle CSA (12, 14). 
In accordance, we observed a concomitant increase in leg lean mass (6±1%) 
and quadriceps CSA (9±1%; Table 5.2). The latter clearly shows the 
efficacy of the 12 wk exercise program to increase muscle mass and strength 
in healthy, elderly men. 
Previous studies by other groups (9, 24, 26) as well as from our laboratory 
(44) have shown that the loss of muscle mass with aging is largely attributed 
to the specific atrophy of type II muscle fibers. In the present study, we 
confirm a substantially smaller type II muscle fiber area when compared to 
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type I muscle fibers at baseline in the elderly males (Table 5.3). 
Furthermore, we observed a significantly lower myonuclear and SC content 
in the type II vs type I muscle fibers prior to intervention (Figure 5.2, Table 
5.4). The latter is consistent with our recent findings showing a lower SC 
content in type II muscle fibers in muscle tissue from elderly versus young 
men (44). In the present study, no young control group was included, and 
type II muscle fiber characteristics at baseline could only be compared to 
type I muscle fibers, which were relatively large in the present study. 
However, the latter was probably due to the lower fiber circularity as 
compared with our previous study (0.71 vs 0.74, (44)). In addition, inter-
individual variability was large in the present study, with fiber size ranging 
from 3700 to 9000 µm2. Despite these findings, specific type II muscle fiber 
atrophy was still apparent when the present data were compared to the young 
control group in our previous study (44). Moreover, we (44) and others (21) 
have previously shown that SC content is similar between type I and type II 
muscle fibers in young adults. Therefore, we argue that the lower fiber size 
and SC content of the type II vs type I muscle fibers at baseline in the 
present study are consistent with and indicative of the specific reduction of 
type II muscle fiber size and SC content with aging. Similar fiber type-
specific changes in SC content have also been observed in animal studies 
(41). These data might suggest a causal relationship between a decline in 
myonuclear and/or SC content and muscle fiber type-specific atrophy. The 
lower number of SC might be insufficient to support myofiber maintenance 
and, as such, contribute to the gradual loss of muscle mass with aging (41). 
Reduced neuromuscular activity (due to a more sedentary lifestyle and/or 
functional disability) and/or impaired neuronal input might represent 
important factors contributing to the age-related decline in myonuclear and 
SC number and activity, and the associated reduction in muscle fiber size (2, 
7). More research is warranted to elucidate the potential role of the decline in 
type II muscle fiber SC content in the etiology of sarcopenia. 
To further investigate the proposed functional relationship between the 
reduced SC content in the type II versus type I muscle fibers and the 
accompanying smaller type II muscle fiber size in elderly males, it is of 
substantial clinical relevance to assess whether strategies that induce muscle 
fiber hypertrophy are associated with an increase in muscle fiber SC content. 
This would provide important novel information, offering new targets for the 
evaluation of effective nutritional, pharmaceutical and/or exercise 
interventions to combat sarcopenia in the elderly. Resistance type exercise 
training has been established as an effective therapeutic strategy to induce 
muscle hypertrophy in the elderly, and has been associated with a more 
pronounced hypertrophy of the type II muscle fibers (4, 23, 29, 42). The 
latter is supported by the present findings, as we observed a 28±6% increase 
in type II muscle fiber cross-sectional area following 12 wks of training 
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(Table 5.3). Notably, differences in fiber size between type I and II muscle 
fibers as observed prior to intervention were no longer apparent after 
completing the exercise intervention program (Table 5.3). 
There has been much discrepancy in the literature on the proposed impact of 
resistance type exercise training on myonuclear and/or SC content in muscle 
tissue in the elderly (18, 27, 36, 40). The apparent discrepancy is likely 
attributed to the lack of fiber type-specific data on muscle fiber 
hypertrophy/atrophy and the associated changes in myonuclear and/or SC 
content. In the present study, the specific hypertrophy of type II muscle 
fibers after training was accompanied by a substantial 76±15% increase in 
type II muscle fiber SC content (Figure 5.2, Table 5.4). In addition, the 
number of myonuclei per type II muscle fiber tended to increase from 
2.8±0.2 to 3.3±0.3 (P=0.091), while the fiber area per myonucleus was 
maintained throughout the intervention period (P=0.531; Table 5.4). These 
findings are in line with the rationale that myofiber hypertrophy is facilitated 
by increased translational activity of pre-existing myonuclei and/or the 
incorporation of newly formed myonuclei (10, 37, 43). Consequently, our 
findings suggest that the maximum amount of cytoplasm that can be 
controlled by one myonucleus, referred to as the ‘myonuclear domain’ 
ceiling (6, 36), was reached during the intervention program. Therefore, SC 
proliferation and the subsequent incorporation of their differentiated progeny 
(i.e. newly formed myonuclei) was essential to allow further type II muscle 
fiber hypertrophy. In that respect, it was surprising that we only observed a 
tendency towards an increase in type II muscle fiber myonuclear content 
(P=0.091). However, as described by Petrella et al. in their recent paper (37), 
the myofiber response to an exercise program can be highly variable. By 
using cluster analysis, the authors reported that subjects with extreme 
myofiber hypertrophy also showed the largest increases in SC content and 
both myonuclear number and domain size (37). In accordance, inter-
individual variability plays an important role in the apparent discrepancy 
between significant myofiber hypertrophy and non-significant changes in 
myonuclear content and/or domain as observed in the present and previous 
studies (18, 36). Supposedly, some subjects might have relied more heavily 
on expansion of the myonuclear domain, whereas most subjects were able to 
incorporate new myonuclei. In the present study, we observed a non-
significant 25±12% increase in the number of myonuclei per type II muscle 
fiber. The latter tends to be in line with the 26% increase observed by 
Petrella et al. (37). Since only pre- and post-intervention biopsy samples 
were collected, we can only speculate on the proposed time line between an 
increase in SC number, the incorporation of new myonuclei, and subsequent 
muscle fiber hypertrophy. However, in vitro data and rodent studies indicate 
that an increase in SC number and subsequent incorporation of new 
myonuclei precedes muscle hypertrophy (reviewed in (2)). 
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Considering the large inter-individual variability in the hypertrophy response 
and the relations between the changes in myofiber size, SC content and 
myonuclear content, it is interesting to speculate which factors might be 
responsible for the apparent differential responses. Previous research 
implicated that the myogenic regulatory factors (myogenin, MyoD, myf-5, 
MRF4), and various growth agents such as IGF-I, MGF, and HGF play a 
role in the (load mediated) hypertrophy and in SC activation and/or 
proliferation and differentiation (reviewed in (8, 16)). However, most data 
are derived from in vitro and acute in vivo studies and, as such, little is 
known on the potential role these agents might play in the response to 
prolonged exercise training. However, as we restricted ourselves to the 
assessment of the impact of exercise training on muscle fiber characteristics, 
we can only speculate on this matter. 
This is the first study to show that the relatively lower type II muscle fiber 
size and SC content in the elderly can be specifically enhanced following 3 
months of resistance type exercise training. Though the exact signaling 
pathways leading to SC induced muscle fiber hypertrophy, as well as the 
reasons for inter-individual response variability in these pathways remain to 
be elucidated, these findings might open up novel opportunities for 
evaluating the efficacy of nutritional, pharmaceutical, and/or exercise based 
interventional strategies to counteract the loss of muscle mass, strength and 
function with aging. 
We conclude that prolonged resistance type exercise training effectively 
increases muscle mass and strength in healthy, elderly men. The relative type 
II muscle fiber atrophy and the associated lower satellite cell content in type 
II versus type I muscle fibers in the elderly can be reversed by prolonged 
resistance type exercise training. The latter indicates that muscle tissue in the 
elderly is still capable of inducing satellite cell proliferation, differentiation 
and fusion of new myonuclei into existing muscle fibers, resulting in type II 
muscle fiber hypertrophy. 
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ABSTRACT 
Background: There is considerable discrepancy in the literature on the 
proposed benefits of protein supplementation on the skeletal muscle adaptive 
response to resistance type exercise training in the elderly. Objective: To 
assess the benefits of timed protein supplementation on the increase in 
muscle mass and strength during prolonged resistance type exercise training 
(RT) in healthy, elderly males who habitually consume adequate dietary 
protein. Design: 26 healthy, elderly males (72±2 y) were randomly assigned 
to a progressive 12 week RT-program with (PRO) or without (PLA) protein 
provided prior to and immediately after each exercise session (3 sessions/wk, 
20 g protein/session). One-repetition maximum (1RM) tests were performed 
regularly to ensure a progressive workload during the intervention. Muscle 
hypertrophy was assessed on a whole-body (DXA), limb (CT), and muscle 
fiber (biopsy) level. Results: 1RM strength increased ~25-35% in both 
groups (P<0.001). DXA and CT scans showed similar increases in leg 
muscle mass (6±1% in both groups; P<0.001), and in quadriceps area (9±1% 
in both groups, from 75.9±3.7 and 73.8±3.2, to 82.4±3.9 and 80.0±3.0 cm2 in 
the PLA and PRO group, respectively; P<0.001). Muscle fiber hypertrophy 
was greater in type II (PLA: 28±6%, PRO: 29±4%) vs type I fibers (PLA: 
5±4%, PRO: 13±6%), with no differences between groups. Conclusion: 
Timed protein supplementation immediately prior to and after exercise does 
not further augment the increase in skeletal muscle mass and strength 
following prolonged resistance type exercise training in healthy, elderly 
males who habitually consume adequate dietary protein. 
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Introduction 
The age-related loss of skeletal muscle mass and strength, sarcopenia, is 
associated with a progressive decline in functional performance (11, 27, 30, 
48). Resistance type exercise training has been shown to represent an 
effective strategy to augment skeletal muscle mass and strength and improve 
functional capacity in the elderly (9, 12, 14, 17, 26, 33, 44). Physical activity 
stimulates muscle protein synthesis and accelerates protein breakdown (16, 
42, 43, 50, 51). However, in the absence of food intake net muscle protein 
balance will remain negative (38). Post-exercise carbohydrate ingestion 
attenuates the exercise induced increase in protein breakdown (35, 41). 
However, amino acid and/or protein administration, with (23, 24, 40) or 
without carbohydrate (4, 45), is required to inhibit protein breakdown and 
stimulate muscle protein synthesis, resulting in a positive muscle protein 
balance. The timing of protein ingestion seems to represent an important 
factor in stimulating post-exercise muscle protein accretion (2, 28, 46). 
Levenhagen et al. (28) reported an improved post-exercise net protein 
balance following consumption of protein and carbohydrate immediately 
after cessation of exercise as opposed to a more delayed supplementation 
regimen. Furthermore, recent studies suggest that protein co-ingestion prior 
to and/or during exercise can further augment post-exercise muscle protein 
accretion (2, 46). 
Though the acute studies underline the relevance of protein ingestion prior to 
and immediately after exercise, there is considerable discussion on the 
proposed benefits of protein supplementation on the adaptive response to 
more prolonged exercise training in the elderly. From a series of well-
controlled nutritional intervention studies (6, 8, 20), Campbell et al. 
concluded that resistance training induced improvements in muscle mass and 
strength are not enhanced when older people who consume adequate dietary 
protein (in excess of 0.8 g/kg/d) further increase their protein intake (7). The 
latter is in line with previous studies that failed to observe benefits of 
nutritional co-intervention during long-term exercise intervention in the 
elderly (13, 15). The absence of any apparent benefits of protein 
supplementation on the adaptive response to long-term resistance exercise 
training might be attributed to a less than optimal timing of the applied 
feeding regimen. Esmarck et al. (10) reported that the timing of the 
administration of a protein containing supplement following resistance 
exercise is essential for skeletal muscle hypertrophy to occur during exercise 
training in the elderly. In their study, the control group receiving nutritional 
supplementation 2 h after cessation of exercise, as opposed to immediately 
after, did not show any improvements in muscle hypertrophy following 12 
weeks of training (10). However, the latter seems to be in contrast with 
previous studies that generally show muscle hypertrophy following 
resistance exercise training without dietary co-intervention (9, 12, 14, 17, 26, 
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33, 44). Nonetheless, recent studies in other populations (18, 19) showed that 
timed protein supplementation after resistance exercise might induce slight 
benefits over resistance training alone, although the additional effects were 
less marked than suggested by Esmarck et al. (10). 
We hypothesized that protein supplementation immediately prior to and after 
resistance exercise would augment the gain in muscle mass and strength 
during prolonged resistance type exercise training in elderly people. 
Therefore, we assessed the impact of timed protein supplementation on the 
increase in muscle mass and strength during 3 months of resistance type 
exercise training in healthy, elderly males who habitually consume adequate 
dietary protein. 
Subjects and methods 
Subjects 
A total of 28 healthy, elderly men (72±2 y) volunteered to participate in a 12 
week resistance type exercise intervention program, with or without 
additional protein supplementation prior to and immediately after each 
exercise session (3 sessions/wk). Two subjects dropped out during the study, 
one because of an acute back problem that occurred during gardening and 
the other because of fear of regaining an old back injury. Medical history of 
all subjects was evaluated and an oral glucose tolerance test (OGTT) and 
resting ECG were performed before selection. Exclusion criteria were 
defined that would preclude successful participation in the exercise program, 
and included (silent) cardiac or peripheral vascular disease and orthopedic 
limitations. Furthermore, as insulin resistance and/or type 2 diabetes have 
been associated with a more progressive loss of muscle mass and strength 
with aging (37), type 2 diabetes patients were excluded from participation 
(1). All subjects were living independently and had no history of 
participating in any structured exercise training program in the past 5 years. 
All subjects were informed on the nature and possible risks of the 
experimental procedures, before their written informed consent was 
obtained. This study was approved by the Medical Ethics Committee of the 
Academic Hospital, Maastricht. This study is part of a greater project 
investigating the clinical benefits of exercise and/or nutritional intervention 
in the elderly. 
Study design 
After inclusion in this study, subjects were randomly allocated to either the 
protein (PRO) or the placebo (PLA) supplemented group. Before, during, 
and after exercise intervention, anthropometric measurements (height, body 
mass, leg volume (21)), strength assessment (one-repetition maximum), CT 
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and DXA scans were performed and muscle biopsies, blood samples, 24 h 
urine, and dietary intake records were collected. 
Dietary intake and physical activity standardization 
Standardized meals (~51 kJ/kg body mass; 57 Energy% carbohydrate, 13 
En% protein, and 30 En% fat) were provided to all subjects prior to each test 
day (i.e. prior to muscle biopsy and/or blood sampling) and subjects were 
instructed to refrain from strenuous physical activity for 3 days prior to 
testing. Dietary intake was recorded for 2 days prior to blood sample 
collection to standardize food intake prior to blood collection after cessation 
of the intervention program, thereby minimizing the impact of differences in 
food intake on blood glucose homeostasis. On all test days, subjects arrived 
at the laboratory by car or public transportation, following an overnight fast. 
Prior to the onset of the intervention program and in week 11 of the exercise 
intervention, subjects recorded 3-day weighted dietary records (Thursday-
Saturday) to assess potential changes in daily food intake that might had 
occurred during the intervention period. Food intake records were 
scrutinized by a dietician and analyzed with Eetmeter software 2005, version 
1.4.0 (Voedingscentrum, The Hague, The Netherlands). Dietary intake was 
calculated for the entire day, as well as for breakfast and lunch separately. 
The energy derived from the protein supplements was not included in the 
analysis. 
Strength assessment 
Maximum strength was assessed by one-repetition maximum (1RM) 
strength tests on leg press and leg extension machines (Technogym, 
Rotterdam, The Netherlands). During a familiarization trial, proper lifting 
technique was demonstrated and practiced and maximum strength was 
estimated using the multiple repetitions testing procedure (34). In an 
additional session, at least one week prior to muscle biopsy collection, each 
subject’s 1RM was determined as described previously (48). 1RM testing is 
preferred to evaluate changes in muscle strength during resistance type 
exercise training (49). Therefore, 1RM tests were repeated after 4 and 8 
weeks of intervention and 2 days after the last training session of the 
intervention program. None of the subjects experienced any joint pain and/or 
muscle soreness due to the 1RM testing procedures. 
Exercise intervention program 
Supervised resistance type exercise training was performed 3 times a week 
for a 12-week period. All sessions were performed in the morning, at the 
same time of day. Training consisted of a 5 min warm-up on a cycle 
ergometer, followed by 4 sets on both the leg press and leg extension 
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machines, followed by a 5 min cooling-down period on the cycle ergometer. 
During the first 4 weeks of training, the workload was increased from 60% 
of 1RM (10-15 repetitions in each set) to 75% of 1RM (8-10 repetitions). 
Starting at week 5, 4 sets of 8 repetitions were performed at 75-80% of 1RM 
on each machine. Resting periods of 1.5 and 3 min were allowed between 
sets and exercises, respectively. Workload intensity was adjusted based on 
the 1RM tests (week 4 and 8). In addition, workload was increased when 
more than 8 repetitions could be performed in 3 out of 4 sets. On average, 
subjects attended 35±1 of the 36 scheduled exercise sessions in both groups. 
Protein supplementation 
During the 5 min warm-up and cooling-down procedure, subjects received 
250 mL of a beverage containing either water only (placebo group, PLA) or 
protein (protein group, PRO). The protein beverages contained 10 g protein 
(casein hydrolysate, DSM, Delft, The Netherlands); as such, the PRO group 
received 20 g protein per exercise session. All beverages were flavoured to 
mask the contents of the drinks (cream vanilla: 5 g/L, citric acid: 1.8 g/L, 
and sodium saccharinate: 0.28 g/L). All subjects ate breakfast at least 1.5 h 
before starting the exercise sessions, and lunch was eaten no less than 2 h 
after cessation of each session. On training days, no food or drinks were 
allowed other than the experimental beverages between breakfast and lunch. 
Subjects were allowed to drink water prior to, during and after each exercise 
session. 
CT-scans 
Anatomical cross-sectional area (CSA) of the quadriceps muscle was 
assessed by CT scanning (IDT 8000, Philips Medical Systems, The 
Netherlands) prior to and after cessation of the exercise intervention program 
(3 days after strength assessment and prior to muscle biopsy collection). 
With subjects lying supine, legs extended and their feet secured, a 3 mm 
thick axial image was taken midway between the anterior superior iliac spine 
and the distal end of the patella. Scanning characteristics were 120 kV, 300 
mA, with a rotation time of 0.75 s and a field of view of 500 mm. The exact 
scanning position was measured and marked, to be replicated after cessation 
of the intervention program. Using the described approach, we determined 
the CV for repeated scans to be less than 0.6%. Images were loaded onto a 
pc using AGFA IMPAX imaging software, version 5.2 (AGFA Healthcare, 
Belgium). Muscle CSA of the right leg was selected between -29 and +150 
Hounsfield units (36), after which the quadriceps muscle was selected by 
manual tracing. Quadriceps CSA was calculated using Lucia 4.81 software 
(Nikon, Badhoevedorp, The Netherlands). All analyses were performed by 2 
investigators blinded to subject coding; intraclass correlation coefficients for 
inter- and intra-investigator reliability were 0.997 and 0.998, respectively. 
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DXA-scans 
Directly after CT-scanning, body composition and bone mineral content 
were measured with dual-energy X-ray absorptiometry (DXA, Lunar 
Prodigy Advance, GE Healthcare, Madison, WI). The system’s software 
package (enCORE 2005, version 9.15.00) was used to determine whole-
body and regional lean mass, fat mass and bone mineral content. DXA scans 
were performed in a fasted state, after subjects had voided. CV for repetitive 
scans (n = 4, 2 weeks apart) were 0.4%, 1.0%, and 1.1% for whole-body lean 
mass, fat mass, and leg lean mass, respectively. 
Blood samples 
To determine glucose homeostasis and exclude insulin resistant and/or type 
2 diabetic subjects, fasting blood samples were collected prior to and after 4, 
8, and 11 weeks of intervention, and 4 days after the strength assessment 
performed after cessation of the exercise program. In addition, a standard 
OGTT was performed 2 weeks prior to and 1 week after cessation of the 
intervention. Blood samples were collected in both EDTA containing tubes 
and serum tubes and centrifuged at 1000g and 4°C for 10 min (plasma) or 
18°C for 15 min (serum). Aliquots of plasma and serum were frozen in 
liquid nitrogen and stored at -80°C. Samples were analyzed for plasma 
glucose and insulin, to assess potential changes in whole-body insulin 
sensitivity using the oral glucose insulin sensitivity (OGIS)-index (31). 
Plasma glucose concentrations were analyzed with a COBAS FARA 
analyzer (Uni Kit III, Roche, Basel, Switzerland). Insulin was analyzed by 
RIA (Insulin RIA Kit, LINCO Research INC., St. Charles, MO). Blood 
HbA1c content (3 mL blood sample, EDTA) was analyzed by high-
performance liquid chromatography (Bio-Rad Variant II, Munich, 
Germany). As a measure of renal function, serum creatinine was measured 
using the Jaffe rate method on a Synchron LX20 analyzer (Beckmann 
Coulter Inc., Fullerton, CA). 
24 h urine collection 
To determine urinary nitrogen and creatinine excretion, and 3-
methylhistidine concentration, 24 h urine was collected over the last day of 
the 3-day dietary intake assessment. Urine was collected from the second 
voiding on day 3 until the first voiding on the day after, in containers with 10 
mL 4M H2SO4. After determining total urine production, aliquots of urine 
were frozen in liquid nitrogen and stored at -80°C. Nitrogen content was 
analyzed on an elemental analyzer (model CHN-O-RAPID, Heraeus Co., 
Germany). Total nitrogen excretion was calculated from total urinary 
nitrogen excretion and an estimated 0.031 g/kg body mass for miscellaneous 
nitrogen loss (32). Nitrogen balance was calculated as the difference 
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between nitrogen intake (protein intake (g)/6.25) and total nitrogen 
excretion, and was used to determine nitrogen balance prior to and after 11 
weeks of intervention. Urinary creatinine excretion was measured as 
described above. As a measure of renal function, creatinine clearance was 
calculated from urinary excretion and its serum concentration and corrected 
for body surface area, yielding the amount of blood (in mL) that is cleared 
from creatinine per min per 1.73 m2 of total body surface area (29). As an 
indirect marker for myofibrillar protein degradation, 3-methylhistidine was 
determined by high performance liquid chromatography and fluorescence 
detection (Shimadzu Deutschland GmbH, Duisburg, Germany). Urinary 3-
methylhistidine concentration was expressed relative to creatinine 
concentration. 
Muscle biopsy sampling 
Three days prior to the onset of exercise training and 4 days after the post-
intervention strength assessment, muscle biopsy samples were taken from 
the right leg of each subject, in the morning following an overnight fast. 
After local anesthesia, percutaneous needle biopsies (50–80 mg) were taken 
from the vastus lateralis muscle, ~15 cm above the patella (3). Any visible 
non-muscle tissue was removed immediately, and biopsy samples were 
embedded in Tissue-Tek (Sakura Finetek, Zoeterwoude, The Netherlands), 
frozen in liquid nitrogen-cooled isopentane, and stored at -80°C until further 
analyses. 
Immunohistochemistry 
From all biopsies, 5 µm thick cryosections were cut at -20°C. Pre- and post-
intervention samples from 2 subjects (from both the PRO and PLA group) 
were mounted together on uncoated glass slides. Slides were stained for 
muscle fiber typing as described before (25, 48). First antibodies used are 
directed against MHC-I (A4.951, Developmental Studies Hybridoma Bank 
[DSHB], Iowa City, IA; dilution 1:20), and laminin (polyclonal rabbit anti-
laminin; Sigma, Zwijndrecht, The Netherlands; dilution 1:50). Appropriate 
secondary antibodies were applied: goat anti-mouse IgG1 AlexaFluor488, 
and goat anti-rabbit IgG AlexaFluor555 (Molecular Probes, Invitrogen, 
Breda, The Netherlands; dilution 1:500 and 1:200, respectively). Staining 
procedures were as follows. After fixation (5 min acetone), slides were air-
dried and incubated for 60 min at room temperature with primary antibodies 
directed against laminin and MHC-I, diluted in 0.05% Tween-PBS. Slides 
were then washed (3*5 min PBS), and incubated for 30 min at room 
temperature with the appropriate secondary antibodies, diluted in 0.05% 
Tween-PBS. After a final washing step, all slides were mounted with cover 
glasses using Mowiol (Calbiochem, Amsterdam, The Netherlands). 
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All images were digitally captured, using fluorescence microscopy with a 
Nikon E800 fluorescence microscope (Nikon Instruments Europe, 
Badhoevedorp, The Netherlands) coupled to a Basler A113 C progressive 
scan color CCD camera with a Bayer color filter. Epifluorescence signal was 
recorded using a Texas Red excitation filter (540–580 nm) for laminin, and a 
FITC excitation filter (465–495 nm) for MHC-I. Image processing and 
quantitative analyses were done using Lucia 4.81 software package (Nikon). 
All image recordings and analyses were performed by an investigator 
blinded to subject coding. Images were captured at a 120x magnification. 
Laminin was used to determine cell borders, and for all fibers within each 
image, type I and type II muscle fibers were identified. Within each image, 
the number of fibers, the mean fiber cross-sectional area (CSA), and the 
percentage of area occupied per fiber type were measured for the type I and 
type II muscle fibers separately. As a measure of fiber circularity, form 
factors were calculated using the formula (4π·CSA)/(perimeter)2. No 
differences in fiber circularity were observed over time and between groups. 
A mean number of 335±30 and 265±22 individual muscle fibers were 
analyzed in the pre- and post-intervention biopsy samples, respectively. 
Statistics 
All data are expressed as means±SEM. Baseline characteristics between 
groups were compared by means of an independent t-test. Since all data were 
normally distributed, training induced changes were analyzed with mixed 
model repeated measures ANOVA with time (before vs after exercise 
training) as within-subjects factor and group (protein vs placebo) as 
between-subjects factor. Fiber type-specific variables were analyzed by 
adding a second within-subjects factor (type I vs type II muscle fibers). In 
case of significant interaction, paired t-tests were performed for time effects 
within groups or within type I or II fibers, and independent t-tests for group 
differences in the pre- and post-intervention values. Bonferroni corrections 
were applied when appropriate. In addition to the repeated measures 
analysis, relative changes over time were calculated and analyzed by 
independent t-tests to detect potential differences between groups. Since the 
results from both analyses were identical, we report both absolute and 
relative changes but only present P-values for the repeated measures 
analyses. The relation between the average habitual daily protein intake and 
the degree of hypertrophy was determined by correlation analyses. All 
analyses were performed using SPSS version 15.0 (Chicago, IL). An α-level 
of 0.05 was used to determine statistical significance. 
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Results 
Subjects 
Subjects’ characteristics prior to and after intervention are provided in Table 
6.1. In total, 26 subjects completed the intervention program, 13 in each 
group. No differences were observed in baseline variables between groups. 
Subjects’ age was 72±2 y for both groups. Total body mass, height and BMI 
did not change over the intervention period in either group. Fasting blood 
glucose concentration and HbA1c values were within normal range for 
healthy, elderly individuals and did not change over time, although HbA1c 
tended to decline in both groups (P=0.057; Table 6.1). Whole-body insulin 
sensitivity as determined by OGIS (31) did not change over time in either 
group. 
 
Table 6.1 Subjects’ characteristics 
 Placebo group (n=13) Protein group (n=13) 
 Before After Before After 
Body mass (kg) 80.2±3.4 80.1±3.4 79.2±2.8 78.9±2.9 
Height (m) 1.71±0.01 1.71±0.01 1.73±0.02 1.73±0.02 
BMI (kg/m2) 27.4±1.1 27.4±1.1 26.5±1.0 26.4±1.0 
Leg volume (L) 8.2±0.5 8.3±0.5 * 8.0±0.3 8.2±0.3 * 
Glucose (mmol/ L) 5.6±0.2 5.5±0.1 5.9±0.2 5.8±0.1 
HbA1c (%) 5.8±0.1 5.7±0.1 5.9±0.1 5.8±0.1 
OGIS (mL/kg/min) 368±22 382±19 365±12 368±16 
Data represent means±SEM; OGIS: oral glucose insulin sensitivity-index (31). Data were 
analyzed using repeated measures ANOVA with time and group as factors. No significant 
differences were observed between groups before intervention. No ‘time x group’ interaction 
was observed for any of the variables (P≥0.40). No main effect of group was observed for any 
of the variables. *Indicates a significant time effect compared with before intervention 
(P<0.05). 
Skeletal muscle hypertrophy 
Prior to exercise intervention, no differences were observed between the 
placebo (PLA) and protein (PRO) supplemented group for quadriceps 
anatomical CSA (75.9±3.7 vs 73.8±3.2 cm2, respectively). Over time, 
quadriceps CSA increased 9±1 % in both groups to 82.4±3.9 and 80.0±3.0 
cm2 in the PLA and PRO group, respectively (P<0.001), with no differences 
between groups (Figure 6.1). 
Thesis _Verdijk_v02.pdf   112 11-8-2009   14:55:07
EXERCISE AND PROTEIN INTAKE IN THE ELDERLY 
 113 
q
u
a
d
ri
c
e
p
s
 C
S
A
 (
c
m
2
)
0
20
40
60
80
100 before
after
*
placebo protein
*
 
Figure 6.1 Mean (+SEM) quadriceps cross-sectional area (CSA) before and after 3 months 
resistance exercise training in elderly men with (protein, n=13) or without (placebo, n=13) 
protein supplementation during each exercise session. Data were analyzed using repeated 
measures ANOVA with time and group as factors. No ‘time x group’ interaction (P=0.79) or 
main group effect (P=0.65) was observed. *Indicates a significant time effect compared with 
before intervention (P<0.001). 
 
At baseline, muscle fiber cross-sectional area (CSA) was smaller in type II 
vs type I fibers in both groups (Figure 6.2; P<0.001), with no differences 
between groups. For muscle fiber CSA, a significant ‘time x fiber type’ 
interaction was observed (P<0.001). After intervention, muscle fiber CSA 
had increased in both type I and II muscle fibers in PLA (5±4 and 28±6 %, 
respectively) and PRO (13±6 and 29±4 %, respectively). The increase in 
fiber CSA was greater in the type II vs type I fibers, with no differences 
between groups. As a consequence, differences in muscle fiber type CSA 
were no longer apparent after exercise intervention (Figure 6.2). 
Muscle strength 
At baseline, no differences in muscle strength (1RM) were observed between 
the PLA and PRO group (leg extension: 88±4 vs 84±3 kg, and leg press: 
170±8 vs 173±8 kg, respectively). After intervention, 1RM for leg extension 
had increased by 27±3 and 38±4 % to 111±5 and 115±5 kg in the PLA and 
PRO group, respectively (P<0.001). Likewise, 1RM for leg press increased 
by 24±3 and 24±2 % to 210±10 and 215±11 kg in the PLA and PRO group, 
respectively (P<0.001). No differences were observed between groups. 
Repeated measures analysis revealed that the increase in 1RM strength was 
statistically significant for each 4-week interval during the intervention 
period for both exercises, with no differences between groups (data not 
shown). 
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Figure 6.2 Mean (+SEM) muscle fiber cross-sectional area (CSA) for type I and II muscle 
fibers before and after 3 months resistance exercise training in elderly men with (protein, 
n=13) or without (placebo, n=13) protein supplementation during each exercise session. Data 
were analyzed using repeated measures ANOVA with time, group, and fiber type as factors.  
No ‘time x fiber type x group’ (P=0.17), ‘time x group’ (P=0.54), or ‘fiber type x group’ 
(P=0.82) interactions were observed. A significant ‘time x fiber type’ interaction (P<0.001) 
revealed a difference in type I vs II muscle fiber size before intervention; in addition, the 
increase in muscle fiber CSA over time was greater in type II vs type I muscle fibers. 
#Indicates a significant fiber type effect compared with type I fibers at baseline (‘fiber type x 
group’ interaction: P=0.69; main group effect: P=0.90; main fiber type effect: P<0.001). 
*Indicates a significant time effect compared with before intervention (type I fibers: ‘time x 
group’ interaction: P=0.31; main group effect: P=0.90; main time effect P<0.05. Type II 
fibers: ‘time x group’ interaction: P=0.93; main group effect: P=0.98; main time effect 
P<0.001).  
Body composition 
No differences were observed between groups at baseline for any of the 
DXA measurements. Leg lean mass increased 6±1 % in both groups, from 
18.3±0.5 and 18.0±0.6 kg to 19.3±0.5 and 19.0±0.6 kg in the PLA and PRO 
group, respectively (Figure 6.3; P<0.001). Whole-body lean mass increased 
throughout the intervention period, from 57.4±1.6 and 56.1±1.4 kg to 
58.0±1.7 and 56.8±1.4 kg in the PLA and PRO group, respectively (P<0.01). 
Total fat mass decreased significantly (P<0.01), resulting in a significant 
decline in whole-body fat percentage (PLA: from 23.6±2.2 to 22.9±2.2 %; 
and PRO: from 24.9±1.4 to 23.7±1.4 %; P<0.001). In accordance, leg fat 
percentage was lower following exercise intervention (P<0.001). No 
differences were observed between groups. No changes were observed in 
bone mineral content (data not shown). 
Muscle fiber type composition 
At baseline, no group differences were observed in the percentage of type I 
and II muscle fibers (fiber%) and/or the percentage of muscle area occupied 
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by type I and II fibers (area%). Type I and II muscle fiber% had not changed 
following 3 months of exercise intervention (Table 6.2). In contrast, type II 
muscle fiber area% tended to increase from 48±4 and 40±4 % to 54±3 and 
47±3 % in the PLA and PRO group, respectively (P=0.057). No group 
differences were observed. 
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Figure 6.3 Mean (+SEM) leg lean mass before and after 3 months resistance exercise training 
in elderly men with (protein, n=13) or without (placebo, n=13) protein supplementation 
during each exercise session. Data were analyzed using repeated measures ANOVA with time 
and group as factors. No ‘time x group’ interaction (P=0.79) or main group effect (P=0.65) 
was observed. *Indicates a significant time effect compared with before intervention 
(P<0.001). 
 
 
Table 6.2 Muscle fiber type composition 
  Placebo group (n=13) Protein group (n=13) 
  Before After Before After 
Fiber % Type I 47±4 47±3 56±4 52±4 
 Type II 53±4 53±3 44±4 48±4 
CSA% Type I 52±4 46±3 60±4 53±3 
 Type II 48±4 54±3 40±4 47±3 
Data represent means±SEM; CSA%: percentage area occupied by fiber type. Data were 
analyzed using repeated measures ANOVA with time and group as factors. No significant 
differences were observed between groups before intervention. No ‘time x group’ interaction 
was observed (P=0.48 for fiber %, P=0.70 for CSA%). No significant main effects of group 
and/or time were observed. 
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Dietary intake records 
Analysis of the 3-day dietary intake records collected prior to and after 11 
weeks of intervention did not show any differences in total daily energy 
intake between groups and/or over time (9.2±0.6 and 9.3±0.4 MJ/d to 
9.1±0.4 and 9.4±0.6 MJ/d in the PLA and PRO group, respectively). 
Macronutrient composition of the diet did not change during the intervention 
period and did not differ between groups (Table 6.3). Daily protein intake 
averaged 1.1±0.1 g/kg/d in both groups, and had not changed during the 
intervention period. 
Total energy intake and macronutrient composition of both breakfast and 
lunch did not differ between groups prior to intervention, and did not change 
over time in either group (data not shown). Protein intake at breakfast and 
lunch did not differ between groups and did not change over time (Table 
6.3). 
Correlation analyses revealed that the daily dietary protein intake was 
positively correlated to the degree of muscle hypertrophy. Pearson 
correlation coefficients between total dietary protein intake (g/kg/d) and the 
increase in lean mass and leg lean mass were 0.34 and 0.33, respectively. 
These correlations were unchanged when adjusting for the effect of protein 
supplementation. 
 
Table 6.3 Energy intake and macronutrient composition of the diet 
 Placebo group (n=13) Protein group (n=13) 
 Before After Before After 
Total En (MJ/d) 9.2±0.6 9.1±0.4 9.3±0.4 9.4±0.6 
CHO (En%) 50±2 52±2 52±2 53±2 
FAT (En%) 33±2 32±2 31±1 31±1 
PRO (En%) 17±1 16±1 16±1 16±1 
PRO (g/kg/d) 1.1±0.1 1.1±0.1 1.1±0.1 1.1±0.1 
PRO-bf (g/kg/d) 0.21±0.05 0.23±0.05 0.22±0.02 0.23±0.03 
PRO-lu (g/kg/d) 0.30±0.02 0.32±0.03 0.28±0.03 0.27±0.03 
Data represent means±SEM. En: energy intake per day; En%: energy percentage for daily 
intake of carbohydrate (CHO), fat (FAT), and protein (PRO); bf: breakfast; lu: lunch. Data 
were analyzed using repeated measures ANOVA with time and group as factors. No 
significant differences were observed between groups before intervention. No ‘time x group’ 
interaction was observed for any of the variables (P≥0.30). No significant main effects of 
group and/or time were observed for any of the variables. 
Thesis _Verdijk_v02.pdf   116 11-8-2009   14:55:08
EXERCISE AND PROTEIN INTAKE IN THE ELDERLY 
 117 
Blood and 24 h urine collection 
Serum creatinine concentrations were within a normal range prior to 
intervention and did not change over time in either group (from 1.16±0.04 
and 1.10±0.06 mg/dL to 1.19±0.03 and 1.11±0.06 mg/dL in the PLA and 
PRO group, respectively). No differences were observed between groups. 
Creatinine clearance was similar between groups prior to intervention (PLA: 
59.1±6.3 and PRO: 61.0±4.7 mL/min per 1.73 m2) and did not change over 
time in either group. 24 h nitrogen balance as measured prior to intervention 
revealed that both groups were in nitrogen balance (0.25±0.40 and 0.22±0.92 
g/d in the PLA and PRO group, respectively). No significant changes were 
observed over time, with subjects still being in nitrogen balance after 11 
weeks of intervention (-0.03±0.99 and -0.14±0.87 g/d in the PLA and PRO 
group, respectively). No differences were observed in 3-methylhistidine 
excretion between groups before intervention (14.3±2.0 and 11.7±2.1 
mmol/mol creatinine in the PLA and PRO group, respectively). No 
significant changes were observed over time and/or between groups (mean 
changes were 5±9 and 3±9 % in the PLA and PRO group, respectively). 
Discussion 
The present study shows that timed protein supplementation prior to and 
immediately after each exercise session does not further augment the 
increase in skeletal muscle mass and strength following 3 months of 
resistance type exercise training in healthy, elderly men who habitually 
consume adequate dietary protein. 
Resistance type exercise training has been shown to represent an effective 
interventional strategy to counteract sarcopenia (9, 12, 14, 17, 26, 33, 44). In 
the present study, we observed a 0.6±0.3 kg (PLA) and 0.7±0.2 kg (PRO) 
gain in whole-body lean mass and a concomitant decline in whole-body fat 
mass. The observed improvements are similar to previous findings reported 
after 12-16 weeks resistance exercise training in the elderly (20, 26). 
Improvements were predominantly located in the lower extremities, with a 
6±1 % increase in total leg lean mass and a 9±1 % increase in quadriceps 
CSA in both groups. The increase in quadriceps CSA was very similar to the 
~9 % increase in muscle area observed after exercise training in subjects 
aged 60-72 y (14) as well as in subjects at an age above 85 y (12). Skeletal 
muscle mass and muscle CSA are positively correlated with strength (12). In 
accordance, we observed substantial increases in muscle strength, with 1RM 
leg extension and leg press being increased by 27±3 and 24±3 % (PLA) vs 
38±4 and 24±2 % (PRO). Previously, similar increases in strength, ranging 
between 25-45 %, have been reported (26, 33). 
The loss of skeletal muscle mass with aging is associated with specific type 
II muscle fiber atrophy (27, 30, 48). In accordance, type II muscle fiber CSA 
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was significantly smaller than type I fiber CSA prior to intervention. 
Consistent with previous observations (9, 26, 33, 44), the exercise induced 
increase in muscle fiber size was greater in the type II vs type I muscle fibers 
in both groups (Figure 6.2). As a consequence, differences in muscle fiber 
type size prior to intervention were no longer apparent after the 12 week 
exercise intervention program. Taken together, these data confirm the 
efficacy of resistance type exercise training to improve skeletal muscle mass 
and strength and reverse type II muscle fiber atrophy in the elderly. 
Studies assessing the acute muscle protein synthetic response following 
exercise have provided ample data to suggest that muscle protein balance 
can be substantially increased by ingesting protein and/or amino acids prior 
to and/or immediately after exercise (2, 4, 23, 24, 35, 40, 45, 46). However, 
long-term nutritional intervention studies generally fail to observe additional 
benefits of increasing protein intake during exercise intervention in the 
elderly (5, 13, 15, 20). The latter is in line with Campbell et al. (7) who 
recently concluded that resistance exercise training induced improvements in 
muscle mass and strength are not enhanced when older people who consume 
adequate dietary protein (in excess of 0.8 g/kg/d) further increase their 
protein intake. The absence of any additional benefits of nutritional co-
intervention during more prolonged exercise intervention programs might be 
attributed to an inadequate timing of the protein supplementation after each 
exercise bout (10). Furthermore, ingesting dietary protein prior to and/or 
during exercise has been shown to further improve the post-exercise net 
muscle protein balance (2, 46). Therefore, we hypothesized that the intake of 
10 g protein prior to and 10 g protein immediately after resistance exercise 
would increase muscle mass and strength gains during prolonged resistance 
type exercise training in healthy, elderly males who habitually consume 
adequate dietary protein. Even though we observed large increases in muscle 
mass and strength on a whole-body, limb, and myocellular level, no 
differences were observed between the groups supplemented with (PRO) or 
without (PLA) additional protein (Figures 6.1-6.3). The latter despite the fact 
that with a power of 0.80, we would have been able to detect group 
differences as small as 3.5%, 2.5% and 11% for the changes in quadriceps 
CSA, leg lean mass, and muscle fiber size, respectively. The latter would 
have been more than sufficient to detect even the smallest clinically relevant 
differences compared with previous findings (10). 
The present data seem to be in contrast with Esmarck et al. (10), who found 
that the acute post-exercise ingestion of a protein containing supplement is 
prerequisite for muscle hypertrophy to occur in the elderly. It might be 
suggested that the apparent discrepancy can be explained by differences 
between the supplements that were provided in these studies. In the present 
study we provided 20 g protein, whereas Esmarck et al. (10) provided their 
subjects with supplements containing 10 g protein, 7 g carbohydrate and 3 g 
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fat. However, the lack of carbohydrate in the supplements provided in the 
present study would unlikely have modulated the muscle protein anabolic 
response, as recent work from our group (22) as well as others (35) has 
shown that post-exercise carbohydrate ingestion is not warranted when 
ample protein is ingested. The apparent discrepancy between studies is more 
likely attributed to differences in the outcome of the control groups. In the 
present study, we observed a substantial increase in muscle mass and 
strength following resistance type exercise training without nutritional co-
intervention (PLA). In contrast, Esmarck et al. (10) reported no increase in 
leg muscle CSA and muscle fiber size when protein supplements were 
provided 2 h after cessation of exercise. The latter tends to disagree with the 
plethora of studies that report substantial increases in muscle mass and 
strength following 2-4 months of resistance type exercise training in the 
elderly without any dietary modulation (9, 12-15, 17, 26, 33, 44). In short, 
timed protein supplementation prior to and immediately after exercise does 
not seem to further augment the benefits of prolonged resistance type 
exercise training on muscle mass and strength in healthy, elderly males. 
In the present study, dietary intake remained stable throughout the 
intervention period (Table 6.3). Even without additional protein 
supplementation, habitual dietary protein intake averaged 1.1±0.1 g/kg/d in 
both groups. This value is well in excess of the current RDA values of 0.8 
g/kg/d (39, 47). The latter values have been suggested to be marginal or even 
insufficient for muscle mass maintenance (8) and/or for allowing lean mass 
accrual following resistance training in the elderly (6). However, when older 
people habitually consume adequate dietary protein (i.e. >0.9 g/kg/d), 
improvements in muscle mass and strength following long-term resistance 
exercise training do not seem to be further enhanced by increasing dietary 
protein intake (20). Yet, in line with recent observations by Campbell et al. 
(7), we also observed a positive correlation between daily dietary protein 
intake and the increase in lean mass with training. We can only speculate on 
the physiological relevance of these correlations, which show that the 
regulation of the skeletal muscle adaptive response to exercise and 
nutritional supplementation remains far from being established. 
The additional protein ingested before and after each exercise session 
resulted in an average additional protein intake of 0.1±0.0 g/kg/d. The latter 
induced no side effects and did not induce any changes in markers of renal 
function or 24 h nitrogen balance. Though we could not detect any benefits 
of timed protein supplementation during exercise intervention in healthy, 
well-nourished elderly males, it remains to be determined whether the 
proposed benefits of timed protein supplementation are restricted to specific 
elderly subpopulations, like malnourished or frail elderly. 
We conclude that prolonged resistance type exercise training substantially 
improves skeletal muscle mass and strength in healthy, elderly males. Timed 
Thesis _Verdijk_v02.pdf   119 11-8-2009   14:55:09
CHAPTER 6 
 120
protein supplementation immediately prior to and after each exercise session 
does not further enhance skeletal muscle mass and strength gains following 
prolonged resistance type exercise training in healthy, elderly males who 
habitually consume adequate dietary protein. 
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The loss of skeletal muscle mass and strength with aging is currently 
recognized as one of the major determinants affecting functional capacity in 
the elderly and, as such, the ability to live independently. Skeletal muscle 
satellite cells have been implicated as a key factor in the process of 
sarcopenia. In the present thesis, we studied the age-related changes in 
muscle fiber type-specific satellite cell content and the skeletal muscle 
adaptive response to resistance type exercise training in the elderly. In this 
final chapter, we will address the implications of the findings presented in 
this thesis, and discuss them in a broader perspective. In addition, specific 
areas on which future research should focus will be identified. 
Satellite cells and sarcopenia 
Sarcopenia has been characterized by the specific loss and atrophy of type II 
muscle fibers. In this thesis, we consistently show that type II muscle fiber 
atrophy in the elderly is accompanied by a type II muscle fiber specific 
decline in satellite cell content (chapters 3-5). These results are now 
confirmed by recent findings from other labs (59). Furthermore, we observed 
a positive correlation between muscle fiber type-specific size and satellite 
cell content within the elderly population (chapter 4). Satellite cells play a 
key role in muscle fiber maintenance, growth, and repair (25), and the 
regenerative capacity of skeletal muscle tissue seems to depend on the 
abundance of these satellite cells (55). Therefore, we suggest that the age-
related decline in type II muscle fiber satellite cell content leads to impaired 
muscle fiber maintenance, resulting in the specific type II muscle fiber 
atrophy that is observed with aging. In accordance, the age-related fiber 
type-specific decline in satellite cell content in rodents (4, 55) has been 
shown to precede muscle fiber atrophy (4). However, longitudinal studies in 
humans are warranted to elucidate the timeline of changes in satellite cell 
content and muscle fiber atrophy during aging. The latter could provide 
evidence on a cause or effect relationship between a decline in satellite cell 
content and specific type II muscle fiber atrophy with aging. Another 
strategy to address this topic would be to assess the timeline for changes in 
muscle fiber size and satellite cell content during muscle hypertrophy. As 
such, in chapter 5 we assessed changes in muscle fiber size and satellite cell 
content following 3 months of resistance type exercise training in healthy 
elderly men. We observed a type II muscle fiber specific hypertrophy that 
was accompanied by a fiber type-specific increase in satellite cell content. 
Furthermore, the increase in muscle fiber size following testosterone 
supplementation (56) and resistance type exercise training (48) has been 
shown to be proportional to the increase in satellite cell content. Although all 
these studies lack a specific timeline, the findings support the idea that 
satellite cell content forms a key factor in the regulation of muscle fiber size 
and, as such, the maintenance of skeletal muscle mass. Prolonged 
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intervention studies with a more regular assessment of skeletal muscle fiber 
size and satellite cell content over time may provide more definite evidence 
to support the hypothesis that an increase in satellite cell content is required 
to allow substantial muscle fiber hypertrophy. 
Apart from the age-related decline in satellite cell content, satellite cell 
dysfunction has been suggested to contribute to the loss of skeletal muscle 
mass with aging. In both animal (8, 9) and human studies (12), satellite cell 
activation and/or proliferation have been shown to be attenuated at a more 
advanced age. The progression of satellite cells through the stages of 
activation, proliferation and/or differentiation is mediated by the expression 
of myogenic growth factors, including insulin-like growth factor (IGF)-1, 
mechano growth factor (MGF), MyoD, Myf-5, myogenin, MRF4, and 
myostatin (6, 18, 24, 25, 28, 41, 43, 53). A rapid up- or down-regulation of 
intramuscular mRNA levels of these myogenic factors has been observed in 
response to a single bout of resistance type exercise in healthy young adults 
(3, 13, 23, 33, 42, 62). However, the latter response was shown to be 
attenuated in the elderly (13, 23, 33), which might be indicative of 
impairments in satellite cell activation in elderly muscle (12). Interestingly, 
recent studies indicate that the muscle protein synthetic response to the main 
anabolic stimuli, i.e. physical activity and/or food intake, is blunted in the 
elderly when compared with young adults (11, 31, 34, 36). The latter is now 
believed to represent a key factor in the loss of muscle mass with aging. It 
remains to be determined whether the age-related decline in satellite cell 
content and/or function contributes to the proposed blunted muscle protein 
synthetic response to physical activity and/or food intake in the elderly. 
In summary, aging is associated with a decline in type II muscle fiber size 
and satellite cell content. We speculate that the age-related fiber type-
specific decline in satellite content and/or function represent key factors in 
the etiology of sarcopenia. A reduced satellite cell content and/or impaired 
satellite cell function might contribute to a reduced sensitivity of elderly 
muscle to the main anabolic stimuli, i.e. food intake and/or physical activity. 
Satellite cells, skeletal muscle wasting, and disuse atrophy 
The process of sarcopenia is not related to any specific disease state. Aside 
from sarcopenia, several clinical conditions are accompanied by a rapid 
decline in skeletal muscle mass, often referred to as muscle wasting. 
Studying the muscle fiber type-specific atrophy associated with muscle 
wasting in these disease states might provide more insight into the proposed 
role of skeletal muscle satellite cells in regulating muscle fiber 
atrophy/hypertrophy. Chronic obstructive pulmonary disease (COPD) 
represents one of the many pathologic conditions in which extensive muscle 
wasting is observed. Despite the fact that COPD is associated with muscle 
fiber atrophy, it was recently suggested that skeletal muscle satellite cell 
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content in COPD patients is similar when compared with healthy, age-
matched subjects (14). However, these data were only based on mixed 
muscle fiber analyses. Muscle atrophy in COPD is characterized by a shift 
towards a higher proportion of type II muscle fibers, and specific type II 
muscle fiber atrophy (14, 20, 21). Likewise, muscle wasting in human 
immunodeficiency virus (HIV) and chronic heart failure patients has been 
associated with specific type II muscle fiber atrophy (37, 44). Therefore, it 
would be interesting to assess whether type II muscle fiber atrophy in these 
disease states is accompanied by a muscle fiber type-specific decline in 
satellite cell content. In contrast to sarcopenia, the presence of a chronic 
inflammatory state (with increased circulating and/or intramuscular levels of 
tumor necrosis factor [TNF]α, interleukin [IL]-1ß, IL-6, Interferon-γ, and 
potentially myostatin) has been suggested to be responsible for skeletal 
muscle wasting associated with COPD, cancer cachexia, chronic heart 
failure, and HIV (2, 15, 19, 22, 61). The chronic presence of an 
inflammatory state might impair the activation, proliferation, and 
differentiation of satellite cells. Furthermore, greater oxidative stress 
observed in these pathologic conditions might lead to the apoptotic loss of 
myonuclei and satellite cells, triggering atrophy and further reducing skeletal 
muscle regenerative capacity. Although data in humans are currently 
lacking, we speculate that fiber type-specific changes in skeletal muscle 
satellite cells might also play a key role in skeletal muscle wasting. More 
research is warranted to investigate the mechanisms responsible for muscle 
atrophy in both sarcopenia and muscle wasting conditions, and the potential 
role for satellite cells in these processes. 
The loss of muscle mass with aging is, at least partly, attributed to the 
skeletal muscle adaptive response to a more sedentary lifestyle. In 
accordance, various models of physical inactivity have been associated with 
substantial skeletal muscle atrophy. Such models of disuse/inactivity include 
space flight, bed rest, denervation, and immobilization. It is currently 
unknown what the impact of these different models of physical inactivity is 
on skeletal muscle fiber type-specific satellite cell content and/or function. 
The loss of muscle mass with physical inactivity is an exceptionally fast 
physiological adaptive response, with substantial skeletal muscle atrophy 
(10-12%) already occurring following 10-14 days of immobilization (26, 
57). The latter has been attributed to the absence of mechanical loading as a 
potent anabolic stimulus and a reduced skeletal muscle responsiveness to the 
main anabolic stimuli (17). The changes in muscle fiber size with short-term 
disuse atrophy are remarkably similar to those observed in sarcopenia (58). 
Therefore, it is interesting to assess the changes in satellite cell content 
and/or function with short-term disuse atrophy. The latter might provide a 
more practical model to study the timeline of the changes in muscle fiber 
size and the concomitant changes in satellite cell content and/or function. 
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The absence of major anabolic stimuli might negatively affect the capacity 
of satellite cells to activate, proliferate and/or differentiate. In addition, long-
term inactivity or disuse, as observed in spinal cord injury, has been 
associated with an increased rate of apoptosis which is likely induced by the 
lack of neurogenic input (29). It would be interesting to assess whether the 
latter is also accompanied by a loss of skeletal muscle satellite cell content 
and/or function. Yet, given the observed hypertrophy following electrical 
stimulation of muscle tissue in patients with spinal cord injury (54), it is 
tempting to speculate that a substantial pool of quiescent satellite cells 
remains present, waiting to be activated to reboot myogenesis. Muscle fiber 
type-specific analyses of satellite cell content and/or function in both short- 
and long-term models of ‘disuse’ atrophy will be instrumental to obtain 
evidence on the impact of physical inactivity as a key factor in the etiology 
of sarcopenia. 
Taken together, data on the potential changes in satellite cell content in 
various human models of skeletal muscle atrophy and/or wasting is presently 
lacking. Studying the skeletal muscle fiber type-specific characteristics in 
different models of skeletal muscle atrophy will further elucidate the role of 
satellite cells in the maintenance of skeletal muscle fiber size and provide the 
framework needed to establish the physiological role of skeletal muscle fiber 
satellite cell content and function in the progressive loss of muscle mass with 
aging. 
Satellite cells and skeletal muscle hypertrophy 
Given the general function of satellite cells to provide new myonuclei to 
skeletal muscle tissue, their contribution to skeletal muscle growth during 
postnatal development seems obvious. However, whether satellite cells are 
also required for muscle growth in adults remains a matter of debate. We 
report that specific type II muscle fiber hypertrophy following resistance 
type exercise training is accompanied by an increase in type II muscle fiber 
satellite cell content in elderly men (chapter 5). Other interventions in this 
population that have been shown to induce muscle fiber hypertrophy 
generally also report an increase in satellite cell content (7, 56). These 
findings imply a functional role of satellite cells in allowing skeletal muscle 
fiber hypertrophy in the elderly. In response to acute resistance type 
exercise, muscle protein synthesis rates are rapidly increased, improving 
protein balance during immediate post-exercise recovery (49). Because 
satellite cell proliferation takes at least 24 hours to become evident (50), it 
seems obvious to speculate that the acute post-exercise increase in muscle 
protein synthesis is not directly mediated and/or facilitated by the skeletal 
muscle satellite cells. Thus, it can be questioned whether satellite cells are 
prerequisite to allow skeletal muscle hypertrophy; a topic that was recently 
discussed in the Journal of Applied Physiology (40, 45). One of the main 
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issues relating to this question is whether there is a ceiling in the myonuclear 
domain size that can be reached. The myonuclear domain theory suggests 
that each myonucleus controls the metabolic processes (e.g. gene expression, 
protein synthesis) for a certain volume of cytoplasm. Consequently, to allow 
substantial muscle fiber hypertrophy without an increase in myonuclear 
domain size, more nuclei are needed. In accordance, we observed substantial 
muscle fiber hypertrophy without any changes in myonuclear domain size 
following 3 months of resistance type exercise training (chapter 5). Our 
findings tend to be in line with other studies and suggest that hypertrophy 
can only take place to a certain extent beyond which additional, newly 
formed, myonuclei are required (30, 47, 48). Several animal studies have 
used X-ray irradiation as a technique to completely block skeletal muscle 
satellite cell function and, as such, prevent the incorporation of new 
myonuclei. The latter results in the lack of overload-induced muscle 
hypertrophy when compared with animals not exposed to irradiation (1, 38, 
51). Therefore, those findings also support the idea that satellite cells are 
essential to allow skeletal muscle hypertrophy. Furthermore, myonuclei are 
probably lost with normal muscle use during routine daily activities, due to 
subtle myofiber injuries and/or apoptosis induced by cumulative DNA 
damage (27, 55). This myonuclear loss might be increased by more 
exhaustive physical activity, necessitating the continuous incorporation of 
newly formed nuclei into skeletal muscle tissue. Evidence to date indicates 
that the contribution of other stem cells (such as derived from the brain or 
bone marrow) to muscle repair and/or growth is minimal and that skeletal 
muscle satellite cells are required for the incorporation of new myonuclei 
during normal physiological muscle growth, such as induced by exercise 
(38, 46, 63, 64). Though modest, temporary increases in muscle fiber size 
may be possible without satellite cell involvement, the successful 
incorporation of new myonuclei eventually determines the extent to which 
hypertrophy can occur, supporting a key role for skeletal muscle satellite 
cells in reversing sarcopenia. 
From chapters 5 and 6, it is concluded that skeletal muscle tissue in the 
elderly is still responsive to the anabolic stimuli induced by prolonged 
resistance type exercise training, reflected in a substantial increase in muscle 
mass, strength, and type II muscle fiber size and satellite cell content after 3 
months of exercise training. However, the long-term skeletal muscle 
adaptive response to exercise training seems to be reduced in the elderly 
when compared with healthy young adults (27, 35, 60). Shefer et al. (55) 
argued that a reduced satellite cell pool size might negatively affect the 
myogenic response induced by growth stimuli. This hypothesis was 
supported by Petrella et al. (48), who observed greater hypertrophy in 
response to resistance type exercise training when baseline, pre-intervention 
satellite cell content was larger. However, the latter findings may have been 
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confounded by including both young and elderly men and women in the 
analysis. In chapter 5, only healthy elderly males were subjected to 3 months 
of resistance type exercise training. Unfortunately, we cannot provide 
sufficient data to support the proposed relation between baseline satellite cell 
content and the extent of muscle hypertrophy during subsequent resistance 
type exercise training due to the limited number of subjects (n=13) in this 
study. Nonetheless, we speculate that the specific decline in type II muscle 
fiber satellite cell content with aging (chapter 3) negatively affects the 
capacity of the muscle to hypertrophy. Future studies should assess whether 
differences in baseline satellite cell content can explain inter-individual 
differences in the skeletal muscle adaptive response to exercise intervention 
in healthy elderly, as well as in more clinical populations suffering from 
skeletal muscle wasting. 
In addition to satellite cell content, muscle hypertrophy following prolonged 
exercise intervention might also depend on the potential of these satellite 
cells to activate, proliferate, and differentiate. Results from animal studies 
suggest that the systemic environment plays an important role in inducing 
satellite cell activation/proliferation and, as such, in determining the 
regenerative potential of skeletal muscle tissue with aging (5, 9). However, 
as mentioned earlier in this chapter, attenuated satellite cell activation, 
proliferation and/or differentiation in response to the main anabolic stimuli 
(i.e. food intake and physical activity) in the elderly may be functionally 
coupled to the blunted exercise-induced response in intramuscular growth 
factor mRNA expression. In contrast with the proposed importance of 
systemically circulating factors (5, 9), the latter may underline the 
importance of local processes (i.e. local growth factor expression) in 
regulating satellite cell function. In accordance, unilateral loading induces an 
increase in satellite cell content in the exercised muscle tissue only (10, 52). 
Likewise, skeletal muscle hypertrophy following resistance type exercise 
training is only observed in the exercised muscle groups and not throughout 
the entire body (chapters 5-6) (18, 24). Therefore, even though systemic 
factors might play a permissive role, local myocellular factors seem to 
regulate the skeletal muscle adaptive response to exercise. However, it 
remains to be established if and how different aspects of satellite cell 
function are specifically regulated by local growth factor expression. For 
example, cell culture and animal experiments have suggested that specific 
growth factors (i.e. MyoD, myogenin, myf-5, MRF4, MGF, and myostatin) 
mediate satellite cell activation, proliferation and differentiation. Although 
exercise induces an increase in intramuscular mRNA expression of these 
growth factors, a direct link with in vivo satellite cell activation, 
proliferation, and/or differentiation remains to be established. Furthermore, 
previous research has shown that intramuscular expression of myogenic 
growth factors at the transcript (i.e. mRNA) level may have limited 
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predictive value for the actual growth factor expression at the protein level. 
The latter is apparent for MyoD and myogenin in the basal state (13), and for 
MyoD, myogenin and MRF4 in response to resistance loading (35). 
Therefore, in vivo studies are warranted to establish a direct relation between 
the upregulation of specific myogenic factors, the activation, proliferation 
and differentiation of satellite cells, and the subsequent incorporation of 
newly formed myonuclei into skeletal muscle tissue in humans. To assess 
potential age-related impairments in these processes, both young and elderly 
subjects should be studied. A combination of immunoblotting and/or 
histochemical analyses should be performed on skeletal muscle biopsy 
samples collected at regular intervals to investigate both the short and long-
term skeletal muscle adaptive response to exercise. The latter will give 
further insight into the timeline of myogenic pathways induced by anabolic 
stimuli, the specific role of different growth factors in regulating satellite cell 
function, and the age-related changes that might cause the skeletal muscle 
anabolic response to be attenuated in the elderly. 
In conclusion, satellite cells seem to play a key role in regulating the skeletal 
muscle adaptive response to anabolic stimuli. Although substantial skeletal 
muscle hypertrophy can be achieved by prolonged resistance type exercise 
training in the elderly, an age-related decline in satellite cell content and/or 
impaired satellite cell function seem to attenuate the skeletal muscle adaptive 
response to prolonged exercise intervention. Determining the regulation of 
satellite cell content and/or function in vivo will provide many new targets 
for the development of interventional strategies to more effectively 
counteract the progressive loss of muscle mass with aging. 
Maximizing the skeletal muscle adaptive response 
Given the age-related blunted activation, proliferation and/or differentiation 
of satellite cells, as well as the attenuated skeletal muscle protein synthetic 
response to food intake and/or physical activity in the elderly, it appears that 
aged muscle tissue is generally less sensitive to the main anabolic stimuli. It 
would be interesting to assess whether the reduced sensitivity can be 
reversed by prolonged exercise, nutritional and/or pharmacological 
intervention. We hypothesize that resistance type exercise training can 
rejuvenate aging muscle, thereby restoring the attenuated skeletal muscle 
adaptive response in the elderly. Such an increased sensitivity to anabolic 
stimuli would improve skeletal muscle maintenance and, as such, skeletal 
muscle strength and function. To assess potential changes in the sensitivity 
and/or responsiveness of skeletal muscle tissue to the main anabolic stimuli, 
future studies should investigate the muscle protein synthetic and/or 
proteolytic response to food intake and/or physical activity as well as 
satellite cell content and/or function, both before and after prolonged 
resistance type exercise training. 
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Resistance type exercise training has been well established as the most 
effective strategy to increase muscle mass and strength in the elderly. As the 
long-term skeletal muscle adaptive response to resistance type exercise 
training appears to be attenuated with aging, it is imperative to define more 
effective exercise, nutritional and/or pharmacological interventions to further 
augment skeletal muscle mass and strength in the elderly. Given the 
proposed insensitivity of aged skeletal muscle tissue to the main anabolic 
stimuli, the time required to allow skeletal muscle hypertrophy might be 
different in the elderly when compared with young subjects. As such, more 
prolonged resistance type exercise training in the elderly will further 
augment muscle mass and strength when compared with only 3 months of 
training. In short, resistance type exercise training should be implemented as 
a standard component of lifestyle intervention programs aiming to improve 
general health in the elderly population. 
Furthermore, previous studies have suggested that specific nutritional and/or 
pharmacological interventions may augment the increase in skeletal muscle 
mass and strength following resistance type exercise training. For example, 
protein and/or specific amino acid (e.g. leucine) supplementation has been 
shown to substantially augment muscle protein synthesis rates at rest and/or 
following a single session of resistance type exercise (32, 34). In chapter 6, 
we report no benefits of timed protein supplementation before and after each 
exercise session on the increase in muscle mass, strength, and muscle fiber 
size following 12 weeks of resistance type exercise training in healthy, 
elderly men consuming ample amounts of protein in their habitual diet. Yet, 
we still speculate that (timed) protein supplementation can improve the 
skeletal muscle adaptive response to exercise training in more compromised 
subpopulations such as frail and/or malnourished elderly. In addition, certain 
nutritional and/or pharmacological compounds (e.g. leucine, testosterone, 
IGF-1) may have specific anabolic properties, e.g. increasing muscle protein 
synthesis rates, and/or directly stimulating satellite cell activation, 
proliferation and/or differentiation (16, 32, 56). Administration of these 
compounds may further boost myogenesis, increase satellite cell content and, 
as such, improve the long-term skeletal muscle adaptive response to 
resistance type exercise training in the elderly. Future research should pursue 
the development of more effective interventional strategies to maximize the 
skeletal muscle adaptive response to exercise in the elderly. 
Conclusions and future research 
Since the discovery of skeletal muscle satellite cells in 1961 (39), a 
substantial body of scientific research has been devoted to the properties and 
function of these satellite cells. The results of these studies have prompted 
Zammit et al. (64) to state that the satellite cell has earned its place at the 
very centre of adult myogenesis. In this thesis, we provide the first evidence 
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for a muscle fiber type-specific decline in satellite content with human 
aging. We have shown that the age-related muscle fiber type-specific 
changes are accompanied by and functionally related to the loss of muscle 
mass and strength. Furthermore, the loss of muscle mass and strength with 
aging can, at least partly, be reversed by prolonged resistance type exercise 
training. The latter is associated with an increase in type II muscle fiber size 
and satellite cell content. Based on these findings, we suggest that skeletal 
muscle satellite cells play a key role in both age-related muscle atrophy and 
in the hypertrophic response to exercise intervention programs aiming to 
counteract sarcopenia. 
Although resistance type exercise represents a potent stimulus for the 
recruitment of satellite cells in humans, the molecular regulation of satellite 
cell activation, proliferation and differentiation in vivo is still poorly 
understood. It remains to be determined which specific satellite cell 
processes are involved in the differential adaptive response of skeletal 
muscle tissue to aging and/or anabolic stimuli. Whereas the use of cell 
culture systems and animal models may answer specific questions on the 
signaling pathways involved in muscle maintenance and growth, only human 
in vivo research will provide information on whether these pathways are still 
functional in the elderly and/or how they can be stimulated by exercise or 
other interventions. To gain further insight into the role of satellite cells in 
age-related skeletal muscle atrophy and hypertrophy, future studies should 
address the following questions: 
 
• Which pathways are involved in, and what is the timeline for the in vivo 
regulation of satellite cell activation, proliferation, and differentiation? Are 
these processes impaired in aged muscle? 
 
• What are the fiber type-specific changes in muscle fiber size, composition, 
and satellite cell content in various conditions of skeletal muscle wasting 
and/or disuse atrophy?  
 
• Is it possible to reverse the age-related blunted skeletal muscle adaptive 
response to anabolic stimuli (i.e. both satellite cell proliferation and/or 
muscle protein synthesis) and, as such, rejuvenate aging muscle by 
prolonged resistance type exercise training? 
  
• To what extent does baseline satellite cell content and/or function, restrict 
the skeletal muscle adaptive response to resistance type exercise training in 
the elderly? 
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• What distinguishes the relative importance of an increase in myonuclear 
domain versus an increase in the number of myonuclei for skeletal muscle 
hypertrophy? 
 
• Which nutritional and/or pharmacological compounds stimulate satellite 
cell activation, proliferation and/or differentiation? 
 
• How can we optimize the skeletal muscle adaptive response to combined 
exercise, nutritional, and pharmacological intervention in the elderly? 
 
The increasing number of elderly in today’s society faces us with the 
challenging task of developing effective interventional strategies to prevent 
and/or treat the progressive loss of skeletal muscle mass and function 
associated with aging. The latter would delay the onset of functional 
limitation and improve quality of life in the elderly population. Although 
much work has already been devoted to this area, a more comprehensive 
insight into the mechanisms underlying the loss of muscle mass and the 
factors that determine the skeletal muscle adaptive response to intervention 
is urgently warranted. Fortunately, the remarkable capacity of skeletal 
muscle tissue to adapt to exercise intervention provides a solid foundation 
for future research in this interesting field. 
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The progressive loss of skeletal muscle mass and strength with aging, 
sarcopenia, is associated with functional impairments in daily life activities, 
the loss of independence, an increased risk of developing chronic metabolic 
diseases, and an overall decrease in the quality of life. Satellite cells (muscle 
stem cells) play a key role in the maintenance, repair and regeneration of 
skeletal muscle tissue. Therefore, age-related changes in satellite cell content 
and/or function might represent a key factor in the etiology of sarcopenia. In 
this thesis, we assess the age-related changes in skeletal muscle mass, 
strength, and muscle fiber type characteristics. We specifically focus on the 
changes in muscle fiber type-specific satellite cell content with aging and the 
impact of resistance type exercise training in the elderly. 
In chapter 2, we assess the validity of one-repetition maximum (1RM) 
strength testing by comparing it with gold standard dynamometry testing in a 
population healthy adult men and women of varying ages (n=55: 19-84 y). 
Both 1RM leg extension and leg press correlate strongly with dynamometer 
results (0.72≤r≤0.88), and these correlations do not differ between young 
and old, or male and female subgroups. We conclude that 1RM testing 
represents a valid means to assess leg muscle strength in both young and 
elderly men and women. As such, we used 1RM testing in subsequent 
studies to assess age-related changes in muscle strength and to evaluate the 
impact of prolonged exercise intervention on muscle strength in the elderly. 
In chapter 3, 1RM leg muscle strength is shown to be 25-30% lower in 
healthy elderly versus young men. Histochemical analyses of muscle 
biopsies show that the latter is accompanied by a reduced proportion of type 
II muscle fibers and specific type II muscle fiber atrophy in the elderly. 
Furthermore, the number of skeletal muscle satellite cells is substantially 
reduced in the type II muscle fibers in the elderly. No differences in type I 
muscle fiber characteristicss are observed between elderly versus young 
men. We speculate that a decline in type II muscle fiber satellite cell content 
with aging might play a key role in the etiology of sarcopenia. In chapter 4, 
41 healthy elderly men were included in a cross-sectional analysis to show 
that type I and II muscle fiber myonuclear content and satellite cell content 
correlate with muscle fiber size (0.50≤r≤0.56). In addition, type I and II 
muscle fiber size correlate with quadriceps muscle size (measured with CT 
scans). Furthermore, muscle fiber size, quadriceps muscle size, and leg lean 
mass (measured with DXA scans) are shown to correlate strongly with leg 
muscle strength. These findings support the idea that muscle fiber type-
specific changes in satellite cell content, myonuclear content and muscle 
fiber size are associated with the age-related loss of skeletal muscle mass 
and strength. 
Although resistance type exercise training represents an effective strategy to 
counteract the loss of skeletal muscle mass and strength with aging, the 
mechanisms underlying the skeletal muscle adaptive response to exercise 
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remain poorly understood. Therefore, chapter 5 focuses on the role that 
satellite cells might play in the skeletal muscle adaptive response to exercise. 
Three months of resistance type exercise training in the elderly is shown to 
result in a 6% increase in lean tissue in the legs, a 9% increase in quadriceps 
muscle size, and a concomitant 25-30% increase in 1RM leg extension and 
leg press strength. Furthermore, a substantial increase in type II muscle fiber 
size is observed, accompanied by a ~70% increase in type II muscle fiber 
satellite cell content. No changes are observed in myonuclear domain size. In 
addition, no changes are observed in type I muscle fiber size or satellite cell 
content. These findings imply that skeletal muscle tissue in the elderly is still 
capable of inducing satellite cell activation, proliferation, and differentiation, 
and fusion of new myonuclei into existing muscle fibers, allowing type II 
muscle fiber hypertrophy. 
Previous studies have suggested that timed protein supplementation may 
further augment the skeletal muscle adaptive response to exercise in the 
elderly. Therefore, in chapter 6 we assessed the effects of timed protein 
supplementation on the increase in skeletal muscle mass and strength 
following 3 months of resistance type exercise training. Progressive 
resistance type exercise training is shown to result in similar increases in leg 
muscle mass and strength in healthy elderly men provided with either 
placebo or protein supplements immediately before and after each exercise 
session. In accordance, muscle fiber hypertrophy is shown to be similar in 
both groups for both the type I (~10%) and type II (~28%) muscle fibers. 
Dietary protein intake in these elderly men is shown to be above current 
dietary guidelines, with an intake 1.1±0.1 g protein per kg body weight per 
day. We conclude that timed protein supplementation does not further 
augment skeletal muscle hypertrophy after 3 months of resistance type 
exercise training in well-nourished, healthy, elderly males. 
The final chapter addresses the implications of the findings presented in this 
thesis, and provides key topics for future research. This thesis shows that 
sarcopenia is associated with a muscle fiber type-specific decline in satellite 
content. Resistance type exercise training can, at least partly, reverse the loss 
of muscle mass and strength with aging. The latter is associated with an 
increase in type II muscle fiber size and satellite cell content. We suggest 
that skeletal muscle satellite cells play a key role in both age-related muscle 
atrophy and in the skeletal muscle adaptive response to exercise intervention 
programs aiming to counteract sarcopenia. 
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Veroudering gaat gepaard met een progressief verlies van spiermassa en 
spierkracht, ook wel sarcopenie genoemd. Dit leidt tot functionele 
beperkingen in het dagelijkse leven, verminderde zelfredzaamheid, een 
verhoogde kans op de ontwikkeling van chronisch metabole ziekten, en een 
afname in de kwaliteit van leven. Satellietcellen (de zogenaamde 
“spierstamcellen”) zijn van essentieel belang voor het onderhoud en de 
regeneratieprocessen van skeletspierweefsel. Een daling in het aantal 
satellietcellen en/of een afname in hun functioneren zou een belangrijke 
factor kunnen zijn in de ontstaansgeschiedenis van sarcopenie. In dit 
proefschrift richten we ons op leeftijdsgerelateerde veranderingen in 
spiermassa, spierkracht, en spiervezelkarakteristieken. Speciale aandacht 
wordt besteed aan de spiervezelspecifieke veranderingen in het aantal 
satellietcellen in relatie tot veroudering en de effecten van krachttraining in 
oudere mensen. 
In hoofdstuk 2 bepalen we de validiteit van 1-RM (“one-repetition 
maximum”) testen voor het meten van spierkracht, door deze te vergelijken 
met dynamometrie als de gouden standaard. Dit doen we in een groep van 55 
gezonde mannen en vrouwen (19-84 jaar). Zowel de 1RM resultaten van de 
“leg press” als de “leg extension” fitness toestellen correleren goed met de 
dynamometer resultaten (0,72≤r≤0,88), en dit geldt eveneens voor aparte 
subgroepen (man versus vrouw als ook jong versus oud). Het gebruik van 
1RM testen blijkt een valide manier om spierkracht te meten in zowel jonge 
als oudere mannen en vrouwen. Daarom werden 1RM testen in de overige 
studies gebruikt om leeftijdsgerelateerde veranderingen in spierkracht te 
onderzoeken en om de toename in spierkracht na krachttraining in oudere 
mensen te bepalen. Hoofdstuk 3 laat zien dat de 1RM kracht in de benen 25-
30% lager is in gezonde oudere mannen in vergelijking met gezonde jonge 
mannen. Histochemische analyses van spierbiopten tonen aan dat dit gepaard 
gaat met een lager percentage type II spiervezels en specifieke atrofie 
(afname in grootte) van de type II spiervezels in oudere mannen. Bovendien 
is het aantal satellietcellen in type II spiervezels aanmerkelijk lager in de 
ouderen dan in de jongeren. De afname van het aantal satellietcellen in type 
II spiervezels met veroudering zou een belangrijke rol kunnen spelen bij het 
ontstaan van sarcopenie. In hoofdstuk 4 tonen we bij 41 gezonde oudere 
mannen aan dat voor zowel de type I als de type II spiervezels het aantal 
kernen en satellietcellen per spiervezel positief correleert met 
spiervezelgrootte (0,50≤r≤0,56). Spiervezelgrootte correleert daarnaast 
positief met de grootte van de quadriceps spier (gemeten met CT scans). 
Spiervezelgrootte, quadriceps grootte en totale beenspiermassa (gemeten 
met DXA scans) zijn bovendien sterk gecorreleerd met spierkracht. Deze 
resultaten ondersteunen de gedachte dat spiervezelspecifieke veranderingen 
in het aantal satellietcellen, het aantal kernen, en de spiervezelgrootte 
geassocieerd zijn met verlies van spiermassa en spierkracht bij veroudering. 
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Hoewel krachttraining het verlies van spiermassa en spierkracht met 
veroudering tegen kan gaan, zijn de onderliggende mechanismen van de 
positieve effecten van lichamelijk inspanning nog grotendeels onduidelijk. 
Daarom onderzoeken we in hoofdstuk 5 de rol die satellietcellen zouden 
kunnen spelen in de respons op inspanning bij ouderen. Na drie maanden 
krachttraining wordt een 6% toename in spiermassa in het been, een 9% 
toename in de grootte van de quadriceps spier, en een 25-30% toename in 
spierkracht waargenomen. Er wordt een substantiële toename in type II 
spiervezelgrootte aangetoond, die bovendien gepaard gaat met een 70% 
toename in het aantal satellietcellen per type II spiervezel. Er worden geen 
veranderingen aangetoond in de spiervezeloppervlakte per kern. Ook worden 
er geen veranderingen aangetoond in de spiervezelgrootte en/of het aantal 
satellietcellen per type I spiervezel. Deze bevindingen geven aan dat 
skeletspierweefsel in oudere mensen nog steeds in staat is om activatie, 
proliferatie en differentiatie van satellietcellen te induceren en nieuwe 
kernen te laten fuseren met bestaande spiervezels, wat uiteindelijk bijdraagt 
aan hypertrofie (toename in grootte) van de type II spiervezels. 
Eerder onderzoek heeft gesuggereerd dat de inname van eiwitsupplementen 
de effecten van inspanningsinterventie bij oudere mensen verder zou kunnen 
verhogen. In hoofdstuk 6 onderzoeken we daarom de additionele effecten 
van eiwitsuppletie in combinatie met langdurige krachttraining. De toename 
in spiermassa en spierkracht na een krachttrainingsprogramma bij gezonde 
oudere mannen blijkt onafhankelijk te zijn van het al dan niet innemen van 
een eiwitsupplement direct voor en na iedere trainingssessie. Ook voor 
hypertrofie van de type I (~10%) en type II spiervezels (~28%) worden geen 
verschillen aangetoond tussen de eiwit- en placebogroep. De gemiddelde 
dagelijkse eiwitinname in deze gezonde oudere mannen blijkt met een 
inname van 1,1 g eiwit per kg lichaamsgewicht per dag ruim boven de 
geldende richtlijn te liggen. Deze studie toont aan dat eiwitsuppletie voor en 
onmiddellijk na elke training geen additioneel effect heeft op de toename in 
spiermassa en spierkracht gedurende een krachttrainingsprogramma in 
gezonde oudere mannen met voldoende eiwitinname. 
In het laatste hoofdstuk worden de onderzoeksresultaten uit dit proefschrift 
nader bediscussieerd en worden specifieke doelen voor toekomstig 
onderzoek gedefinieerd. Dit proefschrift toont aan dat veroudering gepaard 
gaat met een specifieke afname van het aantal satellietcellen in de type II 
spiervezels. Krachttraining kan het verlies van spiermassa en spierkracht 
(deels) tegengaan. Dit laatste gaat gepaard met een toename van type II 
spiervezelgrootte en het aantal satellietcellen. Op basis van onze 
bevindingen suggereren wij dat satellietcellen een primaire rol spelen bij het 
verlies van spiermassa tijdens veroudering en bij de adaptieve respons van 
de skeletspieren op krachttraining in ouderen. 
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Dankwoord 
Ik heb lang zitten twijfelen over wat te doen met dit dankwoord. Wordt het 
een lijst met namen, met als onvermijdelijk gevolg dat ik mensen ga 
vergeten? Wordt het een lijst met clichés, wat de originaliteit van het 
proefschrift wellicht geen goed zou doen? Of wordt het een kort en bondige 
opsomming van rake one-liners (helaas, was een collega mij net even voor)? 
Mijn sterke neiging tot wollige schrijfstijl uiteindelijk volledig negerend 
(…☺), heb ik besloten om het nog simpeler te houden, en me hier tot één 
pagina met een algemeen “bedankt” te beperken. 
De meeste dingen die je in je leven doet, kun je niet alleen. En als je het al 
alleen zou kunnen, dan is er niet veel aan als je het niet met anderen kunt 
delen of beleven. Dankbaarheid is voor mij dan ook de waardering die je 
voelt voor iets wat je overkomt, voor iets wat je met hulp van anderen 
bereikt, of simpelweg voor iets wat anderen voor je doen. Zonder al te 
lyrisch te worden, kan ik in alle eerlijkheid zeggen dat ik bijzonder gelukkig 
ben met de dingen die ik dagelijks doe, de dingen die ik bereikt heb en de 
mensen die me daarbij geholpen hebben. En dat geldt uiteraard specifiek 
voor de periode die uiteindelijk heeft geleid tot de totstandkoming van dit 
boekje. Mijn dank gaat dan ook simpelweg uit naar iedereen die iets - groot 
of klein - voor mij betekend heeft, nog steeds betekent, en hopelijk ook blijft 
betekenen; van thuisfront tot werkplek, en van familie tot vrienden en 
collega’s (gelukkig sluit het een het ander niet uit). Degenen die mij goed 
kennen, weten waarschijnlijk dat ik mijn dankbaarheid niet te pas en te 
onpas hardop uit. Maar hopelijk weten zij wel dat ik veel waardering heb 
voor: de diepe of juist lekker oppervlakkige alledaagse gesprekken; de 
momenten waarop blijkt dat je (bijna tot op het enge af) wel heel erg op 
dezelfde golflengte met elkaar zit; het “Brabantse thuisgevoel”; een 
uitgebreid diner in een van die fijne restaurants die Maastricht rijk is, of 
gewoon lekker thuis; een simpele eierkoek bij de (senseo) koffie; een biertje 
in de kroeg of juist het borreltje op de bank; de groene matten op vrijdag (en 
de rest van de week), het “Brabantse werkgevoel”, enzovoorts. 
Ik hoop dan ook dat dit soort aangelegenheden zich in de toekomst 
veelvuldig mogen blijven voordoen. En hopelijk met dezelfde mensen die 
mij de afgelopen jaren hebben geholpen, bijgestaan, en begeleid; kortom, 
met wie ik alles heb mogen delen en beleven, en die mijn tijd in Maastricht 
tot nu toe tot een heel fijne tijd hebben gemaakt. 
Dank jullie wel!! 
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Netherlands. He attended secondary school at the Elzendaalcollege in 
Boxmeer and graduated from the VWO in 1997. He then studied Physical 
Therapy at the Hogeschool van Arnhem and Nijmegen and received his 
diploma as a physical therapist in 2001. In the same year, he started a 2 year 
master’s program at the Faculty of Health Sciences at Maastricht University. 
He obtained his Master’s degree in Human Movement Sciences in 2003, 
after working as an intern on the age-related changes in the human walking 
pattern, and on the self-stabilizing function of intrinsic muscle properties. 
For his Master thesis, he received the SWUM award (2003). 
After working as a research assistant at Human Movement Sciences 
(Maastricht University), Lex started his PhD project entitled “structural and 
metabolic basis of sarcopenia” at the same department in July 2004. During 
the first years as a PhD student, he received a Young Investigators Award 
from the European College of Sport Science (2006), for his presentation on 
age-related fiber type-specific differences in satellite cell content. 
Currently, Lex Verdijk works as a Post Doctoral fellow at the Human 
Movement Sciences Department of the Maastricht University Medical 
Centre+, on the TIFN project entitled “dietary strategies to augment muscle 
mass and function in the elderly”. He continues his work in the field of 
sarcopenia, with special focus on the role of satellite cells in the atrophy and 
hypertrophy of senescent skeletal muscle, and the benefits of exercise and 
nutritional interventions to improve muscle mass and strength in the elderly. 
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